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ABSTRACT
Cyclization Cascades Leading to the Tricyclic Fragment of Armatol A
The synthesis of the fused 6,7,7-tricycle of armatol A was investigated. Fragments containing
both a ketone and an aldehyde for subsequent fragment coupling were generated via a triepoxide
cascade. Elimination of the secondary alcohol in the oxepane ring proved challenging; however,
employing the Shapiro reaction successfully provided the desired oxepene. Ketone and aldehyde
tricycles were synthesized in 11 and 7 steps, respectively, and both enantiomers of aldehyde
fragment were synthesized. These short routes enable the preparation of sufficient quantities of
these tricycles for fragment coupling studies.
Fragment Coupling, Synthesis, and Determination of the Absolute Configuration of
Armatol A
A stereoselective synthesis of a bromooxepane ring via a bromonium-initiated epoxide-opening
cyclization was explored. Functionalization of the primary alcohol formed from this cascade
allowed for a variety of coupling strategies to be explored to form the carbon framework of
armatol A. Difficulties reducing a cis alkene adjacent to a tertiary alcohol forced a strategic
revision; an analogous trans alkene was easily reduced to form the acyclic alkyl chain connecting
the ring-containing fragments of armatol A.
Stereoselective installation of the tertiary alcohol allowed for a detailed investigation of the
absolute structure of armatol A. At the outset, four diastereomers were consistent with the
published data for the natural product. After determining that this tertiary alcohol must be syn to
the adjacent THP ring stereocenter, the syntheses of the two remaining possible diastereomers of
armatol A were completed. Of the four diastereomers shown in the figure, diastereomer B was
confirmed by synthesis to be the correct structure of armatol A. Using this information,
structural revisions of the entire family of armatols were proposed, as was a new biogenesis of
these natural products.
Four possible diastereomers of armatol A based on reported data
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Chapter 1
Cyclization Cascades Leading to the Tricyclic Fragment of Armatol A
Background
Marine natural products are a diverse set of complex molecules. The ocean provides vast
biodiversity with an array of organisms forming structurally distinct and biologically active
natural products. Harmful algal blooms, also known as red tide events, occur throughout the
world in both temperate and tropical climates and are characterized by their intense colors
resulting from a rapid growth of these microbes.' Many of the complex molecules produced by
those microbes are known for their potent toxicity toward other organisms. Ingestion of large
quantities of the harmful algae by shellfish and fish results in an accumulation of the toxic
chemicals in higher organisms and can cause severe poisoning upon human consumption. Four
distinct classes of shellfish poisonings result from the consumption of structurally unique marine
toxins: paralytic shellfish poisoning (PSP) is caused by saxitoxin (1, Figure 1-1), diarrheal
shellfish poisoning (DSP) results from high molecular weight polyethers including okadaic acid
(2) and yessotoxin, neurotoxic shellfish poisoning (NSP) is associated with the brevetoxins
including brevetoxin B (3), and amnesic shellfish poisoning (ASP) comes from the unusual
amino acid, domoic acid (4).
Figure 1-1. Marine toxins responsible for shellfish poisoning
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The biological activity of some of these marine polyethers derives from their effects on
sodium and potassium ion channels. 2 Although hundreds of polyethers exist, the unique
scaffolds can be divided into three categories: polyether ionophores, ladder polyethers,4 and
squalene-derived polyethers.5 The Jamison group has focused on the synthesis of ladder
polyethers (e.g., 3 and 6, Figure 1-2) and squalene-derived polyethers (e.g., 5 and 7) to examine
the scope and utility of epoxide-opening cascades that have been developed in our laboratory.
Figure 1-2. Representative ladder and squalene-derived polyethers
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One of the unique structural features of marine polyethers is the relative configurations at
the ring junctions, appearing as trans-syn-trans in almost all cases in the ladder polyethers and as
a mixture of other configurations, with trans-anti-trans, for example, found in the squalene-
derived polyethers. These scaffolds present an interesting structural challenge for chemical
synthesis. The earliest report in the general scientific literature for a biosynthetic model that
accounts for the trans-syn-trans configurations found in the ladder polyethers was by Nakanishi
in 1985.6 However, Nakanishi in turn acknowledges Robert Thomas as the inspiration for his
model.7 Furthermore, around the same time, Shimizu3 and Nicolaou9 conceived of similar
biosyntheses. All of these authors hypothesized that the distinctive trans-syn -trans
stereochemistry could be derived from a series of endo-selective epoxide-opening cyclizations
(Scheme 1-1).
Scheme 1-1. Nakanishi's biosynthetic proposal for ladder polyethers
brevetoxin B (3)
Research in the Jamison group has focused on methods for epoxide-opening cascade
reactions to form ladder polyether structures similar to those found in marine environments.10
The intrinsic bias of epoxide-opening of the simple epoxy alcohol 10, as demonstrated by Coxon
(Scheme 1-2),"1 tends towards nucleophilic substitution at the proximal site of the epoxide by the
alcohol, resulting in exo-opening to favor formation of the THF 12. While the terms exo and
endo originate from Baldwin's rules' 2 for cyclizations, they do not apply directly to epoxide
opening since the bond breaking occurs outside the ring in both cases. Baldwin does discuss
opening three-membered rings in a general context based on epoxynitrile cyclizations and
concludes that the geometry of three-membered rings seems to lie between tetrahedral and
trigonal and that their cyclizations generally prefer the exo mode.13 These terms, nevertheless,
are commonly used, convenient, and well known identifiers of the two cyclization products, the
larger (endo, e.g., 11) and smaller (exo, e.g., 12) rings.
Scheme 1-2
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Many groups have investigated approaches towards overcoming this selectivity trend by
using directing groups to promote endo-selective ring opening; examples are shown in Scheme
1-3.'4 These directing groups modulate the reactivity of an epoxide by either activation of the
distal site of an epoxide or deactivating the proximal site. Mori relies on an electron-
withdrawing sulfone to deactivate addition to the proximal site and favor tetrahydropyran (THP)
formation, 5 while Murai proposes that chelation of a Lewis acid by the epoxide and a
methoxymethyl group favors the desired product.16 McDonald has employed Lewis acids to
promote opening of trisubstituted epoxides in cascades that provide a trans-fused bisoxepane
motif. In this approach the methyl groups attached to the epoxide serve as the directing groups.17
Jamison and co-workers used a silyl group to stabilize positive charge on the distal side of the
epoxide leading to 6-endo epoxide-opening. 10d They extended this methodology to a cascade
with the silyl group acting as a disappearing directing group due to protiodesilylation during the
reaction. Morimoto has used the steric bulk of triisopropylsilyl triflate to activate a trisubstituted
epoxide towards endo attack by a tertiary alcohol nucleophile in his synthesis of aurilol.18
Scheme 1-3. Use of directing groups to
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Terpenoid polyethers, also known as oxasqualenoids (e.g., 5 and 7, Figure 1-2) are
derived from squalene and contain methyl groups at each ring junction. The isolation of a
monoepoxide, (1OR,1 1R)-squalene 10,11-epoxide (25), from the Laurencia family of marine
algae led to a series of proposals for the biosynthesis of a large class of natural products. 5"19 For
example, Suzuki proposed (6S,7S,1OR,11R,14R,15R,18S,19S)-squalene tetraepoxide as a
common intermediate towards enshuol (29) in which methyl groups direct the regioselectivity of
epoxide cyclizations.20 Morimoto's total synthesis of this molecule led to the structural
reassignment of (+)-enshuol (29). 18,21 The revised structure of enshuol suggests that tetraepoxide
26 might be a biosynthetic intermediate for enshuol (29), instead of
(6S,7S, 1 OR, 11 R, 14R, 1 5R, 1 8S, I 9S)-squalene tetraepoxide that had previously been invoked as a
common intermediate in Laurencia triterpenoids (Scheme 1-4). A different tetraepoxide (30)
may also be invoked to account for a biosynthetic pathway to aurilol (32).
Scheme 1-4. Proposed biosynthetic hypothesis for enshuol and aurilol (Suzuki, 1995)
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As the methyl groups present in squalene were used by Morimoto to direct single
epoxide-opening events in a stepwise fashion, it appeared feasible to install many of the
stereogenic centers in these natural products through a series of epoxidations followed by a
methyl group-directed epoxide-opening cyclization. 22
Armatol family of natural products
As an avenue to explore the use of methyl groups to control the regioselectivity of
epoxide-opening events, the armatol family (Figure 1-3) presented itself as intriguing targets.2 3
All six of the armatol natural products were isolated in 2000 from Chrondria armata by Ciavatta
and coworkers. Since that time, no total syntheses have been disclosed, with the only reports
published being by the Fujiwara group on their progress towards the ABC rings of armatol F
(37).24 Of particular interest to the Jamison group was that armatol A is the only natural product
in this family that, to our knowledge, contains a 6,7,7-fused system in which one of the 7-
membered rings is an oxepene. The other armatol natural products contain a bromine atom at
C22, suggesting that armatol A might be an elimination product of armatols B or D, and
furthermore, that bromination of armatol A could provide access to two other members of the
armatol family.
Figure 1-3. Armatol family of marine polyethers isolated by Ciavatta
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Despite extensive spectroscopic analysis, the absolute structure of any of the members of
the armatol family has yet to be fully elucidated. While NOESY and HMBC techniques allowed
assignment of the relative configuration of the tricycle, the stereochemnical relationship between
this tricycle and the tertiary alcohol at C10 allows for four possible diastereomers of the natural
product (38-41, Figure 1-4). Although the relative and absolute configuration of the natural
product is not known, the absolute configuration of the bromooxepane has been confirmed by
Mosher ester analysis of the resultant C7 secondary alcohol formed after treatment with zinc and
ammonium chloride.2 5 Based on the structural similarities within the family, it stands to reason
that once the absolute structure of one member of the family has been resolved, the absolute
structures of the remaining five armatol products could be proposed with some confidence.
Figure 1-4. Four possible diastereomers for armatol A
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Retrosynthetic analysis of armatol A
Ciavatta and co-workers put forth a biosynthetic hypothesis that all of the armatol natural
products could arise from the common precursor to the Laurencia family
(6S,7S, 1 OR, 11 R, 14R, 1 5R, 1 8S, 1 9S)-squalene tetraepoxide. However, they note that due to the
stereochemical inconsistencies at C6, C18, and C22, the biosynthesis of the armatol natural
products may proceed in a stepwise manner. Without a confirmed biosynthetic proposal and in
order to determine the absolute and relative configuration of armatol A, we devised a convergent
synthesis, as shown in Scheme 1-5. This chapter will focus on the challenges in forming the
fused tricycle of armatol A (43), while Chapter 2 will discuss the bromooxepane (42) synthesis
and the coupling strategies explored to prepare the four possible diastereomers of armatol A.
Our detailed analysis and assignment of the absolute configuration of the natural product will
also be presented.
Scheme 1-5. Retrosynthetic analysis of diastereomer D of armatol A
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We envisioned two possible synthetic precursors that would lead to the relative
stereochemistry found in the fused tricycle of armatol A (Scheme 1-6). A base-induced pathway
could be used with a tertiary allylic alcohol as the initiating nucleophile leading to a 7-endo
cyclization onto a trisubstituted epoxide. This strategy would allow the exploration of the use of
steric interactions to control regioselectivity in Bronsted base-induced epoxide-openings.14, 26 The
sterically demanding resulting tertiary alcohol (45) could favor the same endo selectivity in
opening of the second epoxide, i.e., at the less substituted carbon of the epoxide, to provide the C
and D rings of armatol A (46). The third tertiary alcohol, again guided by steric interactions,
could react in a 6-exo manner to form the THP ring and the tertiary alcohol at C10. This
proposed synthetic route would lead to the same stereochemical configuration as diastereomer D
(41) and was the first stereoisomer we investigated. While the use of THP rings as templates for
endo-selective opening of epoxides has been extensively explored by our group,' 0 the use of
oxepanes or oxepenes as templates for forming additional oxepane rings has not.2 7
Scheme 1-6. Possible mechanisms to form the 6,7,7-tricycle of armatol A
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A Lewis-acid initiated cascade' 7 could also be employed on tetraepoxide 47 with the
methyl groups directing epoxide-opening to the more substituted position (Scheme 1-6).
Consecutive endo-opening of the first three epoxides followed by trapping with water could lead
to a secondary alcohol such as 49. Further synthetic manipulations would then form the
oxepene in armatol A.
Synthetic studies towards armatol A
Prior to attempting the proposed base-initiated cascade, a synthesis of the triepoxide 44
was needed. The cis alkene of triepoxide 44 could be formed by partial hydrogenation of alkyne
50, which itself could be derived from fragments 51 and 52 (Scheme 1-7).28 A cross-metathesis
between vinyl epoxide 53 and geraniol-derived fragment 54 would provide triepoxide 51.29
Scheme 1-7. Retrosynthetic analysis of the tricycle fragment
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Based on the assumption that the final ring may be formed by an exo-cyclization, we
designed a simpler model system (55) to investigate the regioselectivity of the first two epoxide-
opening steps (Scheme 1-8). A copper-mediated coupling of allylic bromide 57 and alkyne 52,
followed by epoxide installation would lead to diepoxide 56. Fragment 57 could be assembled
from geraniol (59) via allylic alcohol 58.
Scheme 1-8. Diepoxide model system 55
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The preparation of 55 began with protection of the hydroxyl group of geraniol followed
by a chemoselective SeO 2-catalyzed oxidation to afford allylic alcohol 58 (Scheme 1-9).
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Conversion of alcohol 58 to the allylic bromide with phosphorous tribromide, followed by a
copper-mediated coupling with alkyne 52, provided the skipped diene-yne 61 in 60% yield as a
mixture of the SN2 and the SN2 ' displacement products. 32 Shi epoxidation3 3 of the diene provided
diepoxide 56, which was then reduced with hydrogen in the presence of Lindlar's catalyst3 4 to
provide model system 55.
Scheme 1-9. Synthesis of model system 55
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1) PBr3, Et20 Shi ketone 62 (200 mol%), Na2B407-10 H20,2) Cul, DBU, BHT, DMF BnO OH Bu4NHSO 4, Oxone/EDTA
Me Me Me Me(_OH 61 Me 0.89 M K2CO 3, DMM/CH 3CN (2:1)
Me 60% yield, 2 steps 83% yield, 4:1 dr
52 6.8:1 SN2:SN2'
Me 0te MekMePd on CaCO 3 with Pb MOM
BnO quinoline, H2  BnO O O
Me Me Me EtOH Me Me 0 0
56 Me 46% yield 55 Me O 62Me
Table 1-1 depicts a summary of the conditions attempted to achieve the endo-selective
opening of both epoxide rings. Unfortunately, in all cases where reactivity was observed, a'
mixture of the 6,5-exo,exo product (63) and the 6,6-exo,endo product (64) was obtained, with the
first ring consistently opening with undesired exo-selectivity. The modest endo-selectivity
(-2:1) observed in the second ring, slightly favoring the THP ring over the THF, may support the
proposed steric basis of regioselectivity in base-mediated cyclizations. In many cases, complex
tDiastereomeric ratio for all Shi epoxidations were determined by 'H-NMR analysis. The given ratio is the amount
of the major diastereomer relative to the sum of all other diastereomers that were detected in the reaction. The
yields for all Shi epoxidations represent the sum of all epoxide diastereomers.
product mixtures were generated that were difficult to analyze by proton NMR. In light of this
challenge, the analysis of a simpler monoepoxide model system was undertaken.
Table 1-1. Cyclization Screen of 55
63
6,5-exoexo product
Base
1 Cs2CO3
2 Li2CO3
3 K2C03
4 Rb2CO3
5 Cs2CO3
6 Cs2CO3
7 K3PO4
8 NaOH
9 t-BuOK
10 DBU
11 KCH2SOCH 3
12 NaCH2SOCH3
13 LiCH 2SOCH 3
14 BF3-OEt 2
15 BF3-OEt2
Equiv Solvent Temperature
5 H20 (0.1 M) 55 *C
5 H20 (0.1 M) 55 *C
5 MeOH (0.1 M) 60 *C
5 MeOH (0.1 M) 60 *C
30 MeOH (0.06 M) 60 *C
5 MeCN (0.1 M) 60 *C
5 MeOH (0.1 M) 60 *C
138 MeOH (0.1 M) 60 *C
7 THF (0.1 M) rt
5 THF (0.1 M) rt to reflux
5 THF (0.1 M) rt
5 THF (0.1 M) rt
5 THF (0.1 M) rt
HO Me
0~+ BnO MeO Mee+N H H
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6,6-exo,endo product
Time
16 h
14 d
16 h
16 h
16 h
16 h
16 h
3 d
16 h
16 h
16 h
16 h
16 h
1 CH2Cl2 (0.03 M) 0 *C 30 min
1 CH2Cl2 (0.03 M) -78 *C 30 min
Conversion
<5%
<5%
100%
100%
100%
100%
100%
100%
100%
0%
100%
100%
0%
63:64
n.d.
n.d.
n.d.
1:3.1
1:2.1
n.d.
1:1.8
1:2.8
n.d.
n.d.
n.d.
n.d.
n.d.
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7,7-endo,endo product
Not observed
Comments
Decomposition
Decomposition
Decomposition
100% n.d.
n.d. n.d. Some SM remained (55)
A phenyl group was incorporated in monoepoxide 69 was chosen to provide an UV-
active chromophore and to minimize the volatility of synthetic intermediates. The desired allylic
alcohol 69 was synthesized starting with a Wittig homologation of hydrocinnamaldehyde (66)
and phosphorane 67, followed by reduction using lithium aluminum hydride to provide allylic
alcohol 65 in good yield (Scheme 1-10). Treatment of this alcohol with phosphorous tribromide
led to the corresponding allylic bromide, which was then coupled with 2-methyl-3-butyn-2-ol
Entry
(52) in the presence of copper iodide to provide the propargylic alcohol. Shi epoxidation
followed by Lindlar reduction provided the desired cis-alkene 69.
Scheme 1-10. Synthesis of monoepoxide model system 69
H 1) PBr3, Et2O, 0 *C, 87% yield
Ph O 2) Cul, DBU, 52, BHT HO MeMe66 1) CH2CI2, reflux DMF, rt, 47% yield, 2.2:1 SN2:SN2'
+Ph OH Ph
Ph2)LiAH 4 Et 0 C Me 3) Shi epoxidation 62 (100 mol%) P3P CO2Et 75%il, two s Me 88% yield Me
yield, two steps 68 4) Pd on CaCO 3 with Pb, quinoline, H2 (1 atm) 69
EtOH, 47% yield
67
Table 1-2 summarizes the conditions used in an attempt to select for endo-opening of the
epoxide. Both basic conditions, which did not prove fruitful, and Lewis acids were screened. A
possible mechanism for a Lewis acid-mediated pathway is shown in Scheme 1-11 and involves
ionization of the tertiary allylic alcohol with subsequent epoxide attack on the allylic cation to
form intermediate epoxonium ion 72. The epoxonium ring could then undergo ring-opening
with water upon quenching.
Scheme 1-11. Possible mechanism for oxepene formation via an allylic carbocation
( OH 2G [@Ph H Me
PO Conditions 0 Me
Me Me
70 endo
\ - 73-
mel
Ph Me
Me _
71 OH 2
Table 1-2. Cyclization screens on monoepoxide 69
OH H Me 0 1
Ph Me Conditions Ph 
Me + unknown products
Me Me
Endo Exo
(not observed)
69 74 75
Entry Conditions Temperature Time Ratio of 75 :69a Byproducts?
1 Cs2CO3, MeOH 60 *C 16 h >20:1 N
2 Cs2CO3, H20 rt 16 h <1:10 N
3 H20 rt 9 d <1:10 N
4 CH2Cl2  rt 9 d >20:1 N
5 BF3-OEt2, CH2CI2  -78 *C 15 min >20:1 N
6 BF3-OEt2, CH 2Cl2  -40 *C 15 min >20:1 N
7 BF3-OEt2, CH2Cl2  0 *C 15 min - Y
8 BF3-OEt2, CH2CI2  rt 15 min - Y
9 Yb(OTf)3, CH2Cl2  rt 15 min >20:1 N
10 Gd(OTf) 3, CH2Cl2  rt 15 min >20:1 N
11 PBr 3, Et20 0 *C 30 min Y
12 MgBr 2-OEt2  0 *C 30 min 1.5:1 Y
13 TiCI4, CH2Cl2  rt 16 h - Y
14 SnCl4, CH2Cl2  rt 16 h - Y
15 SbCI5, CH2Cl2  rt 16 h - Y
16 Ti(Oi-Pr)4, CH2Cl2  rt 16 h 1.5:1 N
a) Conversion determined by 1H NMR analysis
Concurrent with the investigations into acid- and base-mediated cyclization reactions of
69 other members of the Jamison discovered that aqueous conditions gave high selectivity for
endo-selective epoxide openings to form THP rings when using an alcohol nucleophile on a THP
template (Scheme 1-12).10a In light of this discovery, epoxy alcohol 69 was subjected to a range
of phosphate buffers where the pH varied from 2-12. Unfortunately, the desired phenomenon
was not observed in this case; none of the oxepane product was observed. As expected, a faster
cyclization was observed at lower pH, with the exo product formed exclusively.
Scheme 1-12. Template effect directing endo-opening of an epoxide in an aqueous environment
(Vilotijevic, Jamison, 2007)
H H H HHO H20 Me HO H M
rt H Me 0
H >10:1 77:78 H H H
76 77 78
Lewis acid-mediated approach towards armatol A
Due to the failure of a Bronsted base-mediated cascade, an alternative strategy was
formulated based on the Lewis acid-mediated pathway' 7 proposed in Scheme 1-6. Earlier
experiments by Dr. Sze-Sze Ng with a monoepoxide and an allylic secondary alcohol
nucleophile showed that the yield for the THP ring formation was dependent on the relative
configuration of the epoxide and the alcohol nucleophile. 35 In light of this trend, we reasoned
that a stereodefined, intramolecular alcohol nucleophile might serve as a trapping nucleophile in
an epoxide-opening cascade. Structural analysis of a monoepoxide related to our system is
shown in Scheme 1-13. A matched case involving an (R)-secondary alcohol nucleophile with an
(S,S)-epoxide may be predicted to favor a transition state geometry in which the tertiary alcohol
side chain lies in a pseudo-equatorial position. This configuration should favor THP formation.
In the mismatched case, the tertiary alcohol side chain is expected to reside in a pseudo-axial
orientation, generating 1,3-diaxial interactions with the incoming epoxide in the proposed
transition state that would lead to the THP product. This mismatched case, therefore, would be
expected to lead to the THF product 83 with high regioselectivity.
Scheme 1-13. Comparison of relative configuration of two epoxy alcohols
Matched case, (R)-diastereomer with (S,S)-epoxide Mis-matched case, (S)-diastereomer with (S,S)-epoxide
HO Me 0HO Me H Me HO Me '0R HMeH0MeR
R R' ---- R R, R R'-
6HH
OH 79 Me OH OH 81 Me 82
80 Me Me
H H Me R
Me OH R
Me Me 83
R' H 
'OR oR' H
A possible model system (84) also contains a primary alcohol that may be used as a
functional group handle for further elaboration after the cyclization (Scheme 1-14). An
acetonide protecting group was selected to prevent these two hydroxyl groups from participating
in the cyclization. In order to probe the stereochemistry of the natural product, the tertiary
alcohol would have to be installed in a stereoselective manner. Alkene 86 was thus targeted, as
it could be obtained from allylic alcohol 87 derived from known aldehyde 88.36 Developing a
short synthetic route to this proposed epoxide would allow investigation of the feasibility of this
cyclization strategy and, if successful, to extend it to a triepoxide system.
Scheme 1-14. Model THP ring retrosynthetic analysis
HO Me OH Me OH Me
HO OH O Me Me e MeMe Me 0e
*~'H Me Me
84 Me 85 Me 86
ll Me
H Me 
O eMe HO MeMe
88 87
The synthesis of epoxy alcohol 85 commenced with a Claisen rearrangement between
ethyl vinyl ether (89) and 2-methyl-3-buten-2-ol (90), to provide the aldehyde 88 in 89% yield
(Scheme 1-15).36 A Horner-Wadsworth-Emmons reaction with (carbethoxyethylidene)-
triphenylphosphorane (67) cleanly provided the E-olefin. Reduction to the allylic alcohol set the
stage for a Sharpless asymmetric epoxidation.37 Directed addition of benzoic acid, using a
titanium-assisted epoxide opening,38 provided diol 93, which was then protected as an acetonide.
Deprotection of the benzoate ester proceeded in modest yield to furnish 86. Shi asymmetric
epoxidation provided model system 85 in 85% yield with no cyclization detected under the basic
conditions of the Shi epoxidation.39
Scheme 1-15. Synthesis of epoxy alcohol 85
0
Me Me Hg(OAc)2  H Me Ph3P.YlkOEt 0 Me LiAIH4MeM+g(A) Me 67
130 *C, 5 h PhH,rtto80 C,.4hh Me Et20
89 90 89% yield 88 83% yield 91 0 to 40 *C
94% yield
Ti(Oi-Pr)4  BzOH - 2,2-dimethoxypropaneMe D-(-)-DET * ,Me Ti(Oi-Pr)4  OO z Me (±)-CSA
HO - ~ Me 10HO ^'Me HO Mes:" 
Me 87TBHP Me 92CHC1 3  Hd Me 937%yedjw tp87 CH2CI2, -23 *C 92 _ 73% yield, two steps
90% yield, 92% ee
Shi ketone 62 (100 mol%),
OH Me Na2B407-10 H20, OH MeOBz Me NaOH n-Bu4NHSO4, Oxone/EDTA
M O Me O Me
Me MeOH 6 Me K2CO 3, DMM/CH 3CN (2:1) 6 Me 0
Me 6 94 50% yield Me Me 86 85% yield, 4:1 dr Me Me 85Me
With the model monoepoxide 85 in hand, a variety of cyclization conditions were
examined (Table 1-3). As expected, basic conditions favored the exo product, while acidic
conditions led predominately to the endo cyclization product. A pH screen in aqueous 0.1 M
phosphate buffers also displayed this trend, with increasing THF formation at higher pH. Upon
treatment with BF 3*OEt2, the major epoxide diastereomer produced the endo product 95 and
acetonide-cleaved product 96 almost exclusively, while the minor diastereomers led to exo
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product 97. This trend is in good agreement with the observations of Dr. Sze-Sze Ng (vide
supra), discussed earlier in which the 1,3-diaxial interactions in the mismatched diastereomer
disfavored endo opening, even under treatment with a Lewis acid.35 The combined yield of endo
cyclization products (95 and 96), with respect to the major diastereomer, was 88%.
Table 1-3. Cyclization of 85 to furnish the desired THP ring 95
OH Me Me Me Me
OMe Conditions MMO Me Me + HO HO Me Me + Me 0 Me H
Me Me Me Me 
OH
MeMe ~""OH"OH Me
85, dr 4:1 95 96 97
Entry Condition Time Temperature 9 5:97a (yield)
1 Cs2CO3, MeOH 12 h rt O:1b (95 %)
2 pH 4.0, 0.1 M phosphate buffer 3 d rt 1.1:1
3 pH 6.0, 0.1 M phosphate buffer 3 d rt 1:1.4
4 pH 7.0, 0.1 M phosphate buffer 3 d rt 1:2.8
5 pH 8.0, 0.1 M phosphate buffer 3 d rt 1:3.5
6 pH 10.0, 0.1 M phosphate buffer 3 d rt 1:4.1
7 BF3-OEt2, CH2Cl2  15 min -78 *C 4 .7c:ld (85%)
a) Ratio determined by 1H NMR analysis b) 97 was isolated as 4:1 mixture of
diastereomers c) The major product was a triol resulting from acetonide cleavage
in a 6:1 ratio of 96:95. d) 97 was isolated as a 10:1 ratio of diastereomers favoring
reaction from the minor diastereomer
In order to test the epoxide-opening cascade on triepoxide 98 (Scheme 1-16), we would
be able to use the same series of synthetic operations used in the synthesis from 88 to 85
(Scheme 1-15), provided we could prepare aldehyde 99. Aldehyde 99 was synthesized from
trans,trans-farnesol (100).40 Although the aldehyde could in principle be formed in two steps
using a metalloenamine derived from 102, purification of the aldehyde proved difficult. Instead,
the copper enolate of ethyl acetate was combined with allylic bromide 101 via an SN2 -type
reaction. This operation provided a chromatographically stable intermediate that could be
purified prior to reduction with LiAlH 4. Subsequent oxidation under Parikh-Doering conditions
31
gave aldehyde 99 in 59% yield. Alternatively, reduction with DIBAL-H also provided aldehyde
99 in 69% yield in three steps from farnesol.
Scheme 1-16. Synthesis of aldehyde 99
OH Me Me Me0,,, 0, 0
O Me
Me Me-) 98Me
Me Me Me PBr3
HO Me Hexane, -10 *C
trans, trans-farnesol (100)
N'tBu
Me Me I 102
MeA TH 0
LIDA, THF, 0*C
48% yield over 2 steps
1) EtOAc, Cui, LDA, -110 *C
2) LiAlH4, Et2O, 0 -C
1) EtOAc, Cui, LDA, -110 *C
H Me Me Me
Me
99
Me Me Me
Br Me
101
H Me Me Me
0 Me
99
Me Me Me
HO
103
S03-py, DMSO, Et3N, CH2CI2
59% over 4 steps
H Me Me Me
2) DIBAL-H, CH2CI2, -83 *C 0 Me
69% over 3 steps 99
Scheme 1-17 shows a similar seven-step synthesis to that shown in Scheme 1-15 for the
monoepoxide 85, and the Shi epoxidation was the only reaction that required optimization in this
series. Increasing the amount of Oxone to 300 mol% led to 96% yield of the desired triepoxide
98 with an overall diastereomeric ratio of 3.5:1. With the goal of preparing the tricyclic
fragment in sight, triepoxide 98 was treated with BF 3-OEt2 in dichloromethane. The desired
tricycle was more easily purified as an acetate ester 110 and isolated in 10% yield. One of the
reasons for the low yield could be due to the loss of the acetonide. Despite the low yield of
tricycle 110, this experiment demonstrated that the Lewis-acid mediated endo-selective
ME
Br Me
101
101
cyclization of a triepoxide was possible, and we therefore explored more robust protecting
groups that could survive the cascade conditions. In addition, we desired a route that involved
the late stage installation of the tertiary alcohol, as this stereogenic center would require varying
in order to synthesize the four possible diastereomers of armatol A.
Scheme 1-17. Formation and cyclization of triepoxide 98
H Me Me Me
O~ "Me
99
0
Ph3PY kOEt 67 Me Me Me
Me II-
EtO Me Mel
benzene, rt to 80 *C, 4 h'
74% yield Me 104
Ti(Oi-Pr)4
Me Me Me D-(-)-DET Me Me Me
HO Me TBHP HO Me
Me 105 CH2CI2, -23 *C Me 10663% yield, 80% ee
OBz Me Me Me 2,2-dimethoxypropane OBz Me Me Me(±)-CSA
HO Me O Me
107 79% yield Me Me 108Me
LiAIH4
Et 20
0 to 40 *C
68% yield
BzOH
Ti(Oi-Pr)4
CHC13
61% yield
NaOH
MeOH
69% yield
OH Me Me Me
Me Me
O Me 109
Me Me
Shi ketone 62 (300 mol%),
Na2B40 7-10 H20,
n-Bu 4NHSO4, Oxone/EDTA
K2CO 3, DMM/CH 3CN (2:1)
96% yield, 3.5:1 dr
OH Me Me Me
0 Me Me
6e Me698
Me Me
OH Me Me Me 1) BF3-OEt2,0 0 0 -78 *C, CH2CI2, 1 h
Me
Me O Me 2) Ac2O, Et3N,
Me 98 DMAP, CH 2Cl2
10% yield, two steps
Me Me
Me ' eO m
0,Me MeO 0, HO Me
0  Me
Me "OAc
110
Revised synthetic strategy toward the tricyclic fragment
Based on the successful synthesis of 110, we turned our attention to triepoxide 111 which
contains an olefin as a masked carbonyl that could also serve as a functional group handle
(Scheme 1-18). After forming the 6,7,7-tricycle, conversion of the isopropenyl group to the
ketone 111 could provide a suitable electrophile site for fragment coupling. As the previous
cascade precursor 98 did not cyclize before the cascade reaction, a similar secondary alcohol
nucleophile was developed. The acetonide was replaced with an isoprenyl group for late-stage
functionalization. Shi asymmetric epoxidation of 114 could provide triepoxide 113, which could
then cyclize to afford tricycle 112.
Scheme 1-18. Revised retrosynthetic analysis
e e Me H Me0 H 0 HMe M Me Me Me
H0  Me MeMe "'Me "OH
Ill 112
OH Me Me Me OH 0Me 0Me 0Me
Me Me
Me Me
114 113
A direct approach to secondary alcohol 114 would involve an asymmetric addition of
isopropenyl zinc into aldehyde 99. A report from Walsh and co-workers on a related system
demonstrated the viability of this approach using the chiral ligand (-)-3-exo-
morpholinoisoborneol (MIB) (Scheme 1-19).41 Significantly, the use of either (+) or (-)-MIB
could provide either 114 or ent-114 on route to both enantiomers of tricycle 111.
Scheme 1-19. Enantioselective alkenyl zinc addition with in situ epoxidation (Walsh, 2004)
0 Me 1) (-)-MIB (4 mol %) OH Me Me
.nT +2 ZnEt2 HO Me
H R Zn 2 2) 02 (1 atm) O> HON
R=alkyl or aryl 100 mol% 310 mol% 3) Ti(Oi-Pr)4 (20 mol%) Me O H
1580-87% yield, 87-97% ee _JH
(-)-MIB
The in situ epoxidation would also prove useful once the configuration of the tertiary
alcohol is determined; the enantioselective isopropenyl zinc addition would be sufficient to
provide 114. Use of (+)-MIB42 as a catalyst for the enantioselective addition of isopropenyl zinc
(115)43 to aldehyde 99 gave allylic alcohol 114 in 84% yield and 79% ee (Scheme 1-20). Initial
attempts at Shi epoxidation of allylic alcohol 114 gave substantial over-epoxidation, with
tetraepoxide 116 as the major product. Even with fewer than 3 equivalents of Oxone, only 27%
of the desired triepoxide 113 could be isolated. Fortunately, a good yield of the desired product
was obtained by deactivating the allylic alcohol. Conversion of the alcohol to acetate ester 117
prevented epoxidation at this site, giving triepoxide 118 in 74% yield and 3.5:1 drt. Selective
acetate hydrolysis of 118 by LiOH in THF/MeOH/H 20 revealed the allylic alcohol in 69%
isolated yield. Other deprotection conditions led to undesired cyclization of the first ring to a
THF product, which further suggested that basic conditions should be avoided in the cascade
reaction.
Scheme 1-20. Asymmetric synthesis of triepoxide 113
H Me Me Me
0 Me
99
OH Me Me Me
Me
Me 114
Ac 2O
Et3N, DMAP
CH 2CI2
96% yield
Me Zn Me
115
(+)-MIB
ZnEt 2
PhMe, 0 *C
84% yield, 79% ee
Shi ketone 62 (55 mol%),
Na2B407-10 H20,
nBu 4NHSO 4,
2.5 equiv Oxone/EDTA,
0.89 M K2CO 3
DMM/CH 3CN (2:1)
Shi ketone 62 (55 mol%),
Na2B407-10 H20,
nBU4NHSO4,
OH Me Me Me
Me
Me
114
OH Me Me Me
Me
Me 113
27% yield, 3.5:1 dr
OH Me Me Me
O .Me
Me 116
L 42% yield
OAc Me Me Me 3.0 equiv Oxone/EDTA, QAc Me Me Me
Me 0.89 M K2CO3 Me
Me 117 DMM/CH 3CN (2:1) Me 118
74% yield, 3.5:1 dr H2 IHFUOH (12),0C
OH Me Me Me
Me
Me 113
Table 1-4 shows a range of conditions investigated for the cyclization of triepoxide 113
to desired tricycle 112. Treatment of epoxide of 113 with a Lewis acid, such as BF3*OEt2, led to
a modest yield of the tricycle (isolated as acetate ester 119). Using substoichiometric quantities
of BF3*OEt2 or higher temperatures led to decreased yield. The desired tricycle was the major
product of the cascade reaction, with the mass balance accounted for by other cyclization
products from diastereomers obtained in the Shi epoxidation and from exo opening of the desired
diastereomer. 4 4 Use of camphorsulfonic acid as an activator gave none of the desired product.
The use of a bulky silylating reagent, such as TJPSOTf 18 led exclusively to epoxide
decomposition. Ultimately, BF3-OEt2 was determined to be the best activating agent for the
cascade.
Table 1-4. Cyclization screens of triepoxide 113
OH Me Me Me Conditions Me
Me CH2CI2Me
113
Entry Conditions Time
1 BF3-OEt2 (1 equiv) 15 min
2 BF3-OEt2 (1 equiv) 15 min
3 (±)-CSA (1 equiv) 16 h
4 TIPSOTf, 2,6-lutidine 1 h
a) Crude reaction treated with Ac2O, Et3N,
b) Reaction quenched directly with Ac 2O
112
Temperature Yield
-78 *C 23% 119a
-78 *C 1 5 % 1 19 b
0 *C 0%
-78 C 0%
DMAP to provide acetate
Hj Me
O H
Me 0 Me
Me
H 0Me OAc
119
Subsequent studies were directed towards the elimination of the secondary alcohol and
further functionalization of the ispropenyl group, and a variety of approaches were investigated.
Formation of the ketone via ozonolysis of 119 proceeded smoothly to give 120 (Scheme 1-21).
Removal of the acetate protecting group in 120 proved challenging as the reaction proceeded in
just 23% yield (based on recovered starting material). Fortunately, the low yield could be
improved by reversing the order of these synthetic operations. Acetate hydrolysis of 119 gave
free alcohol 112 in 71% yield and subsequent ozonolysis furnished the desired ketone 121 in
77% yield. To accommodate the use of organometallic reagents in addition to the ketone, the
secondary alcohol was protected using TBSOTf and ozonolysis gave 122 in moderate yield.
Ketone 122 provided for the first time a coupling partner in which the key C10 quaternary center
would be installed after the fragment coupling.
Scheme 1-21. Formation of coupling fragment 122
H Me
O~ HMe Me LiOH
Me
H q e -"OAc H20/MeOHITHF (1:2.5:5)
119 71% yield
03, CH2CI2, -78 C; PPh 3
74% yield
O HMe
Me O H Me
0 Me
M~e "QOAc
120
H Me
Me H Me
Me
HMe 
-'OH
112
H Me
00Me '- O Me
Me
HeH iSe 
~OH
112
03, CH2Cl2, -78*C; PPh 3
77% yield
LiOH
H20/MeOH/THF (1:1:2)
0 *C
17% yield (23% BRSM)
1) TBSOTf,
2,6-lutidine, CH2Cl2
2) 03, CH2CI2, -78 *C;
PPh 3
30% yield (two steps)
Alternative coupling partner to probe absolute con figuration of armatol A
Ketone 122 was selected as a coupling partner because chelation-controlled addition of a
suitable nucleophile would likely proceed with high stereoselectivity. In order to prepare the
other configuration at this carbon, we pursued an aldehyde coupling partner. Chelate-controlled
addition to 124 would lead exclusively to the (S)-configuration of the tertiary alcohol 125
(Scheme 1-22). In order to obtain the (R)-configuration with high selectivity secondary alcohol
127 would be prepared from aldehyde 126, and a subsequent oxidation followed by chelation-
controlled addition of methylmagnesium bromide would then form 128.
Scheme 1-22. Chelation control strategies to establish the key C10 stereocenter
0 MeOHMe H H Me Chelate-controlled Me H Me Me
Me R Me H Me addition Me 0OR
Br OH Me Br A BO ~ e
MHMe OR Me 125 H M e '
123 124
Me H 0 H Me O H
Me O~ R H , H 0Me Me HMe
+ 0 A ld e h y d e a d d itio n M e O RBr OH 0 Me ~ 0 MeMe He Br OH M
MeMe 127 M~e ~OR
123 126
Oxidiation followed by chelate-
controlled addition of a methyl group
Me H Me ".OH Me
Me 0~ = H
A 10B C ,,HOMe
Br AMe
B Me ORMe128 1
We pursued several variants of the tricycle containing a pendant aldehyde to test various
coupling strategies. An added feature of the aldehyde electrophile would be the increased
reactivity toward softer transition metals, thus requiring a less robust protecting group on the
secondary alcohol. Modification of the synthetic route towards 112 involving an asymmetric
vinyl addition into 99 could provide an aldehyde after ozonolysis, rather than a ketone. Based on
our synthesis of triepoxide 113 (Scheme 1-20), asymmetric addition of a vinyl zinc to aldehyde
99 would ultimately lead to an aldehyde similar to 126 to test coupling strategies. Oppolzer
reported that tridentate ligand ent-130 gave greater than 96% enantioselectivity for the addition
of divinyl zinc (129) in diethyl ether to 1 -hexanal.45 In this case, using toluene as the solvent and
a solution of divinyl zinc in THF, tridentate ligand 130 gave an unacceptable 33% ee (Scheme 1-
23).46 Pentane as solvent provided higher enantioselectivity, but still not to the desired level of
enantiocontrol. Before optimizing this enantioselective reaction further, we decided to
investigate an enzymatic resolution of a racemic alcohol in order to quickly provide both
enantiomers.
Scheme 1-23. Asymmetric addition of divinyl zinc into aldehyde 99
S1,4-dioxaneZnCl 2 + fMgBr n
THF 129
Me
Me Me N-Me
0 Me Me Me Me OH 130
H Me HOH M Me e
99 Me Zn' 129 Me
Solvent, 0 *C, 4 h 131
Toluene - 33% ee
Pentanes - 79% ee
Because secondary allylic alcohols are amenable to enzymatic resolution,47 both
enantiomers of the tricyclic fragment could be prepared in high enantioselectivity (126 and ent-
126, Scheme 1-24). This strategy would thus provide a straightforward way to fully assign the
absolute stereochemistry of armatol A. Enzymatic resolution (Novozyme 435) of racemic
alcohol 131 facilitated the isolation of the (S)-acetate ester in high enantioselectivity. It was
necessary to resubject the less reactive enantiomer (ent-131) to slightly different reaction
conditions to improve its optical purity. 48
Scheme 1-24. Enzymatic resolution leading to both enantiomers of tricyclic fragment
0 Me Me Me -MgBr OH Me Me Me
H Me THF, -10 *C Me
99 65% yield (i)-131
vinyl acetate
Novozyme 435
4 h, rt
OAc Me Me Me
Me
132
40% yield, 99% ee
vinyl acetate Me + Me Me
QH Me Me Me Novozyme 435 H M Me e
x MeMe Et2O, 16.5 h, ent-Me
ent-131ent-31
33% yield, 98% ee 53% yield, -80% ee
Both enantiomers of 131 were carried forward, using opposite enantiomers of the Shi
ketone 62 to install the correct absolute configuration of all the epoxides in each case. Shi
epoxidation of the allylic ester 132 proceeded in an 88% yield, but subsequent base-induced
cleavage of the acetate ester 133 induced a rapid cyclization of the allylic alcohol, producing 135
in considerable quantities. Deprotection of the acetate ester using potassium carbonate in
MeOH, followed by direct Shi epoxidation on secondary alcohol 131 proceeded in 69% yield
with only 16% of the over-epoxidized product obtained. Using ent-Shi ketone (ent-62) the
epoxidation of ent-131 proceeded in a comparable 61% yield.49 Cyclizations of both of these
triepoxides proceeded in modest yields of 23% and 25% after acetylation, giving 137 and ent-
137, respectively. Both alkenes were readily converted to the corresponding aldehydes upon
treatment with ozone in about 70% yield for both substrates.
126 ent-126
Scheme 1-25. Synthesis of both coupling fragments 138 and ent-138
Shi ketone 62 (75 mol%),
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Elimination of secondary alcohol
The final challenge in constructing the right-hand fragment of armatol A involves the
elimination of the sterically encumbered secondary alcohol. Table 1-5 provides a summary of
the methods investigated, via either direct elimination or by elimination of the acetate. Attempts
to eliminate the acetate using 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) lead to recovered
starting material. The free alcohol was subjected to a variety of direct elimination conditions,
including Martin's sulfurane, 50 Mitsunobu conditions, and the Grieco protocol,51 which all failed
to give the desired alkene. Burgess's reagent (139, Scheme 1-26)52 did produce an interesting
ring contraction product, 142, resulting most likely from deprotonation of one of the geminal
methyl groups, with displacement of the sulfate group by the oxepane oxygen. The exact
mechanism of this elimination is uncertain, however, the formation of the exo-alkene exclusively
suggests that the deprotonation may occur due to an ion pair interaction.
Table 1-5. Elimination attempts on ketone 120 and 121
0H Me 0H Me
Me 0 Conditions Me Me
Me Me
Me 0 H 
0
H0 Me 'M OR
Entry R Conditions Solvent Temp Time Result
1 Ac, 120 DBU DMF 140 *C 24 h No reaction
2 Ac, 120 DBU DMF 170 *C 60 h No reaction
3 H, 121 Martin sulfurane CH2CI2 rt to 40 *C 16 h No reaction
4 H, 121 PPh 3, DIAD, 4-nitrobenzoic acid PhMe rt to ref lux 16 h No reaction
Scheme 1-26. Proposed mechanism for ring contraction from Burgess's reagent
00
H Me MeO N 'NEt 3  o
Me P eMe 500* [ MeH
Me 139 M
H 0  Me PhMe, 50'C0
Me ~"OH 2h H 0 I A MeLme 
-j
121 142
H Me ~0 01s H
H Me HZ N OM 0 HMe O Me OMe
HMe
140 000 141 H
Our next approach involved converting 121 to chloromesylate 143, which was then
subjected to a variety of elimination and displacement conditions. However, ring contraction
products (142 and 144, Scheme 1-27) were obtained exclusively,5 3 most likely formed by a
stepwise displacement of the mesylate with subsequent deprotonation via intermediate 141.
Models of the tricycle suggest that the anti proton to the secondary alcohol is not properly
aligned for elimination. Attempts to invert the stereochemistry at the hydroxyl group via the
ketone with both L-Selectride and sodium borohydride, which we proposed would provide a
more favorable elimination substrate, were unsuccessful.
Scheme 1-27. Elimination products from chloromesylate 142
Me "OH CICH 2SO2CI Me HMe0M OMAP Me 0M
Me H00  MeC
HOMe "'O/H pyridine M '"
54% yield 143 I O121Li
0HMe 0HMe
Conditions Me Me-Me OMe
Me3 0 Me
142 a b
M Ie 0 F H Me0 H MeC 0  H
Me 
Me 
________,eMeH
LT 00 Me L b---- 0I
143 141 ' b
Conditions attempted
a) LiBr, Li2CO 3, DMF, 150 *C
b) DBU, THF, reflux
c) LiBr, THF, reflux
d) DMAP, PhMe, reflux
142 and 144 tenatively assigned
by 1H NMR and HRMS
Our final attempt at the installation of the oxepene involved converting the secondary
alcohols to a ketone, then to a corresponding hydrazone, followed by a subsequent Shapiro
reaction. Oxidation of 112 can be performed with either Dess-Martin periodinane or even the
harsher Jones' reagent demonstrating the robustness of the tricycle (Scheme 1-28). Dess-Martin
periodinane also transformed the secondary alcohol to ketone 147 in 78% yield, and hydrazone
148 was formed by condensation with hydrazine. Compared to the difficult direct elimination of
the secondary alcohol 121, formation of the corresponding ketone 147 and the hydrazone 148
was rather facile.
......... ............................... .. .. .. . ......
. ................. .
Scheme 1-28. Oxidation and hydrazone formation attempts
A) Jones' reagent, acetone, 0 0C to rt
64% yield
H Me or H Me
Me H Me B) DMP, NaHCO 3, CH 2C 2  Me H Me
Me 79% yield Me
O 0
H Me/ ''0OH HMe 0
112 145
H Me 
HMe.
H Me DMP, NaHCO 3  H Me
Me CH2C 2, 0 *C Me
H OH 78% yield Me 0
146 147
HMe .
HM eH H Me TsNHNH2  H Me
Me 0M
0 O g Me MeOH, 40*C, 18 h O Me
e 0 43% yield Me
147 148 NHTs
The hydrazone 148 was subjected to an array of conditions reported for the Bamford-
Stevens54 reaction as shown in Table 1-6, but only sodium hydride in toluene or THF led to any
of the desired olefin. 55 Many products were obtained, and 21% yield of the desired oxepane
(149) was the highest observed case. Nevertheless, with a method to form the oxepene in hand,
we looked forward to coupling the two fragments and establishing the absolute configuration of
the natural product.
Table 1-6. Bamford-Stevens reaction on hydrazone 148
0|H H
O Me Conditions
Me
Me N
148 HN'Ts
Entry Conditions Solvent
1 MeLi, -78 0C to rt THF
2 n-BuLi, -78 *C to rt THF
3 LiHMDS, -78 *C to rt THF
4 NaH, reflux THF
5 NaH, 90 00 PhMe
H OMe
O Me
. Me
Me
149
Results
No reaction
Decomposition
No reaction
12% yield 149
21% yield 149
Conclusion
The synthesis of the fused 6,7,7-tricycle of armatol A was investigated. Fragments
containing both a ketone and an aldehyde were generated via a triepoxide cascade for subsequent
fragment coupling (discussed in Chapter 2). Elimination of the secondary alcohol in the oxepane
ring proved challenging; however, employing the Shapiro reaction successfully provided the
desired oxepene, albeit in low yield. The ketone and aldehyde triads were synthesized in 11 and
7 steps, respectively, and both enantiomers could be obtained for the aldehyde system. These
short synthetic routes enable the preparation of sufficient quantities of these triads for fragment
coupling studies.
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Experimental Section
General Information
Unless otherwise noted, all reactions were performed under an oxygen-free atmosphere
of argon or nitrogen with rigorous exclusion of moisture from reagents and glassware. Unless
otherwise noted, all solvents and triethylamine used in the reactions were purified via a SG
Water USA solvent column system. 4A MS used in the Sharpless asymmetric epoxidations were
activated by flame drying under high vacuum three times (with cooling in between) immediately
before use. Analytical thin-layer chromatography was performed using EM Science silica gel 60
F254 plates. The developed chromatogram was visualized by UV lamp or stained using one of
the following: aqueous potassium permanganate (KMnO 4), ethanolic phosphomolybdic acid
(PMA), aqueous cerium ammonium molybdate (CAM, Hanessian's stain), or ethanolic vanillin.
Liquid chromatography was performed using a forced flow (flash chromatography) of the
indicated solvent system on Silicycle silica gel (230-400 mesh).
'H and 13 C NMR spectra were recorded on Varian 300 MHz, Varian 500 MHz, Bruker
400 MHz, or Bruker 600 MHz spectrometer in CDCl 3 or C6 D6. Chemical shifts in 'H NMR
spectra are reported in parts per million (ppm) on the 6 scale from an internal standard of
residual chloroform (7.27 ppm) or residual benzene (7.16 ppm). Data are reported as follows:
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and bs
= broad singlet), coupling constant in hertz (Hz), and integration. Chemical shifts of 13 C NMR
spectra are reported in ppm from the central peak of CDCl3 (77.23 ppm) or C6D6 (128.37 ppm)
on the 6 scale. Infrared (IR) spectra were recorded on a Perkin-Elmer 2000 FT-IR. High-
resolution mass spectra (HRMS) were obtained on a Bruker Daltonics APEXII 3 Fourier
Transform Mass Spectrometer by Ms. Li Li of the Massachusetts Institute of Technology,
Department of Chemistry Instrumentation Facility. Chiral HPLC analysis was performed on a
Hewlett-Packard 1100 chromatograph equipped with a variable wavelength detector and
Chiralcel OD or OD-H, or AD-H columns. Specific Rotations ([a] 24D) were measured on a
Perkin-Elmer 241 polarimeter at 589 nm.
BnO Me
Me Me
60
Benzyl ether 60: To a 250 mL round-bottom flask equipped with a stir bar was added sodium
hydride (1.705 g, 42.6 mmol, 60% in mineral oil) in 4:1 THF/DMF (125 mL). Geraniol (5.1 mL,
29.1 mmol) was added dropwise at 0 'C and stirred for 30 min. Benzyl bromide (4.2 mL, 35.4
mmol) and tetrabutylammonium iodide (261 mg, 0.718 mmol) were added and the reaction was
allowed to warm to room temperature overnight. The reaction was quenched with saturated
NH4Cl and the aqeous layer was extracted 3x with Et20. The organic layers were dried over
MgSO 4, filtered, and concentrated in vacuo. The crude oil was purified by column
chromatography (5% EtOAc in hexanes) to furnish known benzyl ether 60 (6.336, 25.9 mmol,
89% yield)1 as colorless oil.
BnO OH
Me Me
59
Allylic alcohol 59: To a 100 mL round-bottom flask equipped with a stir bar was added
selenium dioxide (59 mg, 0.532 mmol), 4-hydroxybeonzoic acid (145 mg, 1.05 mmol), and a 5.5
M solution of TBHP in decanes (6.5 ml, 35.8 mmol) in 30 mL of CH 2Cl2 and stirred for 1 h at
room temperature. Benzyl ether 60 (2.673 g, 10.9 mmol) was added as a solution in 10 mL of
CH 2Cl2 over 5 min. The reaction was stirred for 24 h and then concentrated in vacuo. The crude
was dissolved in Et2O, washed 2x with saturated Na2SO 3 and 1x with water. The organic layers
were dried over MgSO4, filtered, and concentrated in vacuo. The crude was dissolved in 40 mL
of EtOH in a 100 mL and then cooled to 0 'C. Sodium borohydride (369 mg, 9.75 mmol) was
added in portions and stirred for 1 h. The reaction was quenched with saturated NaHCO 3 and
then the aqueous layer was extracted 3x with Et20. The organic layers were combined and
washed 2x with H20, dried over MgSO 4, filtered, and concentrated in vacuo. The crude was
purified by column chromatography (20% EtOAc in hexanes) to furnish allylic alcohol 59 (877
mg, 3.37 mmol, 31% yield) as colorless oil.
'H NMR (500 MHz; CDCl 3): 6 7.36 (d, J = 4.5, 4H), 7.30 (dd, J = 8.5, 4.3, 1H), 5.43-5.38 (m,
2H), 4.52 (s, 2H), 4.03 (d, J = 6.8, 2H), 3.99 (s, 2H), 2.18 (t, J = 7.5, 2H), 2.09 (t, J = 7.6, 2H),
1.67 (s, 3H), 1.66 (s, 3H)
13C NMR (125 MHz; CDCl 3): 6 140.1, 138.7, 135.3, 128.6, 128.0, 127.8, 125.8, 121.3, 72.3,
69.2, 66.7, 39.3, 26.0, 16.7, 13.9
IR (NaCl, thin film): 3369, 2919, 2851, 1996, 1454, 1068, 736
HRMS-ESI (m / z): [M + Na]* calcd for C17H240 2Na, 283.1669; found, 283.1677.
BnO Me
Me Me Me
61 Me
Tertiary alcohol 61: To a 100 mL round-bottom flask equipped with a stir bar was added allylic
alcohol 59 (877 mg, 3.37 mmol) in 30 mL of Et2 0 and the reaction was cooled to 0 'C.
Phosphorous tribromide (160 uL, 1.69 mmol) was added slowly and stirred for 1 h. The reaction
was quenched with saturated NaHCO 3 and warmed to room temperature, shielded from light.
The aqueous layer was extracted with Et2 0 (3x) and the organic layers were washed with brine.
The organic layers were then dried over MgSO 4 , filtered, and concentrated in vacuo. The crude
allylic bromide was used without further purification.
To a 100 mL round-bottom flask equipped with a stir bar in a glove box was added copper (I)
iodide (615.2 mg, 3.23 mmol). The flask was sealed, removed from the glove box, and
transferred to the hood where 24 mL of DMF was added. Upon addition of DBU (490 uL, 3.28
mmol), the color changed from light green to an olive-green, and the reaction was stirred for 15
min. Two cystals of BHT were added and 2-methyl-3-butyn-2-ol (310 uL, 3.2 mmol) was added
and stirred for an additional 30 min at room temperature. The allylic bromide (632 mg, 1.95
mmol) was dissolved in 8 mL of DMF and added dropwise over 5 min. The reaction was stirred
for 16 h under nitrogen. The crude reaction was poured into Et 20 and then washed with IN HCl
(2x) and with saturated NH 4Cl in NH40H (1x). The aqueous layer was extracted with Et2 0 (3x)
and then combined and dried over MgSO 4 , filtered, and concentrated in vauo. The crude
reaction was purified by column chromatography (3%) to furnish diene-yne 61 (655 mg, 2.01
mmol, 60% yield) as colorless oil.
Data for major diastereomer:
H NMR (500 MHz; CDCl 3): 6 7.36 (d, J = 4.5, 4H), 7.31-7.28 (m, 1H), 5.42 (t, J = 7.3, 2H),
4.52 (s, 2H), 4.03 (d, J = 6.7, 2H), 2.87 (s, 2H), 2.16 (t, J = 7.2, 2H), 2.09 (dd, J = 15.5, 7.8, 2H),
1.67 (s, 3H), 1.65 (s, 3H), 1.51 (s, 6H)
13C NMR (125 MHz; CDCl 3): 6 140.2, 138.7, 130.3, 128.6, 128.1, 127.8, 125.4, 121.3, 112.2,
87.7, 72.2, 66.7, 39.4, 31.9, 28.8, 26.3, 16.7, 16.4
IR (NaCl, thin film): 3428, 2980, 2927, 2858, 1996, 1636, 1456, 1363, 1238, 1168, 1066, 948,
860, 737, 698
HRMS-ESI (m / z): [M + Na]* caled for C2 2H39 0 2Na, 349.2138; found, 349.2149.
BnO
o ><OHMe 0Me Me
56 Me
Diepoxide 56: To a 100 mL round-bottom flask equipped with a stir bar was added a solution of
diene-ye 61 (107 mg, 0.328 mmol) in 11.4 mL of 2:1 DMM/CH 3CN and 7.6 mL of EDTA
buffer. nBu4NHSO 4 (5.7 mg, 0.0168 mmol) was added and the reaction was vigorously stirred
followed by the addition of Shi ketone (173 mg, 0.670 mmol). A solution of Oxone (1.50 g, 2.44
mmol) in 10.7 mL of EDTA solution and a solution of 10.7 mL of 0.89 M K2CO 3 were added
dropwise side-by-side over 30 min. The reaction was allowed to stir for an additional 30 min
before 60 mL of water was added and stirred for an additional 45 min. The reaction was
extracted three times with CH2Cl2 and dried over Na 2SO 4. The reaction was filtered and
evaporated in vacuo and subjected to column chromatography (50% EtOAc in hexanes) to
provide colorless oil 56 (97 mg, 0.271 mmol, 83% yield, 3.5:1 dr).
'H NMR (500 MHz; CDCl 3): 6 7.37-7.35 (in, 4H), 7.32-7.29 (m, 1H), 4.64 (dd, J = 11.9, 1.1,
1H), 4.56-4.52 (in, 1H), 3.72 (ddd, J = 18.7, 11.1, 4.5, 1H), 3.57 (td, J = 10.9, 6.0, 1H), 3.06
(ddd, J = 15.1, 6.0, 4.6, 1H), 2.91-2.89 (in, 1H), 2.52 (dd, J = 17.0, 12.8, 1H), 2.36 (dd, J = 17.0,
11.3, 1H), 2.19 (bs, 1H), 1.82-1.79 (in, 1H), 1.72-1.62 (in, 3H), 1.50 (s, 6H), 1.35 (s, 3H), 1.28
(s, 3H)
13C NMR (125 MHz; CDC13 ): 6 138.0, 128.6, 128.0, 128.0, 87.9, 73.5, 68.9, 62.5, 61.7, 61.0,
59.7, 59.6, 34.9, 31.8, 28.9, 24.3, 17.1, 16.72, 16.72
[a] 24D = -4.9 (c 0.9, CHCl3)
IR (NaCl, thin film): 3424, 2978, 2930, 2865, 1653, 1559, 1455, 1386, 1363, 1239, 1169, 1076,
950, 871, 740, 699
HRMS-ESI (m / z): [M + Na]* calcd for C22H30O4Na, 381.2036; found, 381.2040.
BnO
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Cis olefin 55: To a 10 mL round-bottom flask equipped with a stir bar was added Lindlar's
catalyst (9 mg, 10% by weight palladium on calcium carbonate poisoned with lead) in 1.9 mL of
EtOH followed by quinoline (3 uL, 0.0254 mmol). The reaction was stirred for 20 min under
argon. Alkyne 56 (89 mg, 0.248 mmol) was added as a solution in 1.9 mL of EtOH and stirred
under argon for 30 min. The flask was purged and subjected to hydrogen (1 atm) for 4 h. The
reaction was filtered through Celite and washed with EtOAc. The solvents were removed in
vacuo. The crude oil was purified by column chromatography (20 to 30% EtOAc in hexanes) to
furnish allylic alcohol 55 (41.0 mg, 0.114 mmol, 46% yield) as colorless oil.
'H NMR (500 MHz; CDCl 3): 6 7.36-7.35 (in, 4H), 7.30 (dt, J = 6.7, 3.4, 1H), 5.63 (d, J = 11.8,
1H), 5.35-5.30 (in, 1H), 4.63 (d, J = 11.9, 1H), 4.53 (dd, J = 11.9, 3.5, 1H), 3.69 (td, J = 11.0,
5.3, 1H), 3.58 (dd, J = 11.1, 5.9, 1H), 3.20 (s, 1H), 3.03 (ddd, J = 6.2, 4.4, 2.0, 1H), 2.91 (t, J =
5.9, 1H), 2.66-2.64 (in, 2H), 1.77-1.71 (in, 1H), 1.69-1.61 (in, 3H)
13 C NMR (125 MHz; CDCl 3): 6 141.5, 128.6, 128.0, 128.0, 122.0, 73.5, 71.9, 68.9, 63.1, 61.6,
61.0, 34.9, 31.6, 31.1, 24.1, 17.2, 17.1, 59.8
[a]24D = +4.1 (c 0.8, CHCl3)
IR (NaCl, thin film): 3445, 2968, 2926, 1718, 1653, 1559, 1457, 1386, 1094, 959, 738
HRMS-ESI (m / z): [M + Na]* calcd for C22H330 4Na, 383.2198; found, 383.2199.
Ph OH
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Allylic alcohol 68: To a 25 mL round-bottom flask equipped with a stir bar was dissolved
hydrocinnamaldehyde (100 uL, 0.759 mmol) in 10 mL of CH 2Cl 2. To the flask was added 1-
carbethoxyethylidene triphenylphosphorane (288 mg, 0.795 mmol) in one portion at room
temperature. The reaction was stirred for 24 h at room temperature then for 48 h at reflux. The
solvent was removed in vacuo and then dissolved in Et20 and filtered through a silca gel plug.
The solvent was removed and to furnish a crude solution of allylic ester (171 mg) which was
carried on without further purification.
Lithium aluminum hydride (25 mg, 0.66 mmol) was dissolved in 8 mL of Et2O in a 25 mL
round-bottom flask equipped with a stir bar and cooled to 0 'C. The allylic ester (171 mg) was
added in a 1 mL of Et 20. The reaction was heated to reflux for 30 min and then cooled to room
temperature. The reaction was quenched with 25 uL of H20 at 0 'C then 25 uL of a 15%
solution of NaOH was added, followed to 75 uL of H20. The reaction was then stirred for 10
min and warmed to room temperature. MgSO 4 was added and the suspension was filtered
through Celite to remove aluminum salts. The Celite was washed with Et20, and concentrated in
vacuo. The crude oil was purified by column chromatography (20% EtOAc in hexanes) to
provide known allylic alcohol 68 (83 mg, 0.545 mmol, 72% yield)2 as colorless oil.
MeHO Me
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Tertiary allylic alcohol 69: To a 100 mL round-bottom flask equipped with a stir bar was added
allylic alcohol 68 (795 mg, 4.51 mmol) in 50 mL of Et20 and the reaction was cooled to 0 'C.
Phosphorous tribromide (250 uL, 2.65 mmol) was added slowly and stirred for 45 min. The
reaction was quenched with saturated NaHCO3 and warmed to room temperature in the absence
of light. The aqueous layer was extracted 3x with Et20 and the organic layers were washed with
brine. The organic layers were then dried over MgSO 4, filtered, and concentrated in vacuo. The
crude allylic bromide was used without further purification.
To a 100 mL round-bottom flask equipped with a stir bar in a glove box was added copper (I)
iodide (989 mg, 5.19 mmol). The flask was sealed, removed from the glove box, and transferred
to the hood where 40 mL of DMF was added. Upon addition of DBU (780 uL, 5.22 mmol) the
color changed from light green to an olive-green, and the reaction was stirred for 15 min. Two
cystals of BHT were added and 2-methyl-3-butyn-2-ol (500 uL, 5.16 mmol) was added and
stirred for an additional 30 min at room temperature. The allylic bromide (~5.2 mmol) was
dissolved in 10 mL of DMF and added dropwise over 5 min. The reaction was stirred for 16 h
under nitrogen. The crude reaction was poured into Et20 and then washed with IN HCl (2x) and
with saturated NH 4Cl in NH40H (lx). The aqueous layer was extracted with Et 20 (3x) and then
combined and dried over MgSO 4, filtered, and concentrated in vacuo. The crude reaction was
purified by column chromatography (3%) to furnish a tertiary alcohol (517 mg, 2.13 mmol, 47%
yield) as colorless oil. The alcohol was carried on to the next step without further purification.
To a 125 mL Erlenmyer equipped with a stir bar was added a solution of the tertiary alcohol
(272 mg, 1.22 mmol) in 39 mL of 2:1 DMM/CH 3CN and 24.5 mL of EDTA buffer.
nBu4NHSO4 (171 mg, 0.504 mmol) was added and the reaction was vigorously stirred followed
by the addition of Shi ketone (147 mg, 0.570 mmol). A solution of Oxone (1.377 g, 2.24 mmol)
in 9.9 mL of EDTA solution and a solution of 9.9 mL of 0.89 M K2CO 3 were added dropwise
side-by-side over 30 min. The reaction was allowed to stir for an additional 30 min before 50
mL of water was added and stirred for an additional 45 min. The reaction was extracted three
times with CH2Cl 2 and dried over Na 2SO 4. The reaction was filtered and evaporated in vacuo
and subjected to column chromatography (30% EtOAc in hexanes) to provide an epoxide (278
mg, 1.08 mmol, 88% yield) as colorless oil. The epoxide was carried onto the following
reduction directly without further purification.
To a 10 mL round-bottom flask equipped with a stir bar was added Lindlar's catalyst (20 mg,
10% by weight palladium on calcium carbonate poisoned with lead) in 5 mL of EtOH followd by
quinoline (7 uL, 0.059 mmol). The reaction was stirred for 20 min under argon. The previously
synthesized alkyne (130 mg, 0.503 mmol) was added as a solution in EtOH and stirred under
argon for 30 min. The flask was purged and subjected to hydrogen (1 atm) for 2 h. The reaction
was filtered through Celite (eluting with EtOAc) and concentrated in vacuo. The crude oil was
purified by column chromatography (20% EtOAc in hexanes) to furnish allylic alcohol 69 (62
mg, 0.238 mmol, 47% yield) as colorless oil.
H NMR (500 MHz; CDC13): 6 7.32-7.20 (in, 5H), 5.75 (ddd, J 10.3, 6.4, 2.1, 1H), 5.68 (ddd, J
= 10.3, 2.9, 0.6, 1H), 3.47 (dd, J = 10.6, 1.9, 1H), 2.99 (ddd, J 13.9, 9.7, 4.5, 1H), 2.68 (ddd, J
= 13.7, 9.7, 7.0, 1H), 2.37 (dt, J = 16.7, 2.0, 1H), 1.74 (dddd, J 13.5, 10.1, 7.0, 2.0, 1H), 1.67-
1.59 (in, 2H), 1.29 (s, 3H), 1.24 (s, 3H), 1.16 (s, 3H)
13C NMR (125 MHz; CDCl 3): 6 142.6, 133.5, 128.7, 128.5, 125.9, 120.8, 76.8, 75.5, 72.3, 33.3,
32.2, 31.6, 29.1, 26.9, 22.9
[a]24D = ±27.0 (c 1.9, CHCl3)
IR (NaCl, thin film): 3470, 3029, 2974, 2928, 2864, 1742, 1604, 1496, 1454, 1372, 1205, 1128,
1072, 1007, 922, 749, 715, 700
HRMS-ESI (m / z): [M + Na]* calcd for C17H2 40 2Na, 283.1669; found, 283.1677.
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THP 75: To a 5 mL vial equipped with a stir bar was added allylic alcohol 69 (29 mg, 0.111
mmol) in 1.1 mL of MeOH. Cesium carbonate (182 mg, 0.559 mmol) was added the reaction
was heated to 60 'C for 14 h. The reaction was cooled and concentrated in vacuo. The solid was
dissolved in saturated NH 4Cl and Et 20. The aqueous layer was extracted with Et2 0 (5x), dried
over Na2SO4, filtered, and concentrated in vacuo. The product was purified by column
chromatography (50% EtOAc in hexanes) to furnish secondary alcohol 75.
'H NMR (500 MHz; C6D6): 6 7.21-7.17 (in, 4H), 7.10-7.07 (in, 1H), 5.55-5.51 (in, 1H), 5.42
(ddd, J = 10.2, 3.0, 0.9, 1H), 3.52 (dd, J = 9.6, 3.1, 1H), 3.11 (ddd, J = 13.8, 8.9, 5.1, 1H), 2.84 (s,
1H), 2.76 (ddd, J = 13.6, 9.2, 7.6, 1H), 2.37 (dt, J = 16.7, 2.2, 1H), 1.66-1.60 (m, 2H), 1.34 (ddd,
J = 16.7, 6.6, 0.6, 2H), 1.14 (s, 3H), 1.06 (s, 3H), 0.99 (s, 3H)
"C NMR (125 MHz; C6D6): 6 143.3, 133.9, 129.3, 129.0, 126.4, 121.4, 77.0, 75.9, 72.3, 33.8,
33.0, 31.8, 29.3, 27.7, 22.8
[U]24 D = +26.2 (c 0.07, CHC13)
IR (NaCl, thin film): 3457, 3028, 2974, 2927, 1653, 1496, 1455, 1393, 1372, 1071, 1007
HRMS-ESI (m / z): [M + Na]* calcd for C17H2 4 0 2Na, 283.1669; found, 283.1667.
H Me
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Aldehyde 88: A 100 mL sealed tube equipped with a stir bar in a dry box was charged
Hg(OAc) 2 (3.21 g, 10.1 mmol) and transferred under nitrogen to a hood. To the reaction vessel
was added 2-methyl-3-buten-2-ol (5.3 mL, 50.7 mmol) and ethyl vinyl ether (14.5 mL, 151.4
mmol) and heated for 5 h under reflux. The reaction mixture was concentrated to remove
volatiles and then purified via flash column chromatography (2% EtOAc in hexanes) to give
rather volatile unsaturated aldehyde 88 (3.99 g, 70% yield) as a pale yellow oil. Spectral data
matched previously reported.3
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Ester 91: To a 500 mL round-bottom flame-dried flask equipped with a stir bar was added
aldehyde 88 (3.99 g, 35.6 mmol) followed by benzene (300 mL). (1-
Ethoxycarbonylethyldiene)triphenylphosphorane (12.9 g, 35.6 mmol) was added in one portion
and the reaction was heated to 40 'C for 41 h. The reaction was cooled to room temperature and
the volatiles were removed in vacuo. The remaining yellow solid was loaded with CH 2Cl 2 and
purified via flash column chromatography (2% EtOAc in hexanes) to provide ester 91 (4.79 g,
69% yield) as colorless oil.
H (500 MHz, CDCl 3, 6): 6.75 (dq, J=7.2, 1.6 Hz, 1H), 5,11 (tqd, J=7.0, 1.5 Hz, 1H), 4.18 (q,
J=7.2 Hz, 2H), 2.19 (m, 2H), 2.11 (m, 2H), 1.82 (m 3H), 1.69 (m, 3H), 1.60 (m, 3H), 1.29 (t,
J=7.2 Hz, 3H).
1C (125 MHz, CDCl 3, 6): 168.4, 142.0, 132.7, 128.1, 123.5, 50.5, 29.2, 27.2, 25.9, 17.9, 14.5,
12.5.
IR (NaCl, thin film): 2979, 2930, 1713, 1650, 1447, 1367, 1272, 1240, 1174, 1120, 1078, 1038.
HRMS-ESI (m / z): [M + Na]* calcd for C12H24 0 3Na, 219.1356; found, 219.1364.
Me
HO - ' Me
Me 87
Alcohol 87: To a 200 mL round-bottom flame-dried flask equipped with a stir bar was dissolved
ester 91 (4.79g, 24.4 mmol) in Et 20 (104 mL) and cooled to 0 'C. Lithium aluminum hydride
(937 mg, 24.7 mmol) was added slowly in portions and the reaction was allowed to stir while
warming to room temperature for 10 h. The reaction was returned to 0 'C and 937 uL of water
was added, followed by 937 uL of 15% NaOH in brine, followed by 3 mL of water. The reaction
was allowed to warm to room temperature while stirring for 45 min. MgSO 4 was added and
stirred for an additional 30 min. The reaction was filtered through Celite washing with Et20 and
then concentrated in vacuo to provide colorless oil. The residue was purified via flash column
chromatography (10% EtOAc in hexanes) to provide alcohol 87 (2.84g, 76% yield) as colorless
oil.
IH (500 MHz, CDCl 3, 6): 5.43 (m, 1H), 5.13(m, 1H), 4.00 (d, J=5.1 Hz, 2H), 2.06 (m, 5H), 1.70
(s, 3H), 1.67 (s, 3H), 1.61 (s, 3H).
13C (125 MHz, CDCl 3, 6): 135.1, 132.1, 126.3, 124.3, 69.2, 28.2, 28.1, 25.9, 17.9, 13.9.
IR (NaCl, thin film): 3341, 2921, 1673, 1456, 1376, 1224, 1065, 1006.
HRMS-ESI (m / z): [M + Na]* calcd for CioH 18ONa, 177.1250; found, 177.1243.
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Epoxy alcohol 92: To a 250 mL round-bottom flame-dried flask equipped with a stir bar was
added 4 A molecular sieves (3.07g) and heated under vacuum for 15 min. CH2Cl 2 (108 mL) was
added and the flask was cooled with a CryoCool to -20 'C. Titanium isopropoxide (725 uL, 2.4
mmol) and D-(-)-diethyl tartrate (505 uL, 2.95 mmol) were added and stirred for 35 min. A
solution of tert-butyl hydrogen peroxide (5.5 M in decanes, 6.7 mL, 36.7 mmol) was added and
stirred for 30 min. A solution of alcohol 87 (2.84 g, 18.4 mmol) in 10 mL of CH 2Cl 2 was added
slowly over 20 min. The reaction was stirred at this temperature for 9.5 h. The reaction was
quenched by adding 4.65 mL of a 40% solution of NaOH in brine (6.5 mL: 5.85 mL H20, 2.6 g
NaOH, 325 mg NaCl) and then 11.2 mL of Et 20 and let warm while stirring for 30 min. 4.7 g of
MgSO 4 was added along with 468 mg of Celite and stirred for 30 min at room temperature. The
reaction was filtered through Celite washing with CH 2Cl 2 and concentrated in vacuo. The crude
oil was purified via flash column chromatography (30% EtOAc in hexanes) to provide epoxy
alcohol 92 (2.81g, 90% yield) as colorless oil. Enantiomeric excess determined to be 92% via
chiral GC analysis of the acetonide product 90.
'H (500 MHz, CDCl3, 6): 5.12 (tqd, J=7.3, 1.4 Hz, 1H), 3.64 (d, J=12.2 Hz, 1H), 3.51 (d, J=12.2
Hz), 3.01 (t, J=6.2 Hz, 1H), 2.36 (bs, 1H), 2.12 (dt, J=8.0, 7.3 Hz , 2H), 1.67 (s, 3H), 1,62 (m,
1H), 1.55 (m, 1H), 1.25 (s, 3H).
13C (125 MHz, CDCl 3 , 6): 132.6, 123.3, 65.7, 61.3, 60.1, 28.5, 25.8, 25.0, 17.8, 14.3.
[a] 24D= 18.4 (c 1.5, CHCl 3).
IR (NaCl, thin film): 3429, 2966, 2926, 2861, 1452, 1382, 1232, 1040.
HRMS-ESI (m / z): [M + Na]* caled for CIoHisO 2Na, 193.1199; found, 193.1200.
OBz Me
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Benzoate 93: To a 250 mL round-bottom flame-dried flask equipped with a stir bar was
dissolved epoxy alcohol 92 (2.78 g, 16.3 mmol) in 108 mL of chloroform. 25.8 mL of a solution
of benzoic acid and titanium isopropoxide in CHCl3 was added (To a 50 mL round-bottom flask
equipped with a stir bar was added (3.28 g, 26.9 mmol) followed by 24.4 mL of CHCl3 and
Ti(O'Pr)4 (7.4 mL, 24.4 mmol). The flask was stirred for 30 min at room temperature and the
dissolved solution added to the previous reaction.). The reaction was stirred at room temperature
for 38 h before being concentrated in vacuo. Equal volumes of Et20 and 10% citric acid
solutions were added and stirred for 1 h. The aqueous layer was extracted with Et20 (3x) and
then washed with NaHCO3, dried over Na2SO 4, filtered, and concentrated in vacuo. The crude
oil was used without further purification.
OBz Me
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Acetonide 94: To a 500 mL round-bottom flame-dried flask equipped with a stir bar was added
benzoate 93 (5.42 g, 18.5 mmol) in CH 2Cl 2 (56 mL) and 2,2-dimethoxypropane (73 mL). (+/-)-
CSA (430.9 mg, 1.85 mmol) was added and the reaction was stirred for 5 h at room temperature.
Additional CH 2Cl 2 was added and then washed with saturated NaHCO 3. The organic layers
were dried over Na2 SO 4, filtered, and concentrated in vacuo. The crude oil was purified via
column chromatography (2 to 5% EtOAc in hexanes) to provide acetonide 94 (3.43 g, 73% yield
for two steps) as colorless oil.
'H (500 MHz, CDCl 3 , 6): 8.06 (m, 2H), 7.57 (tt, J=7.4, 1.4 Hz, 1H), 7.45 (m, 2H), 5.25 (dd,
J=10,3, 2.6 Hz, 1H), 5.11 (m, 1H), 4.01 (d, J=8.6 Hz, 1H), 3.71 (d, J=8.6 Hz, 1H), 2.06 (m, 2H),
1.85 (m, 1H), 1.70 (m, 1H), 1.61 (s, 3H), 1.53 (s, 3H), 1.41 (s, 3H), 1.38 (s, 3H), 1.34 (s, 3H).
3C (125 MHz, CDCl 3, 6): 166.1, 133.2, 132.5, 130.4, 129.9, 128.6, 123.6, 110.1, 82.3, 76.7,
72.5, 30.1, 27.2, 26.9, 25.8, 24.8, 21.3, 17.8.
[a] 24D = -10.9 (c 10.9, CHC13).
IR (NaCl, thin film): 3427, 3063, 2984, 2934, 2873, 1722, 1602, 1451, 1378, 1272, 1214, 1060,
1026.
HRMS-ESI (m / z): [M + Na]* calcd for C20H2 80 4Na, 333.2060; found, 333.2046.
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Acetonide 86: To a 200 mL round-bottom flame-dried flask equipped with a stir bar was added
benzoate 94 (3.16 g, 9.5 mmol) in MeOH (48 mL) and THF (48 mL). Potassium carbonate (7.37
g, 53.3 mmol) was added and the reaction was stirred for 4 h at room temperature. The solvents
were concentrated in vacuo and then the crude residue was dissolved in CH2Cl 2 and sat. NH4Cl
was added to quench the remaining carbonate. The aqueous layer was extracted with CH2Cl 2(3x), dried over Na2SO 4, filtered, and concentrated in vacuo. The crude oil was purified using a
Biotage (100g column) to provide acetonide 86 (1.08 g, 50% yield) as colorless oil. Acetonide
migration product SI-86A (484.6 mg, 22% yield) was obtained as well under the reaction
conditions.
Acetonide 86:
'H NMR (400 MHz; CDCl 3): 6 5.11-5.07 (m, 1H), 4.00 (d, J = 8.4, 1H), 3.62 (dd, J = 8.4, 0.5,
1H), 3.49 (dt, J = 10.6, 1.6, 1H), 2.38 (d, J = 3.4, 1H), 2.22-2.15 (m, 1H), 2.07 (dq, J = 14.7, 7.3,
1H), 1.65 (s, 3H), 1.60 (s, 3H), 1.55-1.47 (in, 1H), 1.40 (s, 3H), 1.34 (s, 3H), 1.29-1.23 (m, 1H),
1.22 (s, 3H)
13C NMR (100 MHz; CDCl 3): 6 132.5, 124.0, 109.4, 83.9, 74.2, 70.4, 31.5, 27.6, 26.8, 25.9,
25.2, 21.7, 17.9 -
[]24 D -9.8 (c 4.8, CHCl3)
IR (NaCl, thin film): 3488, 2985, 2932, 2875, 1454, 1378, 1255, 1214, 1114, 1059, 1080, 984,
913, 856, 816
HRMS-ESI (m / z): [M + Na]* calcd for C13H240 3Na, 251.1618; found, 251.1608.
SI-86A:
'H NMR (600 MHz; CDCl 3): 6 5.12-5.09 (in, 1H), 3.81 (dd, J = 10.0, 3.2, 1H), 3.54 (dd, J
10.9, 3.3, 1H), 3.32 (dd, J = 10.9, 9.1, 1H), 2.17 (t, J = 7.2, 1H), 2.08 (td, J = 11.2, 4.5, 2H), 1.69
(s, 3H), 1.62 (s, 3H), 1.64-1.57 (in, 1H), 1.44 (s, 3H), 1.46-1.41 (m, 1H), 1.37 (s, 3H), 1.26 (s,
3H)
13C NMR (150 MHz; CDCl 3): 6 132.7, 123.5, 107.4, 82.4, 82.0, 65.4, 28.6, 28.1, 26.6, 25.9,
21.2, 17.9
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Epoxide 85: To a 200 mL round-bottom flask equipped with a stir bar was added alkene 86
(987.5 mg, 4.32 mmol) in 37.8 mL of a 2:1 v/v solution of DMM:CH 3CN. A 0.05 M solution of
Na2B407-10H20 in 4 x 10-4 M Na2EDTA (25 mL), nBu4HSO 4 (40.9 mg, 0.12 mmol), and chiral
ketone 62 (347.7 mg, 0.1.35 mmol) were added. The biphasic mixture was stirred vigorously at
room temperature. Two solutions (Oxone (2.85 g, 4.64 mmol) in 4x10 4 M Na2EDTA (21.7 mL)
and a 0.89 M solution of K2CO 3 (21.7 mL)) were added simultaneously via syringe pump over
35 min. The reaction was stirred for an additional 30 min and then diluted with water and stirred
for an additional 10 min. The aqueous layer was extracted with CH2Cl 2 (3x) and then the
organic layers were dried over Na2SO 4, filtered, and concentrated in vacuo. The crude oil was
purified by column chromatography (20 to 30% EtOAc in hexanes) to furnish epoxide 85 (894.5
mg, 0.3.66 mmol, 85% yield) as colorless oil.
H NMR (400 MHz; CDCl 3): 6 4.03 (d, J= 8.5, 1H), 3.67 (d, J= 8.4, 1H), 3.59 (d, J = 10.8, 1H),
2.74 (dd, J = 7.8, 4.5, 1H), 2.52 (d, J = 2.1, 1H), 1.88 (ddt, J = 13.9, 9.4, 4.7, 1H), 1.73 (dddd, J =
12.8, 10.9, 6.1, 2.1, 1H), 1.57-1.48 (m, 1H), 1.42 (s, 3H), 1.37 (s, 3H), 1.40-1.34 (m, 1H), 1.30
(s, 3H), 1.27 (s, 3H), 1.26 (s, 3H)
13C NMR (100 MHz; CDCl 3): 6 109.6, 83.8, 74.4, 70.6, 64.6, 58.7, 28.5, 27.6, 26.9, 26.2, 25.0,
21.7, 18.9
[a]2 4 D = +3.8 (c 2.5, CHCl3 ).
IR (NaCl, thin film): 3472, 2984, 2874, 1457, 1379, 1253, 1213, 1118, 1056.
HRMS-ESI (m / z): [M + Na]* calcd for C13H240 4Na, 267.1567; found, 267.1566.
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Tetrahydropyran 95: To a 10 mL round-bottom flask equipped with a stir bar was added epoxy
alcohol 85 (46.0 mg, 0.188 mmol) in 3.5 mL of CH 2Cl 2 . The reaction was cooled to -78 'C and
then BF 3-OEt2 (23 uL, 0.186 mmol) was added dropwise and the reaction was stirred at this
temperature for 1 h. The reaction was quenched with saturated NH4 Cl and extracted with
CH 2Cl 2 (3x). The organic layers were dried over Na2 SO 4, filtered, and concentrated in vacuo.
The product was purified by Biotage (lOg column) to furnish acetonide 95 (4.6 mg, 0.019 mmol,
10% yield) along with diol 96 (27.6 mg, 0.113 mmol, 60% yield)
THF 95:
'H (500 MHz, CDCl 3, 6): 4.03 (d, 8.5 Hz, 1H), 3.67 (d, 8.4 Hz, 1H), 3.59 (d, 10.8 Hz, 1H), 2.75
(dd, 4.5, 7.8 Hz, 1H), 2.52 (bd, 2.1 Hz, 1H), 1.89 (m, 1H), 1.73 (m, 1H), 1.53 (m, 1H), 1.42 (s,
3H), 1.37 (m, 1H), 1.37 (s, 3H), 1.30 (s, 3H), 1.27 (s, 3H), 1.26 (s, 3H).
1C (125 MHz, CDC3, 6): 109.6, 82.2, 75.4, 74.8, 73.8, 73.6, 28.6, 28.5, 27.4, 27.1, 25.5, 19.8,
16.7.
[a]24 D ±18.3 (c 0.1, CHCl3 ).
IR (NaCl, thin film): 3441, 2984, 2937, 2873, 1454, 1371, 1259, 1210, 1162, 1057.
HRMS-ESI (m / z): [M + Na]* calcd for C13H240 4Na, 267.1567; found, 267.1569.
Diol 96:
HO MeHO Me
'IIOH
96
'H NMR (600 MHz; CDCl 3): 6 3.79 (d, J = 11.2, 1H), 3.57 (dd, J = 12.1, 2.1, 1H), 3.43 (dd, J
11.6, 4.7, 1H), 3.37-3.35 (m, H), 3.10 (s, 1H), 2.87-2.86 (m, 1H), 1.91 (td, J = 8.3, 4.2, 1H),
1.77-1.74 (m, 1H), 1.59 (ddd, J = 24.7, 12.9, 4.1, 1H), 1.46 (td, J = 12.7, 4.1, 1H), 1.28 (s, 3H),
1.18 (s, 3H), 1.08 (s, 3H)
13C NMR (150 MHz; CDCl3 ): 6 76.5, 74.3, 72.8, 72.2, 67.7, 28.5, 28.4, 26.3, 20.9, 16.4
Diol 96 also characterized as the diacetate (SI-96A) (Ac20, Et3N, DMAP, CH 2Cl 2)
HO
AcO OAc
SI-96A
'H NMR (600 MHz; CDC13): 6 4.58 (dt, J = 7.1, 3.1, 1H), 4.15 (d, J = 11.3, 1H), 3.99 (d, J =
11.3, 1H), 3.50 (d, J = 10.7, 1H), 2.49 (s, 1H), 2.10 (s, 3H), 2.04 (s, 3H), 1.98-1.96 (m, 1H), 1.75
(dd, J = 6.4, 2.8, 1H), 1.57 (q, J = 8.3, 2H), 1.20 (s, 3H), 1.16 (s, 3H), 1.16 (s, 3H)
13C NMR (150 MHz; CDCl 3): 6 171.3, 170.6, 75.6, 74.3, 73.8, 72.8, 68.5, 28.3, 25.0, 24.8, 21.5,
21.2, 20.3, 17.7
HRMS-ESI (m / z): [M + Na]* calcd for C14H250 6, 289.1646; found, 289.1655.
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THF 97: Epoxy alcohol 85 (48.0 mg, 0.196 mmol) was dissolved in 2 mL of MeOH in a 20 mL
vial with stir bar. Cesium carbonate (95.4 mg, 0.293 mmol) was added and the reaction was
stirred at room temperature for 10 h. The solvent was removed in vacuo and the residue was
dissolved in EtOAc and saturated NH 4Cl. The aqueous layer was extracted with EtOAc (3x) and
then the organic layers were dried over Na 2SO 4, filtered, and concentrated in vacuo. The crude
oil was purified by Biotage (10 g) to furnish a 4:1 mixture of THF 97a:97b (45.6 mg, 0.187
mmol, 95% yield) as colorless oil.
NMR data for the major diastereomer 97a:
IH (500 MHz, CDCl3 , 6): 4.03 (d, 8.5 Hz, 1H), 3.67 (d, 8.4 Hz, 1H), 3.59
(dd, 4.5, 7.8 Hz, 1H), 2.52 (bd, 2.1 Hz, 1H), 1.89 (m, 1H), 1.73 (m, 1H),
3H), 1.37 (m, 1H), 1.37 (s, 3H), 1.30 (s, 3H), 1.27 (s, 3H), 1.26 (s, 3H).
13 C (125 MHz, CDCl 3, 6): 109.8, 86.9, 83.3, 83.0, 72.5, 72.3, 71.5, 28.1,
24.3, 21.1.
(d, 10.8 Hz, 1H), 2.75
1.53 (m, 1H), 1.42 (s,
27.6, 27.2, 27.1, 27.0,
[a]24D= -3.7 (c 1.3, CHCl3).
IR (NaCl, thin film): 3473, 2980, 2874, 1460, 1371, 1257, 1210, 1072.
HRMS-ESI (m / z): [M + Na]* calcd for C13H240 4Na, 267.1572; found, 267.1578.
Me Me Me
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Primary alcohol 103: To a flame-dried 2 L flask with stir bar under N2 , trans,trans-farnesol(30.3518 g, 136.5 mmol) was dissolved in 1.2 L of hexane and cooled to 00 C. To this solution,
phosphorus tribromide (6.5 mL, 68.9 mmol) was added dropwise and the reaction was stirred for
1 h at this temperature. The reaction was diluted with diethyl ether, washed with saturated
NaHCO 3 and saturated NaCl, dried over MgSO4 and concentrated in vacuo to provide known
farnesyl bromide 101 4 as a yellow oil. Product was carried forward without further purification.
To a flame-dried 500 mL flask with stir bar under N2, diisopropylamine (32 mL, 227 mmol) was
dissolved in 92 mL of THF. nBuLi (88 mL, 2.55 M in hexanes, 224 mmol) was added dropwise
over 5 min and the reaction was stirred for 2 h at 0 'C then warmed to room temperature. To a
flame-dried 1 L flask equipped with a stir bar under N2, ethyl acetate (21.9 mL, 224 mmol) was
dissolved in 400 mL of THF and cooled to -104'C. Copper iodide (85.65 g, 450 mmol) was
added. A solution of lithium diisopropylamine (212 mL, 1.057 M solution in THF/hexane, 224
mmol) was added dropwise over 20 min and stirred for 10 min. The reaction was slowly
warmed to -40'C and transferred to an acetonitrile bath. A solution of farnesyl bromide (136
mmol) in 90 mL of THF was added by cannula. After stirring for 3 h at this temperature, the
reaction was poured into 1 L of water and then 500 g of NH4Cl was added until the solution
turned dark blue. The reaction was extracted with hexanes (400 mL, 5x), dried over MgSO 4,
filtered through Celite, and concentrated in vacuo. The product ester was obtained as colorless
oil (35.5 g, 121 mmol, 89% yield) and used without further purification.
To a flame-dried 250 mL flask equipped with a stir bar under N2 was added the previously
synthesized ester (3.212g, 11.0 mmol) and dissolved in 100 mL of diethyl ether and cooled to
00 C. Lithium aluminum hydride (435.6 mg, 11.5 mmol) was added slowly in small portions to
prevent vigorous heating over 5 min. The reaction was quenched with water (440 uL), 15% aq
NaOH (440 uL), and then water (1.32 mL) and warmed to room temperature. MgSO 4 was added
and the reaction mixture was filtered through Celite and concentrated in vacuo to provide a clear
colorless oil of 103 (2.325g, 9.28 mmol, 84% yield).
'H NMR (500 MHz; CDCl 3): 6 5.15 (ddd, J = 8.4, 6.0, 1.2, 1H), 5.12-5.08 (in, 2H), 3.65 (t, J
6.4, 2H), 2.11-2.04 (in, 6H), 1.99 (dt, J = 13.9, 7.2, 5H), 1.69 (d, J = 1.1, 3H), 1.65-1.64 (in, 2H),
1.63 (s, 3H), 1.60 (s, 6H)
13C NMR (125 MHz, CDC 3): 6 136.5, 135.7, 132.0, 125.1, 124.8, 124.4, 63.5, 40.4, 33.5, 27.4,
27, 3, 26.4, 25.0, 18.4, 16.7, 17.0.
IR (NaCl, thin film): 3333, 2925, 1444, 1382, 1057.
HRMS-ESI (m / z): [M + Na]* calcd for C17H30ONa, 273.2189; found, 273.2193.
H Me Me Me
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To a flame-dried 250 mL flask equipped with a stir bar under N2 was added the previously
synthesized alcohol 103 (2.325g, 9.28 mmol) and dissolved in 100 mL of CH2Cl 2 and cooled to
00C. Triethylamine (3.1 mL, 22.2 mmol) and DMSO (3.3 mL, 46.4 mmol) were both added
followed by S0 3opyridine (1.767g, 11.1 mmol) in small portions. The reaction was allowed to
warm to room temperature overnight. The reaction was quenched with saturated NH 4Cl and
extracted with CH 2Cl2 (3x). The organic layers were dried over MgSO 4, filtered, and
concentrated in vacuo. Column chromatography (10% EtOAc in hexanes) was used to purify the
aldehyde (R=0.61 in 20% ethyl acetate/hexane) to give colorless oil 99 (1.832g, 73.7 mmol,
79% yield). Spectra matched previously reported data.5
0 Me Me Me
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Ester 104: To a 1 L round-bottom flame-dried flask equipped with a stir bar was added aldehyde
99 (2.75g, 11.1 mmol) followed by benzene (110 mL). (1-
Ethoxycarbonylethyldiene)triphenylphosphorane (3.29 g, 9.1 mmol) was added in one portion
and the reaction was heated to 40 'C for 10 h. The reaction was cooled to room temperature and
the volatiles were removed in vacuo. The remaining yellow solid was loaded onto silica gel with
CH 2Cl2 and purified via flash column chromatography (2% to 5% EtOAc in hexanes) to provide
104 (2.86 g, 8.6 mmol, 74% yield) as colorless oil which was used without further purification.
Me Me Me
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Alcohol 105: To a 200 mL round-bottom flame-dried flask equipped with a stir bar was
dissolved ester 104 (2.86 g, 8.6 mmol) in Et2 0 (64 mL) and cooled to 0 'C. Lithium aluminum
hydride (341.0 mg, 9.0 mmol) was added slowly in portions and the reaction was allowed to stir
while warming to room temperature for 7.5 h. The reaction was returned to 0 'C and 340 uL of
water was added, followed by 340 uL of 15% NaOH in brine, followed by 1 mL of water. The
reaction was allowed to warm to room temperature while stirring for 30 min. MgSO 4 was added
and stirred for an additional 30 min. The reaction was filtered through Celite (eluting with Et 20)
and then concentrated in vacuo to provide colorless oil. The residue was purified via flash
column chromatography (10% to 20% to 30% EtOAc in hexanes) to provide alcohol 105 (1.69 g,
5.82 mmol, 68% yield) as colorless oil.
H (500 MHz, CDCl 3, 8): 5.43 (in, 1H), 5.13 (m, 3H), 4.01 (d, J=3.3 Hz, 2H), 2.07 (in, 8H), 2.00
(in, 4H), 1.69 (s, 3H), 1.68 (s, 3H), 1.61 (s, 9H), 1.36 (bs, 1H).
13C (125 MHz, CDCl 3 , 6): 135.7, 135.2, 135.0, 131.5, 126.4, 124.6, 124.4, 124.1, 69.3, 39.9,
28.1, 27.0, 26.8, 25.9, 17.9, 16.3, 16.2, 13.9.
IR (NaCl, thin film): 3327, 2965, 2856, 2917, 1667, 1444, 1382, 1222, 1007.
HRMS-ESI (in / z): [M + Na]* calcd for C20H34ONa, 313.2502; found, 313.2504.
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Epoxy alcohol 106: To a 100 mL round-bottom flame-dried flask equipped with a stir bar was
added 4 A molecular sieves (1.06 g) and heated under vacuum for 15 min. CH2Cl 2 (30 mL) was
added and the flask was cooled with a CryoCool to -20 'C. Titanium isopropoxide (230 uL, 0.76
mmol) and D-(-)-diethyl tartrate (160 uL, 0.93 mmol) were added and stirred for 35 min. A
solution of tert-butyl hydrogen peroxide (5.5 M in decanes, 2.1 mL, 11.5 mmol) was added and
stirred for 30 min. A solution of alcohol 105 (1.67 g, 5.75 mmol) in 10 mL of CH 2Cl 2 was added
slowly over 20 min. The reaction was stirred at this temperature for 9.5 h. The reaction was
quenched by adding 1.45 mL of a 40% solution of NaOH in brine (6.5 mL: 5.85 mL H20, 2.6 g
NaOH, 325 mg NaCl) and then 10 mL of Et20 and let warm while stirring for 30 min. 1.5 g of
MgSO 4 was added along with 150 mg of Celite and stirred for 30 min at room temperature. The
reaction was filtered through Celite (eluting with CH 2Cl 2) and concentrated in vacuo. The crude
oil was purified via flash column chromatography (20 to 30% EtOAc in hexanes) to provide
epoxy alcohol 106 (1.10 g, 3.6 mmol, 63% yield) as colorless oil. Enantiomeric excess
determined to be 80% via chiral HPLC analysis of the acetonide product 108.
H (500 MHz, CDCl 3, 6): 5.16 (qt, J=7.2, 1.2 Hz, 1H), 5.10 (in, 2H), 3.68 (dd, J=12.1, 3.4 Hz,
1H), 3.56 (dd, J=12.1, 7.9 Hz), 3.05 (t, J=6.5 Hz, 1H), 1.94-2.24 (in, 1OH), 1.91 (bs, lH), 1.68 (s,
3H), 1.54-1.67 (in, 2H), 1.62 (s, 3H), 1.60 (s, 6H), 1.28 (s, 3H).
13C (125 MHz, CDCl 3 , 6): 136.4, 135.3, 131.5, 124.5, 124.2, 123.2, 65.6, 61.2, 60.1, 39.9, 28.6,
26.9, 26.8, 25.9, 25.0, 17.9, 16.2, 14.5.
[a]24 D 3-3 (c 1.0, CHCl3).
IR (NaCl, thin film): 3425, 2918, 2854, 1441, 1380, 1033.
HRMS-ESI (m / z): [M + Na]* calcd for C20H340 2Na, 329.2451; found, 329.2437.
OBz Me Me Me
HOH6Me
HO Me
107
Benzoate 107: To a 100 mL round-bottom flame-dried flask equipped with a stir bar was
dissolved epoxy alcohol 106 (1.08 g, 3.5 mmol) in 30 mL of chloroform. 5.6 mL of a solution of
benzoic acid and titanium isopropoxide in CHCl3 was added (To a 50 mL round-bottom flask
equipped with a stir bar was added (3.28 g, 26.9 mmol) followed by 24.4 mL of CHCl3 and
Ti(O'Pr)4 (7.4 mL, 24.4 mmol). The flask was stirred for 30 min at room temperature and the
dissolved solution added to the previous reaction.). The reaction was stirred at room temperature
for 42 h before concentrating in vacuo. Equal volumes of Et2O and 10% citric acid solutions
were added and stirred for 1 h. The aqueous layer was extracted with Et20 (3x) and then washed
with NaHCO 3, dried over Na2SO 4, filtered, and concentrated in vacuo. The crude white milky
oil was purified via the Biotage (50 g column) to provide benzoate 107 (929 mg, 61% yield) as
colorless oil.
IH NMR (400 MHz; CDCl 3): 6 8.07 (dd, J = 8.3, 1.4, 2H), 7.63-7.58 (in, 1H), 7.50-7.45 (m, 2H),
5.13-5.04 (m, 4H), 3.48 (dd, J = 11.8, 3.8, 1H), 3.37 (d, J = 4.1, 1H), 3.30-3.27 (m, 1H), 2.94 (s,
1H), 2.10-1.91 (in, 12H), 1.82 (t, J = 5.3, 1H), 1.68 (d, J = 1.1, 3H), 1.60 (d, J = 0.5, 3H), 1.58 (d,
J = 1.0, 3H), 1.52 (d, J = 0.8, 3H), 1.15 (s, 3H)
1C NMR (100 MHz; CDC13): 6 168.0, 136.4, 135.1, 133.7, 131.4, 130.0, 129.6, 128.7, 124.6,
124.3, 123.2, 76.0, 73.6, 67.0, 39.9, 39.8, 28.5, 26.9, 26.7, 25.9, 25.1, 17.9, 17.9, 16.2, 16.2
[a]24D = -34.6 (c 3.4, CHCl3)
IR (NaCl, thin film): 3436, 2966, 2926, 1721, 1700, 1602, 1585, 1451, 1377, 1278, 1177, 1118,
1026, 848, 711
HRMS-ESI (m / z): [M + Na]* calcd for C2 7H4 00 4Na, 451.2819; found, 451.2807.
OBz Me Me Me
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Acetonide 108: To a 25 mL round-bottom flame-dried flask equipped with a stir bar was added
benzoate 107 (861.1 mg, 2.01 mmol) in CH 2Cl 2 (6.1 mL) and 2,2-dimethoxypropane (8 mL).
(±)-CSA (55.1 mg, 0.24 mmol) was added and the reaction was stirred for 5 h at room
temperature. Additional CH 2Cl 2 was added and then washed with saturated NaHCO 3. The
organic layers were dried over Na2SO 4, filtered, and concentrated in vacuo. The crude oil was
purified via Biotage (50 g column) to provide acetonide 108 (743.2 mg, 79% yield) as colorless
oil.
'H NMR (400 MHz; CDCl 3): 6 8.08-8.06 (m, 2H), 7.60-7.56 (m, 1H), 7.48-7.44 (m, 2H), 5.26
(dd, J = 10.3, 2.6, 1H), 5.14-5.07 (m, 3H), 4.02 (d, J = 8.7, 1H), 3.72 (d, J = 8.6, 1H), 2.06 (dt, J
= 11.0, 7.6, 6H), 2.01-1.92 (m, 5H), 1.68 (d, J = 1.1, 4H), 1.60 (d, J = 0.6, 3H), 1.58 (d, J = 1.0,
3H), 1.54 (d, J= 1.0, 3H), 1.41 (s, 3H), 1.39 (s, 3H), 1.34 (s, 3H)
13C NMR (100 MHz; CDCl 3): 6 166.2, 136.3, 135.2, 133.2, 131.5, 130.4, 129.9, 128.6, 124.6,
124.4, 123.4, 110.2, 82.3, 72.6, 39.9, 39.88, 30.3, 27.3, 27.0, 27.0, 26.8, 25.9, 24.8, 21.4, 17.9,
16.3, 16.2
[a]24 D = -8.9 (c 6.0, CHCl3).
IR (NaCl, thin film): 2983, 2931, 1724, 1603, 1451, 1378, 1271, 1110, 1068, 1027.
HRMS-ESI (m / z): [M + Na]- caled for C30H440 4Na, 491.3132; found, 491.3121.
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Acetonide 109: To a 50 mL round-bottom flame-dried flask equipped with a stir bar was added
benzoate 108 (617.4 mg, 1.32 mmol) in MeOH (13 mL) and THF (5 mL). Potassium carbonate
(237.5 mg, 1.72 mmol) was added and the reaction was stirred for 8 h at room temperature. The
solvents were concentrated in vacuo and then the crude residue was dissolved in CH 2Cl 2 and
saturated NH4Cl was added to quench the remaining carbonate. The aqueous layer was extracted
with CH 2 Cl 2 (3x), dried over Na2 SO 4, filtered, and concentrated in vacuo. The crude oil was
purified via the Biotage (50g column) to provide acetonide 109 (331.4 mg, 69% yield) as
colorless oil. Acetonide migration product SI-109A (47.2 mg, 10% yield) was obtained as well
under the reaction conditions.
Acetonide 109:
'H (500 MHz, CDCl 3, 6): 5.12 (in, 3H) , 4.04 (d, J=8.4 Hz, 1H), 3.66 (d, J=8.4 Hz, 1H), 3.55
(ddd, J=10.7, 2.9, 2.1, 1H), 2.23 (dd, J=3.0, 1.2 Hz, 1H), 2.30-1.94 (in, 11H), 1.68 (s, 3H), 1.64
(s, 3H), 1.60 (s, 6H), 1.56 (in, 1H), 1.45 (s, 3H), 1.39 (s, 3H), 1.26 (s, 3H).
13C (125 MHz, CDCl 3, 6): 136.4, 135.3, 131.5, 124.6, 124.3, 123.9, 109.5, 84.0, 74.4, 70.4, 39.9,
31.5, 27.7, 27.0, 26.8, 25.9, 25.2, 21.9, 17.9, 16.3, 16.2.
[a]24 D= -8.2 (c 2.0, CHCl3).
IR (NaCl, thin film): 3492, 2983, 2926, 1452, 1378, 1255, 1214, 1114, 1058.
HRMS-ESI (m / z): [M + Na]* calcd for C23H40O3Na, 387.2870; found, 387.2880.
SI-109A:
'H (500 MHz, CDCl 3, 6): 5.11 (in, 3H), 3.83 (dd, J=10.0, 3.1 Hz, 1H), 3.57 (dd, J=10.9, 3.3 Hz,
1H), 3.32 (dd, J=10.9, 9.3 Hz, 1H), 2.25-1.87 (in, 12H), 1.68 (s, 3H), 1.65 (in, 1H), 1.63 (s, 3H),
1.60 (s, 6H), 1.45 (s, 3H), 1.38 (s, 3H), 1.27 (s, 3H).
13 C (125 MHz, CDCl 3, 6): 136.6, 135.3, 131.5, 124.5, 124.3, 123.4, 107.4, 82.3, 82.0, 65.5, 39.9,
28.6, 28.0, 27.0, 26.8, 26.6, 25.9, 25.5, 21.2, 17.9, 16.3, 16.2.
[]24 D -1.6 (c 2.4, CHCl3).
IR (NaCl, thin film): 3477, 2983, 2930, 1446, 1378, 1247, 1216, 1108, 1053, 1002.
HRMS-ESI (m / z): [M + Na]* calcd for C23H40O3Na, 387.2870; found, 387.2886.
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Triepoxide 98: To a 125 mL Erlenmeyer flask with stir bar was added triene 109 (292.4 mg,
0.802 mmol) in 21 mL of a 2:1 v/v solution of DMM:CH 3CN. A 0.05 M solution of
Na2B407-10H20 in 4 x 10-4 M Na 2EDTA (14 mL), nBu4HSO 4 (21 mg, 0.06 mmol), and chiral
ketone 62 (178.7 mg, 0.692 mmol) were added. The biphasic mixture was stirred vigorously at
room temperature. Two solutions (Oxone (1.6007 g, 2.60 mmol) in 4x1 0-4 M Na2EDTA (11.9
mL) and a 0.89 M solution of K2CO 3 (11.9 mL)) were added simultaneously via syringe pump
over 35 min. The reaction was stirred for an additional 30 min and then diluted with 60 mL of
water and stirred for 1 h. The aqueous layer was extacted with CH2Cl 2 (3x) and then the organic
layers were dried over Na 2SO 4, filtered, and concentrated in vacuo. The crude oil was purified
by Biotage (50 g) to furnish triepoxide 98 (316.6 mg, 0.767 mmol, 96% yield) as colorless oil.
'H NMR (400 MHz; CDCl 3): 6 4.01 (d, J = 8.5, 1H), 3.66 (d, J = 8.5, 1H), 3.56 (dd, J= 8.4, 2.4,
1H), 2.76-2.66 (m, 3H), 2.50 (d, J = 3.0, lH), 1.86 (dt, J = 9.2, 4.6, 1H), 1.77-1.68 (m, 3H), 1.67-
1.50 (m, 8H), 1.41 (s, 3H), 1.35 (s, 3H), 1.28 (s, 3H), 1.27 (s, 3H), 1.25 (s, 3H), 1.24 (s, 3H),
1.24 (s, 3H)
1C NMR (100 MHz; CDCl 3): 6 109.6, 83.8, 74.4, 70.6, 64.0, 63.4, 62.8, 60.6, 60.5, 58.6, 35.3,
28.5, 27.6, 26.9, 26.1, 25.0, 24.7, 24.5, 21.6, 18.8, 16.9, 16.8
[a]24D =+15.1 (c 2.8, CHCl3)
IR (NaCl, thin film): 3487, 2982, 2933, 2872, 1645, 1458, 1379, 1324, 1253, 1213, 1118, 1056,
984, 913, 857, 808, 677
HRMS-ESI (m / z): [M + H]* calcd for C23H4106 , 413.2898; found, 413.2902.
MeMe
O M O H
O Me
H Me '"OAc
110
Tricycle acetate 110: To a 100 mL round-bottom flask equipped with a stir bar was added
triepoxide 98 (363.5 mg, 1.07 mmol) in 22 mL of CH2Cl2. The flask was cooled to -78 'C and
then BF 3-OEt 2 (67 uL, 0.543 mmol) was added dropwise. The reaction was stirred for 1 h at this
temperature and then allowed to warm to room temperature. The reaction was quenched by the
addition of saturated NH 4Cl, and then the aqueous layers were extracted with CH2Cl 2 (3x). The
organic layers were dried over Na2SO 4 , filtered, and concentrated in vacuo. The crude product
was used without purification for the acetate protection.
To a 50 mL round-bottom flask equipped with a stir bar was added crude alcohol (364 mg) in 11
mL of CH 2Cl 2. Triethyl amine (600 uL, 5.44 mmol) and acetic anhydride (205 uL, 2.17 mmol)
were added followed by the addition of DMAP (10 mg, 0.082 mmol). The reaction was stirred at
room temperature for 16 h and then quenched with saturated NH 4Cl. The aqueous layer was
extracted with CH2Cl 2 (3x) and then the organic layers were dried over Na2 SO 4 , filtered, and
concentrated in vacuo. The crude product was purified by column chromatography (5 to 20%
EtOAc in hexanes) to furnish acetate 110 (52.5 mg, 0.138 mmol, 13% yield) as colorless oil.
'H NMR (600 MHz; CDCl 3): 6 4.91 (d, J = 6.7, 1H), 3.97 (d, J = 8.4, 1H), 3.67 (d, J = 8.3, 1H),
3.54 (dd, J = 11.4, 4.2, 1H), 3.46 (d, J = 11.5, 1H), 3.35 (d, J = 11.8, 1H), 2.12 (s, 3H), 2.07-2.01
(in, 2H), 1.88-1.79 (m, 3H), 1.79-1.63 (m, 5H), 1.52-1.47 (m, 2H), 1.38 (s, 3H), 1.37 (s, 3H),
1.25 (s, 3H), 1.22 (s, 6H), 1.15 (s, 3H), 1.14 (s, 3H)
13C NMR (125 MHz; CDCl3): 6 170.3, 109.6, 82.3, 78.8, 78.7, 78.1, 77.3, 77.2, 73.8, 73.6, 70.6,
40.6, 36.8, 29.2, 28.9, 27.6, 27.4, 27.1, 25.7, 23.2, 21.8, 21.3, 20.2, 20.0, 16.5
[a]24 D 18-1 (c 0.34, CHCl3)
IR (NaCl, thin film): 2982, 2937, 2872, 1741, 1453, 1371, 1241, 1211, 1085, 1029
HRMS-ESI (m / z): [M + H]* caled for C25H430 7, 455.3003; found, 455.3008.
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Allylic alcohol 114: To a 25 mL round-bottom flask equipped with a stir bar was added (+)-
MIB6 (33.3 mg, 0.139 mmol) and transferred into a wet box. Added diisopropenyl zinc 1157
(573.5 mg, 0.3.89 mmol) and 10 mL of toluene and stirred for a few min. Added ZnEt2 (1.1 mL,
10.5 mmol) and transferred out of a glove box and into a hood under N2. The reaction was
cooled in an ice bath to 00 C and then a solution of 99 (855.5 mg, 3.44 mmol) in 5 mL of toluene
and added slowly to the reaction. The reaction was stirred at 00 C for 20 h. The reaction was
quenched with 15 mL of saturated NH4Cl and warmed to room temperature. The aqueous layer
was extracted with Et2 O( 3x, 40 mL). The combined organic layers were dried over MgSO 4 ,
filtered, and concentrated in vacuo. The reaction mixture was purified by column
chromatography (10% EtOAc in hexanes) to give 114 (809.3 mg, 2.79 mmol, 81% yield) as
colorless oil.
'H NMR (500 MHz; CDCl 3): 5 5.16 (ddd, J = 8.4, 6.0, 1.2, 1H), 5.13-5.08 (in, 2H), 4.08 (td, J
5.9, 4.4, 1H), 2.11-2.05 (in, 5H), 2.03-1.97 (m, 4H), 1.74 (t, J = 1.1, 3H), 1.69 (d, J = 1.2, 3H),
1.63 (d, J = 0.9, 3H), 1.61 (s, 6H), 1.62-1.57 (in, 1H), 1.52 (d, J= 3.9, 1H)
13C NMR (125 MHz; CDCl3 ): 6 147.8, 136.0, 135.3, 131.5, 124.6, 124.3, 124.0, 111.2, 75.9,
39.9, 35.2, 27.0, 26.8, 25.9, 24.4, 17.9, 17.9, 16.3, 16.2
[a]2 4 D = -2.6 (c 0.23, CHCl3)
IR (NaCl, thin film): 3368, 2926, 1653, 1559, 1540, 1457, 1057, 897
HRMS-ESI (m / z): [M + Na]* calcd for C20H34 ONa, 313.2502; found, 313.2509.
OAc Me Me Me
Me
Me 117
Acetate 117: To a 20 mL vial equipped with a stir bar was added 114 (151 mg, 0.520 mmol)
and dissolved in 5.2 mL of CH 2Cl2. To the vessel was added Ac 20 (100 uL, 1.06 mmol) and
Et3N (290 uL, 2.08 mmol) followed by two crystals of DMAP. The reaction was stirred for two
h before being quenched with saturated NH4Cl and extracting with CH 2C12 (3x). The organic
layers were dried over MgSO4, filtered, and concentrated in vacuo. The reaction mixture was
purified by column chromatography to provide colorless oil of 117 (183 mg, 0.550 mmol, 95%
yield).
'H NMR (500 MHz; CDCl 3): 6 5.16 (dd, J = 7.4, 6.1, 1H), 5.13-5.09 (m, 3H), 4.95 (t, J = 0.8,
1H), 4.89 (t, J = 1.6, 1H), 2.10-2.05 (m, 4H), 2.07 (s, 3H), 2.01-1.96 (m, 6H), 1.73 (t, J = 0.9,
3H), 1.69 (d, J= 0.8, 3H), 1.66-1.63 (m, 2H), 1.61 (s, 6H), 1.59 (s, 3H)
1C NMR (125 MHz; CDC63): S 170.5, 143.4, 136.1, 135.2, 131.4, 124.6, 124.3, 123.4, 112.8,
77.2, 39.9, 39.9, 27.0, 26.8, 25.9, 24.1, 21.4, 18.3, 17.9, 16.2, 16.2
[a] 24D -6.6 (c 2.2, CDCl3) (77% ee)
IR (NaCl, thin film): 2967, 2922, 2956, 1742, 1653, 1437, 1370, 1238, 1021, 902, 834
HRMS-ESI (m / z): [M + Na]* calcd for C22H360 2Na, 355.2608; found, 355.2613.
OAc Me Me Me
Me
Me 118
Triepoxide 118: To a 20 mL vial equipped with a stir bar was added a solution of acetate 117
(183 mg, 0.550 mmol) in 15 mL of 2:1 DMM/CH 3CN and 15 mL of EDTA buffer. nBu4NHSO 4(10 mg, 29.5 umol) was added and the reaction was vigorously stirred followed by the addition
of Shi ketone 62 (79 mg, 0.306 mmol). A solution of Oxone (1.002 g, 1.63 mmol) in 6.5 mL of
EDTA solution and a solution of 9.5 mL of 0.89 M K2C0 3 were added dropwise side-by-side
over 25 min. The reaction was allowed to stir for an additional 30 min before equiv volume of
water was added. The reaction was extracted with CH 2Cl2 (3x) and dried over Na2SO 4. The
reaction was filtered and concentrated in vacuo and purified by column chromatography to
provide colorless oil 118 (98 mg, 0.258 mmol, 47% yield).
'H NMR (400 MHz; CDCl 3): 6 5.18 (q, J = 7.1, 1H), 4.92 (dt, J = 18.6, 1.1, 2H), 2.75-2.68 (in,
3H), 2.06 (s, 3H), 1.72 (s, 3H), 1.90-1.42 (in, 12H), 1.30 (s, 3H), 1.27 (s, 3H), 1.27 (s, 3H), 1.26
(s, 3H)
13C NMR (100 MHz; CDCl 3): 6 170.4, 142.9, 113.2, 64.0, 62.8, 62.76, 60.6, 60.5, 60.5, 58.6,
35.4, 35.3, 29.7, 25.0, 24.8, 24.78, 24.6, 21.4, 18.9, 18.4, 16.9, 16.8
[a]24 D +13.9 (c 1.2, CHCl3)
IR (NaCl, thin film): 2964, 2930, 1739, 1457, 1378, 1240, 1022, 900
HRMS-ESI (m / z): [M + Na]+ calcd for C22H360 5Na, 403.2455; found, 403.2437.
OH Me Me Me
Me
Me 113
Allylic alcohol 113. To a 20 mL vial equipped with a stir bar was added 118 (99 mg, 0.240
mmol) and cooled to 00C. Lithium hydroxide (36 mg, 0.250 mmol) in a 1:1:1 solution of
THF/MeOH/H 20 (700 uL) was added and the reaction was stirred for 1.5 h and then quenched
with saturated NH 4Cl. The reaction was extracted 3x with Et20 and then dried over Na 2SO 4 ,
filtered, and concentrated in vacuo. The reaction was purified by column chromatography to
provide colorless oil 113 (45 mg, 0.133 mmol, 55% yield) along with THF SI-1 13A.
113:
'H NMR (500 MHz; CDCl 3): 6 4.96 (dt, J = 1.7, 0.9, 1H), 4.85 (d, J = 0.9, 1H), 4.13-4.11 (m,
1H), 2.81-2.68 (in, 3H), 1.73 (d, J = 0.5, 3H), 1.79-1.55 (in, 12H), 1.30 (s, 3H), 1.29 (s, 3H), 1.27
(s, 3H), 1.26 (s, 3H)
13C NMR (125 MHz; CDCl 3): 6 147.5, 111.2, 75.3, 64.0, 63.4, 62.8, 60.7, 60.6, 58.7, 35.4, 32.0,
25.0, 25.0, 24.8, 24.6, 18.9, 18.8, 18.1, 16.9, 16.8
[]24 D 1 0. 2 (c 0.73, CHC13)
IR (NaCl, thin film): 3452, 2966, 1653, 1559, 1457, 1386, 1251, 1068, 897
HRMS-ESI (m / z): [M + Na]+ calcd for C20H340 4Na, 361.2349; found, 361.2355.
HO Me Me Me
Me Me
SI-113A:
1H NMR (500 MHz; CDCl 3): 6 4.99 (dd, J = 1.9, 1.0, 1H), 4.80 (dt, J = 1.4, 0.7, 1H), 4.38 (dd, J
= 8.6, 6.4, 1H), 3.87 (dd, J = 9.2, 6.2, 1H), 2.77 (dd, J = 6.7, 5.8, 1H), 2.72 (t, J = 6.1, 1H), 2.15-
2.06 (in, 2H), 1.92-1.84 (in, 2H), 1.82-1.67 (in, 3H), 1.71 (s, 3H), 1.66-1.52 (in, 5H), 1.32 (s,
3H), 1.30 (s, 3H), 1.27 (s, 3H), 1.23 (s, 3H)
13C NMR (125 MHz; CDCl 3): 6 146.2, 110.0, 86.1, 83.0, 73.1, 64.1, 63.5, 60.7, 58.7, 35.4, 33.8,
32.1, 27.0, 25.1, 24.8, 24.1, 23.2, 18.9, 18.1, 16.9
[a]24D -2-6 (c 0.26, CHCl3)
IR (NaCl, thin film): 3465, 2967, 2927, 1653, 1559, 1507, 1457, 1376, 1249, 1076, 955, 896
HRMS-ESI (m / z): [M + Na]* calcd for C20H340 4Na, 361.2349; found, 361.2361.
119
Acetate 119: To a 100 mL round-bottom flask equipped with a stir bar was added triepoxide
113 (363.5 mg, 1.07 mmol) in 22 mL of CH 2 Cl 2 . The flask was cooled to -78 'C and then
BF3-OEt2 (67 uL, 0.543 mmol) was added dropwise. The reaction was stirred for 1 h at this
temperature and then allowed to warm to room temperature. The reaction was quenched by the
addition of saturated NH4 Cl and then the aqueous layers were extracted with CH 2Cl 2 (3x). The
organic layers were dried over Na2 SO 4, filtered, and concentrated in vacuo. The crude product
was used without further purification for the acetate protection.
To a 50 mL round-bottom flask equipped with a stir bar was added crude alcohol 112 (364 mg)
in 11 mL of CH 2Cl 2 . Triethyl amine (600 uL, 5.44 mmol) and acetic anhydride (205 uL, 2.17
mmol) were added followed by the addition of DMAP (10 mg, 0.082 mmol). The reaction was
stirred at room temperature for 16 h and then quenched with saturated NH 4Cl. The aqueous
layer was extracted with CH 2Cl 2 (3x) and the organic layers were dried over Na 2SO 4 , filtered,
and concentrated in vacuo. The crude product was purified by column chromatography (5 to
20% EtOAc in hexanes) to furnish acetate 119 (52.5 mg, 0.138 mmol, 13% yield) as colorless
oil.
'H NMR (500 MHz; CDCl 3): 6 4.96 (t, J = 0.9, 1H), 4.91 (d, J = 6.8, 1H), 4.81 (dd, J = 1.3, 0.6,
1H), 3.90-3.88 (dd, J = 11.8, 1.5, 1H), 3.61 (dd, J = 10.8, 5.3, 1H), 3.47 (dd, J = 11.4, 2.3, 1H),
2.12 (s, 3H), 2.07-2.04 (m, 1H), 1.95 (dq, J = 15.0, 4.5, 1H), 1.87 (ddt, J = 11.8, 6.9, 2.2, 2H),
1.79 (td, J = 13.8, 2.4, 2H), 1.73 (s, 3H), 1.71-1.64 (m, 2H), 1.54-1.42 (m, 4H), 1.29 (s, 3H), 1.26
(s, 3H), 1.16 (s, 3H), 1.14 (s, 3H)
13 C NMR (125 MHz; CDCl 3): 6 170.8, 146.8, 111.1, 79.3, 79.1, 78.8, 77.8, 77.8, 73.5, 70.8,
41.3, 37.3, 31.4, 29.7, 29.4, 28.5, 23.7, 22.3, 21.8, 20.6, 19.6, 16.9
IR (NaCl, thin film): 2879, 2938, 1741, 1457, 1375, 1240, 1075
[]24 D 13-3 (c 0.65, CHCl3)
HRMS-ESI (m / z): [M + H]+ calcd for C22H370 5, 381.2636; found, 381.2642.
Me
M Me OAc
120
Ketone 120: To a 20 mL vial equipped with stir bar was added acetate 119 (67.7.6 mg, 0.178
mmol) in 2 mL of CH 2Cl 2 . The reaction was cooled to -78 'C and subjected to ozone until the
reaction turned light blue (~5 min). Oxygen was bubbled through the solution for 2 min,
followed by nitrogen for 1 min. The reaction was quenched by the addition of
triphenylphosphine (53.4 mg, 0.204 mmol) and allowing the reaction to warm to room
temperature for 1 h. Reaction was concentrated in vacuo and the reaction was loaded directly
onto a silica gel column. The crude reaction mixture was purified by column chromatography
(20% EtOAc in hexanes) to furnish ketone 120 (50.5 mg, 0.132 mmol, 74% yield) as colorless
oil.
'H NMR (500 MHz; CDCl 3): 6 4.92 (d, J = 6.7, 1H), 3.92 (dd, J = 12.1, 2.8, 1H), 3.61 (t, J = 8.1,
1H), 3.46 (dd, J = 11.4, 2.4, 1H), 2.18 (s, 3H), 2.12 (s, 3H), 2.19-1.76 (m, 6H), 1.69-1.65 (m,
3H), 1.53-1.41 (m, 3H), 1.26 (s, 6H), 1.16 (s, 3H), 1.15 (s, 3H)
13C NMR (100 MHz; CDCl 3): 6 209.9, 170.3, 78.9, 78.6, 78.2, 77.9, 77.4, 76.0, 69.7, 40.5, 36.7,
29.1, 28.9, 28.3, 27.4, 26.0, 23.2, 21.8, 21.3, 19.7, 16.4
HRMS-ESI (m / z): [M + Na]* calcd for C21H340 6Na, 405.2248; found, 405.2251.
P0 Me
1 H0  M e
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112
Secondary alcohol 112: To a 5 mL flask equipped with a stir bar was added acetate 119 (32.9
mg, 86.5 mmol) in 533 uL of MeOH and 1.1 mL of THF. A 1 M solution of LiOH was added
(210 uL, 210 mmol) and the reaction was stirred at room temperature for 30 min. The reaction
was quenched with saturated NH4 Cl and extracted with CH 2Cl 2 (3x). The organic layers were
dried over Na2 SO 4, filtered, and concentrated in vacuo. The crude oil was purified by column
chromatography (20 to 50% EtOAc in hexanes) to furnish alcohol 112 (17.9 mg, 52.9 mmol,
71% yield) as a colorless oil.
IH NMR (500 MHz; CDCl 3): 6 4.96 (t, J = 1.0, 1H), 4.80 (t, J = 1.4, 1H), 3.89 (dd, J = 11.4, 1.3,
1H), 3.76 (ddd, J = 6.1, 4.0, 1.7, 1H), 3.62 (t, J = 3.1, 1H), 3.59 (dd, J = 7.0, 3.8, 1H), 2.08-2.01
(m, 1H), 2.00-1.91 (m, 2H), 1.89 (dd, J = 5.3, 3.7, 1H), 1.84-1.78 (m, 2H), 1.78-1.75 (m, 1H),
1.72 (s, 3H), 1.71-1.67 (m, 1H), 1.65 (dt, J = 5.1, 2.8, 1H), 1.50 (dt, J = 6.9, 3.4, 2H), 1.48-1.45
(m, 1H), 1.45-1.42 (m, 1H), 1.27 (s, 3H), 1.25 (s, 3H), 1.25 (s, 3H), 1.10 (s, 3H)
13C NMR (125 MHz; CDCl3 ): 6 146.4, 110.6, 79.1, 78.0, 77.9, 77.4, 76.8, 73.0, 70.5, 40.5, 36.1,
30.9, 29.3, 29.1, 27.9, 25.9, 21.7, 19.7, 19.1, 16.6
[a]24D 29-8 (c 0.5, CHCl3)
IR (NaCl, thin film): 3432, 2935, 1653, 1559, 1540, 1507, 1457, 1375, 1074, 1034, 889
HRMS-ESI (m / z): [M + H]* calcd for C2 0H3 4 0 4, 339.2530; found, 339.2526.
121
Ketone 121: To a 20 mL vial equipped with a stir bar was added alcohol 112 (13.6 mg, 40.2
mmol) in 2 mL of CH 2Cl2. The reaction was cooled to -78 'C and subjected to ozone until the
reaction turned light blue (~5 min). Oxygen was bubbled through the solution for 2 min,
followed by nitrogen for 1 min. The reaction was quenched by the addition of
triphenylphosphine (17.6 mg, 67.1 mmol) and allowing the reaction to warm to room
temperature for 1 h. The reaction was concentrated in vacuo and then loaded directly onto a
silica gel column. The crude was purified by column chromatography (50% EtOAc in hexanes)
to furnish ketone 121 (10.5 mg, 30.8 mmol) as a colorless oil.
'H NMR (500 MHz; CDCl 3): 6 3.92 (dd, J = 12.2, 2.9, 1H), 3.78-3.77 (m, 1H), 3.62 (dd, J
11.5, 2.7, 1H), 3.60-3.58 (m, 1H), 2.18 (s, 3H), 2.07-1.91 (m, 4H), 1.86-1.79 (m, 3H), 1.68 (ddd,
J = 11.4, 8.1, 3.6, 2H), 1.52-1.40 (m, 3H), 1.26 (s, 3H), 1.25 (s, 3H), 1.25 (s, 3H), 1.10 (s, 3H)
13C NMR (100 MHz; CDCl 3): 6 210.0, 79.2, 78.0, 77.9, 77.4, 76.7, 75.9, 69.9, 40.2, 35.9, 29.2,
29.1, 28.4, 27.4, 26.0, 25.8, 21.7, 19.3, 16.5
OH Me Me Me
Me
(t)-1 31
Allylic alcohol (128). Dissolved aldehyde (99) (5.85 g, 23.6 mmol) in 200 mL of THF in a 500
mL flame-dried round-bottom flask equipped with a stir bar. Cooled reaction to -10 'C in a
acetone/dry ice bath and added solution of vinyl magnesium bromide in THF (50 mL, 1.0 M, 50
mmol) slowly over 5 min. The reaction was allowed to warm to room temperature over 1 h, then
was quenched with saturated NH4 Cl and transferred into a separatory funnel. Extracted 3x with
Et2 0, washed organic layers with brine, and then dried over MgSO 4. Filtered off solids and
removed solvent in vacuo. Purified reaction by column chromatography (5 to 10%
EtOAc/hexanes) to give (±)-131 (4.73 g, 17.1 mmol, 73% yield) in 10% EtOAc/hexanes) as a
colorless oil.
'H NMR (500 MHz; CDCl 3): 6 5.88 (dddd, J = 17.0, 10.6, 6.3, 1.2, 1H), 5.23 (dd, J = 17.2, 1.4,
1H), 5.17-5.14 (m, 1H), 5.12-5.08 (m, 3H), 4.12 (d, J = 6.2, 1H), 2.12-2.04 (m, 6H), 1.99 (dt, J
13.6, 7.0, 4H), 1.68 (s, 3H), 1.62 (s, 3H), 1.60 (s, 6H), 1.58-1.56 (m, 2H)
13C NMR (100 MHz; CDCl3): 6 141.4, 136.1, 135.2, 131.5, 124.6, 124.3, 124.0, 114.7, 73.1,
39.9, 37.2, 27.0, 26.8, 25.9, 24.1, 17.9, 16.3, 16.2
IR (NaCl, thin film): 3364, 2924, 2967, 2855, 1643, 1444, 1382, 1055, 990, 921, 835
HRMS-ESI (m / z): [M + Na]* caled for C19H32ONa, 228.2345; found, 229.2340.
OAc Me Me Me
Me
132
Allylic acetate (132). To a 20 mL vial equipped with a stir bar was added alcohol 131 (571.1
mg, 2.07 mmol) in 1 mL of Et 20 followed by vinyl acetate (950 uL, 10.3 mmol). Beads of
Novozyme 435 enzyme (33 mg, Aldrich L4777 from Candida antartica) were added and the
reaction was stirred for 2.5 h at room temperature and then 13.5 h at 4 'C in the fridge. The
reaction was filtered through glass wool and washed with Et 20 (5x). The reaction was
concentrated in vacuo and then purified by column chromatography (5 to 10% EtOAc/hexanes)
to give 132 (263.5 mg, 0.827 mmol, 40% yield, 99% ee) in 10% EtOAc in hexanes) and ent-131
(303.5 mg, 1.10 mmol, 53% yield, 29% ee). Resubjecting ent-131 to the reaction conditions for
an additional 16.5 h provided ent-131 in 98% ee.
132:
Chiral HPLC analysis: (Chiralcel OD, hexanes:2-propanol, 210 nm): tR (R) = 10.9 min; tR (S)
11.4 min. The enantiomeric excess was determined to be 98%.
IH NMR (500 MHz; CDCl 3): 6 5.78 (ddd, J = 17.1, 10.6, 6.5, 1H), 5.26-5.22 (m, 2H), 5.19-5.16
(m, 1H), 5.13-5.09 (m, 3H), 2.08 (s, 3H), 2.09-2.06 (m, 3H), 2.06-1.96 (m, 7H), 1.69 (d, J = 1.1,
3H), 1.68-1.62 (m, 2H), 1.61 (s, 3H), 1.60 (s, 3H), 1.59 (s, 3H)
13C NMR (125 MHz; CDCl 3): 6 170.6, 136.7, 136.2, 135.2, 131.5, 124.6, 124.3, 123.3, 116.8,
74.7, 39.93, 39.90, 34.5, 26.96, 26.78, 25.9, 23.8, 21.5, 17.9, 16.23, 16.20
[a] 24D = -3.1 (c 0.17, CHC 3)
IR (NaCl, thin film): 2924, 1996, 1741, 1653, 1540, 1457, 1374, 1237
HRMS-ESI (m / z): [M + Na]* calcd for C2 1H340 2Na, 341.2451; found, 341.2455.
OH Me Me Me
Me
ent-1 31
ent-131:
Chiral HPLC analysis of the benzonate derivative (BzCl, Et 3N, DMAP, CH2Cl 2): (Chiralcel OB-
H, hexanes:2-propanol): tR (S) 7.5 min; tR (R) = 8.4 min. The enantiomeric excess was
determined to be 98%.
[a]24D -- 3.4 (c 1.3, CHC 3)
OAc Me Me Me
Me
133
Triepoxide 133: To a 250 mL round-bottom flask equipped with a stir bar was added a solution
of acetate 132 (260.1 mg, 0.817 mmol) in 37 mL of 2:1 DMM/CH 3CN and 25 mL of EDTA
buffer. nBu4NHSO 4 (34.7 mg, 0.102 mmol) was added and the reaction was vigorously stirred
followed by the addition of Shi ketone 62 (155.4 mg, 0.602 mmol). A solution of Oxone (2.78 g,
4.52 mmol) in 20.5 mL of EDTA solution and a solution of 20.5 mL of 0.89 M K2CO3 were
added dropwise side-by-side over 30 min. The reaction was allowed to stir for an additional 30
min before 100 mL of water was added and stirred for an additional 45 min. The reaction was
extracted with CH 2Cl2 (3x) and dried over Na 2SO 4. The reaction was filtered and concentrated
in vacuo and subjected to column chromatography (20 to 50% EtOAc in hexanes) to provide
colorless oil 133 (263.2 mg, 0.718 mmol, 88% yield, 3.5:1 dr).
1H NMR (500 MHz; CDCl 3): 6 5.78 (ddd, J = 17.2, 10.7, 6.4, 1H), 5.29-5.24 (m, 2H), 5.20 (dt, J
= 10.5, 1.0, 1H), 2.76-2.69 (m, 3H), 2.08 (s, 3H), 1.84-1.52 (in, 12H), 1.31 (s, 3H), 1.28 (s, 3H),
1.27 (s, 3H), 1.26 (s, 3H)
"C NMR (125 MHz; CDCl 3): 6 170.5, 136.3, 117.3, 74.5, 64.20, 64.03, 63.6, 63.3, 62.8, 60.7,
35.80, 35.75, 35.4, 31.2, 29.9, 25.06, 24.98, 24.80, 21.4, 18.9, 16.6
OH Me Me Me
Me
134
Triepoxide 134: To a 20 ml vial equipped with a stir bar was added acetate 133 (259.1 mg,
0.707 mmol) in 1.5 mL of THF and cooled to 0 'C. 750 uL of MeOH was added followed by a
750 uL of a 1 M LiOH solution (prepared from 30.9 mg of LiOH in 815 uL of H20) added
dropwise. The reaction was stirred for 30 min at which time TLC showed complete consumption
of the starting material. The reaction was quenched with saturated NH4Cl and extracted with
Et20 (3x). The organic layers were combined and dried over Na 2SO 4, filtered, and concentrated
in vacuo. Column chromatography provided the colorless oil 134 (213.1 mg, 0.657 mmol, 93%
yield, 7:1 ratio with 136).
'H NMR (500 MHz; CDCl 3): 6 5.92-5.84 (in, 1H), 5.25 (d, J = 17.2, 1H), 5.13 (d, J = 10.4, 1H),
4.20-4.17 (in, 1H), 2.82-2.77 (in, 1H), 2.76-2.69 (in, 2H), 1.81-1.53 (m, 14H), 1.31 (s, 3H), 1.30
(s, 2H), 1.28 (s, 4H), 1.27 (s, 3H)
13C NMR (125 MHz; CDCl3): 6 141.0, 115.1, 72.6, 64.2, 64.0, 63.3, 63.1, 62.8, 60.8, 35.8, 35.4,
33.9, 25.0, 25.0, 24.8, 24.6, 18.9, 16.9, 16.8
[a]24D =+17.5 (c 0.44, CHCl3)
IR (NaCl, thin film): 3448, 2926, 1653, 1636, 1617, 1559, 1507, 1473, 1457, 1437, 1387, 1177
HRMS-ESI (m / z): [M + Na]* calcd for C19H320 4Na, 347.2198; found, 347.2195.
OH Me Me Me OH Me Me Me
e 0 0 0Me
ent-134 Me ent-1 36
Triepoxide ent-134 and tetraepoxide ent-136: To a 250 mL round-bottom flask equipped with
a stir bar was added a solution of allylic alcohol ent-131 (260.1 mg, 0.817 mmol) in 37 mL of
2:1 DMM/CH 3CN and 25 mL of EDTA buffer. nBu4NHSO 4 (34.7 mg, 0.102 mmol) was added
and the reaction was vigorously stirred followed by the addition of Shi ketone 62 (155.4 mg,
0.602 mmol). A solution of Oxone (2.78 g, 4.52 mmol) in 20.5 mL of EDTA solution and a
solution of 20.5 mL of 0.89 M K2CO3 were added dropwise side-by-side over 30 min. The
reaction was allowed to stir for an additional 30 min before 100 mL of water was added and
stirred for an additional 45 min. The reaction was extracted with CH 2Cl 2 (3x) and dried over
Na 2SO 4. The reaction was filtered and concentrated in vacuo and subjected to column
chromatography (20 to 50% EtOAc/hexanes) to provide a colorless oil of triepoxide ent-134
(263.2 mg, 0.718 mmol, 61% yield, 3.5:1 dr) and tetraepoxide ent-136 (35 mg, 0.232 mmol, 20%
yield, 1:1 dr).
ent-136:
Data for a 1:1 mixture of diastereomers
'H NMR (500 MHz; CDCl3): 6 3.84 (dd, J = 7.9, 3.1, 1H), 3.53 (td, J = 4.3, 1.4, 1H), 3.02-2.98
(m, 2H), 2.82-2.76 (m, 4H), 2.75-2.68 (m, 6H), 1.85-1.52 (m, 24H), 1.30 (s, 6H), 1.29 (s, 6H),
1.27 (s, 6H), 1.26 (s, 6H)
1C NMR (125 MHz; CDCl 3): 6 71.2, 68.6, 64.2, 64.0, 63.3, 63.3, 62.8, 62.8, 60.7, 60.6, 58.7,
55.4, 55.4, 54.5, 54.5, 45.1, 43.8, 35.8, 35.4, 31.5, 30.5, 25.0, 24.8, 24.5, 18.8, 16.9
137
Acetate 137. To a flame-dried 100 ml round-bottom flask equipped with a stir bar was added
triepoxide 134 (1.5594g, 4.81 mmol) in 100 mL of dichloromethane and cooled to -78 'C.
BF 3*OEt2 (210 uL, 1.70 mmol) was added dropwise and the reaction was stirred at the same
temperature for 15 min. Saturated NH 4Cl was added to quench the reaction and it was warmed
to room temperature. The reaction was poured into a seperatory funnel and extracted with
CH 2Cl2 (3x) from brine. The organic layers were dried over Na2SO 4, filtered, and concentrated
in vacuo.
The crude reaction mixture was dissolved in 50 mL of dichloromethane in a 100 mL flame-dried
round-bottom flask equipped with a stir bar. Acetic anhydride (950 uL, 10.0 mmol), triethyl
amine (2.8 mL, 20.1 mmol), and DMAP (59.8 mg, 0.490 mmol) were all added and reaction was
stirred at room temperature overnight. Saturated NH 4Cl was added and the reaction was
transferred to a separatory funnel and extracted with CH 2Cl2 (3x). The organics were dried over
Na 2SO 4, filtered, and concentrated in vacuo. Column chromatography provided colorless oil 137
(324.6 mg, 0.886 mmol, 18.4 % yield).
'H NMR (500 MHz; CDCl3): 6 5.84-5.77 (in, 1H), 5.21 (dt, J = 17.3, 1.4, 1H), 5.09 (ddd, J =
10.5, 1.6, 1.1, 1H), 4.92 (d, J = 6.7, 1H), 4.01-3.97 (m, 1H), 3.62 (dd, J = 11.1, 5.0, 1H), 3.46
(dd, J = 11.5, 2.5, 1H), 2.12 (s, 3H), 2.10-2.04 (in, 2H), 2.00-1.81 (in, 3H), 1.81-1.61 (m, 5H),
1.54-1.43 (in, 2H), 1.30 (s, 3H), 1.26 (s, 3H), 1.16 (s, 3H), 1.14 (s, 3H)
1C NMR (125 MHz; CDCl 3): 6 208.5, 139.6, 115.3, 78.8, 78.6, 78.4, 77.4, 77.1, 71.1, 70.2,
40.8, 36.8, 32.1, 29.2, 28.9, 27.8, 23.2, 21.8, 21.3, 20.1, 16.4
[]24 D = +22.9 (c 0.06, CHC13)
IR (NaCl, thin film): 2936, 2361, 2339, 1734, 1653, 1540, 1457, 1241, 1078
HRMS-ESI (m / z): [M + Na]* calcd for C21H3405Na, 389.2298; found, 389.2290.
H H OMe H M0 1%H 0 Me
Me
H Me OAc
ent-1 37
ent-137: An identical procedure as 137 was used to furnish the enantiomer from ent-137.
[a]24 = -18.2, (c 0.58, CHCl3)
H Me
Me4 OAc
138
Aldehyde 138: To a 100 mL round-bottom flask equipped with a stir bar was added acetate 137
(324.6 mg, 0.886 mmol) in 44 mL of CH 2Cl 2. Sodium bicarbonate (20.2 mg, 0.240 mmol) and
8.9 mL of MeOH were added. The reaction was cooled to -78 'C and subjected to ozone until
the reaction turned light blue (~10 min). Oxygen was bubbled through the solution for 2 min,
followed by nitrogen for 1 min. The reaction was quenched by the addition of
triphenylphosphine (256.5 mg, 0.978 mmol) and allowing the reaction to warm to room
temperature for 1 h. The reaction was concentrated in vacuo and then loaded directly onto a
silica gel column. The crude was purified by column chromatography (20% EtOAc in hexanes)
to furnish aldehyde 138 (240.2 mg, 0.652 mmol, 65% yield) as a colorless oil.
H NMR (500 MHz; CDCl 3): 6 9.59 (s, lH), 4.92 (d, J = 6.4, 1H), 3.92 (dd, J = 12.2, 3.0, 1H),
3.62 (dd, J = 10.4, 5.8, 1H), 3.46 (dd, J = 11.3, 2.4, 1H), 2.12 (s, 3H), 2.07-2.00 (m, 2H), 1.94-
1.90 (m, 1H), 1.86 (dtd, J = 11.9, 5.8, 3.0, 2H), 1.82-1.76 (m, 1H), 1.73-1.68 (m, 3H), 1.54-1.45
(m, 3H), 1.28 (s, 2H), 1.26 (s, 3H), 1.17 (s, 3H), 1.15 (s, 3H)
1C NMR (100 MHz; CDCl 3): 6 202.3, 170.2, 79.0, 78.6, 78.3, 78.1, 77.4, 75.0, 69.7, 40.3, 36.7,
29.1, 28.92, 27.0, 26.7, 23.2, 21.8, 21.3, 19.5, 16.4
[a]24D -4.6, (c 0.4, CHCl3)
IR (NaCl, thin film): 2938, 1996, 1739, 1653, 1559, 1540, 1457, 1379, 1241, 1097, 1071, 981,
893
HRMS-ESI (m / z): [M + Na]* calcd for C20H32 O6Na, 391.2091; found, 391.2086.
M H e0 Ho~H H e OMe
Me
Me OAc
ent-1 38
ent-138: An identical procedure as 138 was used to furnish the enantiomer from ent-137.
-Me
145
Ketone 145: To a 5 mL round-bottom flask equipped with a stir bar was added alcohol 112 (74.2
mg, 0.219 mmol) in 2.3 mL of CH2 Cl 2. Sodium bicarbonate (276.0 mg, 3.29 mmol) was added
and the reaction was cooled to 0 'C. Dess-Martin periodinane (232 mg, 0.547 mmol) was added
and the reaction was allowed to warm to room temperature and stir for 3 h. The reaction was
quenched with a 1:1 solution of saturated Na 2S2O3 and NaHCO 3 and extracted with CH2Cl 2 (3x).
The organic layers were dried over Na 2SO 4 , filtered, and concentrated in vacuo. The crude was
purified by column chromatography (10% EtOAc in hexanes) to furnish 145 (58.0 mg, 0.172
mmol, 79% yield) as colorless oil.
H NMR (500 MHz; CDCl 3): 6 4.96 (t, J = 0.8, 1H), 4.81 (t, J = 1.4, 1H), 3.89 (dd, J = 11.6, 1.7,
1H), 3.63 (dd, J = 11.1, 5.1, 1H), 2.99 (ddd, J = 14.4, 11.4, 3.1, 1H), 2.90 (dd, J = 11.3, 2.5, 1H),
2.23-2.18 (m, 1H), 1.98-1.93 (m, 1H), 1.87 (ddd, J = 13.8, 6.2, 3.1, 1H), 1.78-1.74 (m, 1H), 1.73
(s, 3H), 1.68-1.62 (in, 2H), 1.56-1.50 (m, 1H), 1.46 (qd, J = 12.3, 4.9, 1H), 1.39 (s, 3H), 1.34-
1.33 (m, 1H), 1.31 (s, 3H), 1.26-1.25 (m, 1H), 1.24 (s, 3H), 1.22 (s, 3H)
1C NMR (125 MHz; CDCl 3): 6 217.6, 146.2, 110.7, 83.5, 82.9, 77.9, 77.1, 73.0, 70.8, 41.4,
40.5, 35.5, 30.8, 29.2, 27.8, 26.6, 20.9, 19.8, 19.2. 15.8
[a] 24D -10.2 (c 0.26, CHCl3)
IR (NaCl, thin film): 2927, 2853, 1717, 1559, 1457, 1377, 1074, 895
HRMS-ESI (m / z): [M + Na]* caled for C20H320 4Na, 359.2193; found, 359.2198.
-UH M
147
Me
RMe
Ketone 147: To a 5 mL round-bottom flask equipped with a stir bar was added alcohol 146 (53.9
mg, 0.166 mmol) in 7.2 mL of CH 2Cl 2. Sodium bicarbonate (608.7 mg, 7.25 mmol) was added
and the reaction was cooled to 0 'C. Dess-Martin periodinane (670.0 mg, 1.580 mmol) was
added and the reaction was allowed to warm to room temperature and stir for 3 h. The reaction
was quenched with a 1:1 solution of saturated Na 2S2 0 3 and NaHCO 3 and extracted with CH 2Cl2(3x). The organic layers were dried over Na2SO 4 , filtered, and concentrated in vacuo. The crude
was purified by column chromatography (2 to 10% EtOAc in hexanes) to furnish 147 (34.4 mg,
0.107 mmol, 64% yield) as colorless oil.
'H NMR (500 MHz; CDCl 3): 6 5.80 (ddd, J = 17.0, 10.7, 6.1, 1H), 5.21 (dd, J = 17.3, 1.3, 1H),
5.09 (dt, J = 10.4, 1.2, 1H), 4.01-3.97 (m, 1H), 3.64 (dd, J = 11.3, 4.8, 1H), 2.99 (ddd, J = 14.3,
11.3, 2.9, 1H), 2.88 (dd, J = 11.3, 2.4, 1H), 2.23-2.18 (m, 1H), 1.95 (ddd, J = 15.6, 5.2, 3.5, lH),
1.87 (ddd, J = 13.8, 6.2, 3.1, 1H), 1.76-1.68 (m, 3H), 1.66-1.60 (m, 2H), 1.57-1.51 (m, 2H), 1.45-
1.41 (m, 1H), 1.39 (s, 3H), 1.31 (s, 3H), 1.24 (s, 3H), 1.23 (s, 3H)
1C NMR (125 MHz; CDCl 3): 6 217.6, 139.5, 115.4, 83.0, 77.9, 77.4, 77.2, 71.0, 70.6, 41.3,
40.5, 35.5, 32.1, 29.2, 27.6, 26.6, 20.9, 19.7, 15.8
[a]24D = 1.7 (c 0.13, CHCl3)
IR (NaCl, thin film): 2935, 1716, 1462, 1378, 1119, 1075, 1053, 922
S0 Me
0eMe
148 NHTs
Hydrazone 148: To a 5 mL round-bottom flask equipped with a stir bar was added ketone 147
(34.4 mg, 0.107 mmol) and tosyl hydrazide (37.8 mg, 0.203 mmol) in 1 mL of MeOH. The
reaction was heated to 40 'C for 18 h. The reaction was cooled to room temperature and
concentrated in vacuo. The crude white solid was purified by column chromatography (50 to
100% EtOAc in hexanes) to furnish hydrazone 148 (22.6 mg, 0.046 mmol, 43% yield).
1H NMR (500 MHz; CDCl 3): 6 7.84 (d, J = 8.1, 2H), 7.33 (d, J = 8.2, 2H), 7.27 (d, J = 0.6, 1H),
5.81-5.74 (m, 1H), 5.19 (d, J = 17.3, 1H), 5.08 (d, J = 10.4, 1H), 3.98-3.94 (m, 1H), 3.52 (dd, J =
11.3, 4.6, 1H), 2.87-2.76 (m, 1H), 2.44 (s, 3H), 2.24 (dd, J = 10.4, 3.3, 1H), 2.05-2.02 (m, 1H),
1.84 (t, J = 1.9, 1H), 1.72-1.65 (m, 2H), 1.65-1.52 (m, 4H), 1.49-1.31 (m, 3H), 1.23 (s, 3H), 1.22
(s, 3H), 1.15 (s, 3H), 1.11 (s, 3H)
3C NMR (125 MHz; CDCl 3): 6 164.3, 144.3, 139.4, 129.7, 128.5, 128.3, 115.4, 80.6, 79.9, 77.6,
71.07, 70.90, 70.4, 40.45, 40.29, 32.0, 28.9, 27.5, 27.1, 22.9, 21.9, 20.7, 19.6, 15.9
[a] D -14.5 (c 0.4, CHCl3)
IR (NaCl, thin film): 3219, 2977, 2935, 1462, 1379, 1347, 1169, 1075, 1020.
o Me
MMeH~ $
149
Diene 149: To a 1 mL Schlenk flask equipped with stir bar was added 95% sodium hydride in
mineral oil (2.0 mg, 0.079 mmol) from a dry box and transferred to a hood under nitrogen. A
solution of hydrazone 148 (7.9 mg, 0.0161 mmol) in 500 uL of toluene was added and the flask
was sealed and heated to 90 'C for 2.5 h. The flask was cooled and slowly quenched with
saturated NH 4Cl. The aqueous layer was extracted with CH 2Cl 2 (3x) and the organic layers were
dried over Na2 SO 4 , filtered, and concentrated in vacuo. The crude reaction was purified by
column chromatography (5% EtOAc in hexanes) to furnish oxepene 149 (0.8 mg, 0.00261 mmol,
16% yield).
1H NMR (500 MHz; CDCl 3): 6 5.84-5.77 (m, 1H), 5.47-5.42 (in, 1H), 5.38-5.35
5.19 (m, 1H), 5.10-5.06 (m, 1H), 4.02-3.97 (m, 1H), 3.73 (ddd, J = 11.4, 4.8, 2.8,
(m, 1H), 2.51-2.46 (in, 1H), 2.13-2.08 (m, 1H), 2.01-1.88 (m, 2H), 1.87-1.67 (m,
(in, 2H), 1.28 (s, 3H), 1.27 (s, 3H), 1.25 (s, 3H), 1.21 (s, 3H)
1C NMR (125 MHz; CDCl 3): 6 139.7, 136.7, 122.1, 115.2, 78.0,
42.3, 38.8, 32.3, 29.7, 27.64, 27.50, 26.2, 18.2, 17.8
(m, 1H), 5.24-
1H), 3.52-3.48
4H), 1.67-1.59
76.8, 73.8, 73.2, 70.6, 70.4,
1 Donohoe, T. J.; Butterworth, S. Angew. Chem. Int. Ed. 2005, 44, 4766-4768.
2 Browder, C. C.; Marmsater, F. P.; West, F. G. Org. Lett. 2001, 3, 3033-3035.
3 a) Kraus, G. A.; Kim, J. Org. Lett. 2004, 6, 3115-3117. b) Wei, X.; Lorenz, J. C.; Kapadia, S.; Saha, A.;
Haddad, N.; Busacca, C. A.; Senanayake, C. H. J. Org. Chem. 2007, 72, 4250-4253.
4 Griffiths-Jones, C. M.; Knight, D. W. Tetrahedron 2010, 66, 4150-4166.
5 Coates, R. M.; Ley, D. A.; Cavender, P. L. J Org. Chem. 1978, 43, 4915-4922.
6 Chen, Y. K.; Jeon, S.-J.; Walsh, P. J.; Nugent, W. A. Org. Synth. 2005, 82, 87-90.
7 Lurain, A. E.; Maestri, A.; Kelly, A. R.; Carroll, P. J.; Walsh, P. J. J Am. Chem. Soc. 2004, 126, 13608-
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Chapter 1 H NMR and 13C NMR Spectra
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Chapter 2
Fragment Coupling, Synthesis, and Determination of the Absolute
Configuration of Armatol A
185
Background
One of the key challenges in constructing a polyether natural product such as armatol A
(1) is the installation of the bromooxepane ring, which is relatively rare in oxasqualenoids.
Completion of this task is critical to the fragment coupling strategy shown in Scheme 2-1, in
which oxepane 2 could be coupled with a suitably functionalized fragment such as tricycle 3. As
discussed in Chapter 1, this approach was also selected in order to determine the absolute and
relative configuration of the natural product.
Scheme 2-1
Me OH Me OH Me
Me H Me Me H Me
Br 6./ Me RBr Me
Me OH Br OHHme Me me
armatol A (1) bromooxepane (2) fused tricycle (3)
The cis-relationship between the hydroxyl group at C6 and the alkyl chain at C7 in 1 is
unusual among polyether natural products, as many other related oxepanes found from marine
sources have a trans-relationship of these groups (Figure 2-1).1,2 Following the confirmation in
2006 of the correct structure of brevenal (10), the C6-C7 cis-relationship in the oxepane ring of
armatols A (1), B (4), D (6), and F (8) are the only known marine polyethers with this
stereochemical relationship. Since armatols C (5) and E (7) have a different trans-relationship
within the same family of natural products, this family may arise from a different biogenesis than
other oxasqualenoids leading to a different stereochemical relationship between C6 and C7.
186
Figure 2-1. Various marine natural products with cis or trans proton/methyl relationships
H Me OH Me Me OH
Me 2 10 H Me Me H
Me 2 6 H 14 18 O Me Me 0 MeH MeBr Me OM 22 Br Me H O g , 2
21 Me R
armatol A (1) armatol B (4): R1=H, R2=Br
armatol D (6): RI=Br, R2=H
H Me OH MeOHMe H Me ,0 H
Me B CO Me Me o Me
H Me eH .Me
Br Me D 2' MBr Br Me H 0
RI
armatol F (8) armatol C (5): R1=H, R2=Br
armatol E (7): R'=Br, R2=H
OHC Me OC M\ MeH Me OHC Me H Me
MH H H H H HH HH H 7Me O O 26 Me 0 0 26
27. 27 7
H O0 $, - H O :F
Me" i0i H H e 10i H
H Me H MeOH OH
proposed structure of brevenal (9) confirmed structure of brevenal (10) by total synthesis
HO
MeMe Me H H
H H H H * H H/H H HOHC 0 O 0 18 O H19 HO H
O O 3eM1HrVH Me M0'
hemibrevetoxin-B (11) gamberiol (12) 1e
Recently, two reports by Fujiwara and co-workers described the first synthetic effort
toward armatol F (8).3 The total synthesis of armatol F has yet to be reported. Fujiwara's
approach to bromooxepane 2, also found in armatol A (1), B (4), and D (6) involves a
stereoselective Ireland-Claisen rearrangement to form ether 15 and ring-closing metathesis to
provide key intermediate 13 (Scheme 2-2). A three-step protocol (13 to 20) allowed for the
installation of the hindered alcohol at C3, albeit in poor diastereomeric ratio. The synthesis of
compounds bearing a bromine atom at this position was not discussed.
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Scheme 2-2. Fujiwara's strategy for the synthesis of armatol F
Me HMe O0 R
7r
Br 'L 6;. OH =
Me
bromooxepane fragment of
armatol A, B, D, and F (2)
Me OH CO 2Me
Me o H OTH OTHP Me OPMPH OTHPMM
Me OPMP M Me o OPMP Me -Me
Br
Me Me 0
13 14 MeOL OTMS -
Me -
- PMPO -
Ireland-Claisen
rearrangement
'' Me
Me
Me OH
Me Br
HO
+ Me 0
'_- Me
PMPO Me
18
Me O OTHP 1) Os0 4, NMO Me oH OTHP LiEt3BH
Me OPMP Me OPMP
2) TsCI HO d8 yield:
45% yield (two steps) Hdr = 2.3:1
13 TsO 19
Me oH OTHP
Me OPMP
3
HO' Me
20
Synthetic studies
Scheme 2-3. Strategy for the construction of bromooxepane 2
H H OH Me Me
M e M M e m e
Me . e~Me ..' Me ~ eMe6"
Br\ OR HO OH OH OH
bromooxepane (2) 21 22 23
Our initial strategy to form bromooxepane 2 involved assembling alcohol 21 from
epoxydiol 22 (Scheme 2-3). We planned to use a vinyl group 4 to affect an endo-selective
epoxide-opening of substrate 22. In two examples shown (Scheme 2-4), the nucleophile was a
primary alcohol and acid-promoted conditions were used. Generally, stereochemical erosion
occurs to some extent. In the first case, Nicolaou 4 prepared oxepane 29 from vinyl epoxide 27,
188
and in the second, Nakata5 observed that activation of styrenyl epoxide 31 with either PPTS or
CSA gave 4:1 selectivity in favor of oxepane 33, in which the hydroxyl group and the alkyl chain
are cis.
Scheme 2-4. Previous synthetic efforts to form oxepane rings via alkene-directed, acid-
promoted endo-selective cyclizations of epoxy alcohols
Nicolaou (1989):
0.1 equiv CSA H
O_','_ . HO + H
HO H HOjH0HO CH2Cl2, -40 to 25 *C O O
75% yield, 25/26=82:18 HH
25
H I H --
0.1 equiv CSA
O , HO +HO
H CH2Cl2, -40 to 25 *C 073% yield, 29/ent-25/30=25:25:50
27 29 ent
H ~ HOHHO
26
O
-25
H
+ HO O
30
Nakata (1997): Me O
HO
".Ph
Promoter Loading Solvent
PPTS 1.0 equiv CH2CI2
CSA 0.2.equiv CH2CI2
Conditions
T Time
rt 19 h
rt 10 min
Me OH Me OH
H Ph Ph
32 33
Yield (E)-trans-32 (E)-cis-33
80% 16 : 84
83% 21 : 79
To investigate whether a tertiary alcohol might behave similarly under acidic conditions,
diol 22 was constructed from nerol (34, Scheme 2-5). Sharpless asymmetric epoxidation
proceeded smoothly with D-(-)-diethyl tartrate to give 20 in 79% ee. Parikh-Doering oxidation6
provided epoxyaldehyde 35. A Wittig methylenation followed by a Sharpless asymmetric
dihydroxylation7 proceeded in modest yield to provide a 3:1 mixture of diastereomers (22). To
prevent cyclization initiated by the secondary alcohol (which has been observed in related
189
studies),8 selective protection of the secondary alcohol was attempted. Unfortunately, under
basic conditions using reagents such as TBSCl and TESCl, cyclization was observed. Vidari and
co-workers reported an example of a selective protection with a carbamate group in a similar
diol.9 When 22 was treated with phenyl isocyanate the carbamate protected product was
obtained, but treatment of this compound with both CSA and PPTS in dichloromethane led
predominantly to THP 36.
Scheme 2-5. Synthesis and cyclization of diol 22
Ti(Oi-Pr)4 S0 3*Py
D-(-)-DET Et 3N 1) PPh 3MeBr, n-BuLi
TBHP ~ o DMSO ,o THF, rt, 53% yield
Me 'Nme e '
CH2CI2, -23 -C CH2 S2, rt 2) AD-mix-P, t-BuOH/H 20
OH 88% yield OH 66% yield 0 49% yield, 3:1 d.r.
nerol (34) 79% ee 23 35
Me Me ________________FOH
HO Me MO 1) PhNCO, py, CH2Cl2, 0 *C Me MeH
Me 2A) (±)-CSA CH2C2, 2 h P meOH "NOR PhHNOCO
22 2B) PPTS, CH2CI2, 2 h 36
Similar studies in the Jamison group have also shown that the conversion of a similar,
sterically hindered secondary alcohol to a bromide under SN2 conditions was extremely difficult.
Thus, we decided that pursuit of a route based on such a transformation should be reconsidered
(Scheme 2-6).10 The steric hindrance at this center prevented nucleophilic displacement. The
only reaction observed was elimination to the oxepene.
Scheme 2-6. Investigations of conversion of a hindered alcohol to a bromide. 10
Me Me Me
H 0 H M H M
Me O CISO 2CH2CI Me 0 Br0  Me 0
Me Me --- ~~~~* Me
HO Me H Py CIH 2CO2SO Me H Brs Me H
37 38 39
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Bromonium-initiated cyclizations
In Chapter 1 we discussed the formation of the tricyclic fragment via an epoxide-opening
cascade." The configuration at C6 varies among the six members of the armatol family (Figure
2-1), and one way to account for this stereochemical difference would be a trans-to-cis
isomerization of the squalene precursor, thus leading to tetraepoxides 40 and 41 (Schemes 2-7
and 2-8). Isomers (40 and 41) could then react via two different pathways to form the A-ring
of the armatol family. One possibility for the formation of the bromooxepane ring, path a,
involves the attack of a bromonium intermediate by an epoxide to form an epoxonium ion (42
and 43, Scheme 2-7). Opening by water with inversion at C6 would lead to armatols A-E.
Alternatively, in path b, acid-induced nucelophilic attack at the C6 carbon by a molecule of
water would afford tertiary alcohols 44 and 45c (Scheme 2-8). Bromoetherification with the C7
alcohol as a trapping nucleophile would then lead to armatols A-E. Further evidence to support
that some of the armatol members are derived from a trans epoxide and some from a cis epoxide
is the configuration of armatol F (8, Figure 2-1). It is epimeric to armatol B (4) at C18 which
could be accounted for by another trans-to-cis isomerization. Therefore armatol F (8) could be
formed from cis,trans,transcis-squalene while the remaining armatol family members are from
either trans, trans, trans, trans-squalene (armatol A, B, and D) or cis, trans, trans, trans-squalene
(armatol C and E). All previous successful synthetic efforts towards polyether natural products
with bromooxepanes have used some type of bromonium-initiated cyclization.13 Based on these
investigations, it seemed that the best method for the challenging installation of the bromine
atom in the bromooxepane would be a bromonium-initiated epoxide-opening cyclization.
191
Scheme 2-7. Epoxonium formation as a possible biosynthetic pathway to the bromooxepane
ring of the armatols (path a)
Me Me Me OH Me
Me 01R H Me0 M0
Me
path a
epoxonium formation
G
Br
MeGDH Me OH Me
Me 0~ ",\ H M
Br 6 Me
Mee R
H20 42 H20
Me H Me OH Me
Me 0 ~ .~ H e
B~ MeBr A 6 .- O Me
Me me, R
R=Br (R), armatol C (5)
R=Br (S), armatol E (7)
Me OHMe H Me
Me H
2 10 Me
Br A 6 OHe
M~e H me 2  R
R=H, C21-C22 olefin, armatol A (1)
R=Br (R), armatol B (4)
R=Br (S), armatol D (6)
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Scheme 2-8. Nucleophilic trapping of an epoxide with a secondary alcohol as a biosynthetic
pathway to the bromooxepane ring of the armatols
path b
nucleophilic trapping with
secondary alcohol
H20 Me H20
Me Me Me OH Me Me OH
Me Me Me MeMe 0 Mee
Me Me
me IR me " R
40 41
7-endo-trig cyclization 7-endo-trig cyclization
Me OH Me OH Me
M e eH RM e M eR H M e
MeM66 OH MeMe Br, 0.n
me R Me H m R
M MeOH Me Me MeOHMe H H MeMe 0 Me Me 2~ 0
2 H 1 MeBr ::A 6 OH Me Br ::A6OH2
Me Hpd Me HM 2,e . R
R=Br (R), armatol C (5) R=H, C21-C22 olefin, armatol A (1)R=Br (S), armatol E (7) R=Br (R), armatol B (4)
R=Br (S), armatol D (6)
Relative to bromooxepane synthesis, bromooxane synthesis has been more thoroughly
investigated. The formation of THP rings with similarly hindered bromine-containing centers
has been explored since the 1980s, especially in syntheses of venustatriol and thysiferol (Scheme
2-9). 4 Many of the strategies used either NBS or 2,4,4,6-tetrabromocyclohexa-2,5-dienone
(TBCO), 5 with a tertiary alcohol as the internal nucleophile. Because the methods were non-
stereoselective, obtaining a particular diastereomer of the product was only possible via
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purification. Forsyth's studies also demonstrated that this problem could be particularly
challenging (Scheme 2 -9 ).I4'
Scheme 2-9
Broka (1988): Me Me
Me Me
Me Me Me 1.1 equiv NBS Me Me MeMe Me
Me CH2CI2, rt Me H H
22% yield Br
46 47
0
Shirahama (1988): Br Br
Me OH Me 1.4 equiv MeIMe OH Me
19 (TBCO) 0 19HOMe 0 HM Br Br Me Me 0 HOO e,0H Me Me o OH MMe Me
H H Me OH MeNO 2, rt, 1 h H H Me OHMe \ 48, 019 () 22% yield Br C19 (R) thyrsiferol (50)
C19 (S) venustatriol (51)
Corey (1988):
M0 NMe 0 CN
Me MCN .quiTBCO Me CN0, venustatriol (51)00
MeH H H
26% yield Br
52 53
Forsyth (2000):
1) Br2, py, 300 nm
Me 1) Hg(TFA) 2, CH3CN Me MeCN 79% yield Me MeCHO
Me 2) KBr, NaHCO 3  Me 2) DIBAL-H
79% yield BrHg"' 30% yield Br
54 55 (±)-56
Me 1) HClO 4, THF/H 20 HO Me TBCO Me MeOBz 1) K MeOH
Me0O 0Me ~- OBz INMe 0 Oz 23 (+)-56Me OH 2) BzCl, Et3N, DMAP M BzO MeNO 2, rt 2) Nal04, THF/H 20
M 72% yield Me 32% yield Br 70% yieldMe 7Me 58 59
(+)-Aurilol (61), (+)-enshuol (63), dioxepandehydrothyrsiferol (ent-66), and the armatol
family of natural products are the only members of the oxasqualenoids that display a secondary
"neopentyl" stereogenic center in which one of the substituents is a bromine atom (Scheme 2-
10). Morimoto and co-workers reported the 7-endo-trig cyclization of secondary alcohols 60 and
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62 in the presence of NBS in hexafluoroisopropanol (HFIP) to form the bromooxepane rings 61
and 63 in 36% and 22% yields, respectively.16 Tanuwidjaja, Ng, and Jamison recently reported
the synthesis of ent-dioxepandehydrothyrsiferol (66). "7 A key step in the synthesis of 66 was the
installation of the secondary bromide in 65 via a cascade event from triepoxide 64, but no
diastereoselectivity was observed. A recent report from Ishihara describes a method for
enantioselective halocyclizations of polyprenoids in polyene cyclizations, while no methods for
the analogous epoxide-opening cascades are known.' 8
Scheme 2-10
Morimoto (2005):
Me
OH HH M FM HCOH
000,Me HFIP,0~ Me Me Ho/ MeMeMe Me MeH H Me0 MO 10mm H1 M6O
60 36% yield (+)-aurilol (61)
Morimoto (2007):
MeMe H HMe, H MeHme NBS Me Me HH MeMeH Me
Me 0 0 OH AMS BrOH
Me Br'~'*Me
Me O" HFIP, 0 -C Me
10 m2 el Me (+)-enshuol (63)
62 20% yield
Jamison (2009): Me
Me Boc Me H, Me H Me\ H\
Me0NBS MeoH 0 e 0 0 H
Me Me M e Me 4AMS Me O M H OH C
HFP,3 B 0 H Me
Me HIO Br 3 Me%,
15 min Me H
64 72% yield 65 ent-dioxepandehydrothyrsiferol (66)1:1 dr at 03
McDonald reported the construction of bromooxepane rings as part of a study on
regioselective polyepoxide oxacyclizations.19 Treatment of Boc-protected epoxy alcohol 68 with
bis(sym-collidine)bromonium perchlorate 2 0 furnished the desired bromooxepane as a 3:2 mixture
of diastereomers (69 and 70, Scheme 2-11). Noted also was that these bromooxepanes are
similar to subunits found in the armatol family of natural products. However, as discussed in
Schemes 2-7 and 2-8, the trans epoxide of 68, derived from geraniol, would lead only to armatols
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C and E, which possess a trans-fused C6-C7 junction. All other members of the armatol family
bearing a cis-relationship in the analogous region of the molecule would need to arise from nerol
(34) which would lead to 72, epimeric to 68 at C6.
Scheme 2-11
McDonald (2004):
NN'Me
\-/ e MMe Me
Me Me (t-BUOCO) 2 0 /rcl)CO t 7r' 0 0_
00"'1. Ot-Bu Br S +. Br
Me 6 OH (FMe, 0 C 0.05 M 0H 2Cl2  -B O B
geraniol monoepoxide Me 0 -40 *C, 15 min 69 70(67) 68
50% combined yield, dr=3:2
Retrosynthetic strategy toward cis-relationship at C6/C7
Me H MeMe OH Me Me
Me- 0 RMe 0r
Br6 Br'O Me 67 
0
Me Me 0 Ot-Bu
ent-2 71 72
Me Me
Me
OH
34
Use of a bromonium-initiated cyclization toward armatol A
Scheme 2-12
N N'Me
Me Me (- ) Me Me
Me ~~ 6 (t-BUOCO)2O ejMMe ~ 7 =Me O Me
OH PhMe Oj O M
23 OH 74% yield 72 0 0 Me
The previously prepared epoxide 23 was treated with Boc anhydride to give the desired
carbonate 72 (Scheme 2-12). Treatment of 72 with bis(sym-collidine)bromonium perchlorate, as
in Scheme 2-11, in either acetonitrile or dichloromethane, led to about 25% total yield of a
diastereomeric mixture of 71 and 73 (Table 2-1 ),21 with a slight preference for the undesired
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diastereomer (73). Other undesired side products, including bromohydrins and smaller rings,
were formed concomitantly. It seems unlikely that the epoxide stereochemistry could affect the
initial bromonium formation, given the distance between the epoxide and the olefin and the
relatively high reactivity of this particular bromonium reagent. An evaluation of reaction
concentrations in dichloromethane showed concentration and yield to be inversely correlated
(Table 2-1, entries 2-5).
Table 2-1. Cyclization of 72 with Br(coll) 2ClO4
Me Me
Me O
0 Ot-Bu
Br(coll)2CIO4
Me H
Me 0 0
Br0 0
Me
72 71 (desired) 73
Entry Solvent Temperature (*C) Conc. [M] Scale (mmol) Yield 71 (%) Yield 73 (%)
1 CH3CN -40 0.05 0.37 10 n.d.
2 CH2Cl2  -40 0.09 1.23 7 19
3 CH2Cl2  -78 0.5 0.37 3 10
4 CH2Cl2  -78 0.05 0.37 10 13
5 CH2Cl2  -78 0.005 0.37 11 18
6 HFIP 0 0.05 0.37 19 28
Scheme 2-13. Proposed mechanism for bromonium-initiated epoxide-opening cyclization
MeMee Br(coll)2CIO4 BrMe H O OMe H O
Me0Bro 0/ + Br0 0
0 Ot-Bu Me Me
72 71 (desired) 73
O Ot-Bu F e
Me M 
r Ot-Bu
L Me 74 - 75 Me
The reported ability of hexafluoroisopropanol (HFIP) to stabilize a more SNi-type
transition state in similar reactions led us to examine it as a solvent for this transformation.23 The
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first use of this solvent in this context was described by Holton in a total synthesis of
hemibrevetoxin B (Scheme 2-14).24 N-(Phenylseleno)phthalimide proved to be the optimal
electrophile to achieve a single diastereomer of the 6,6,7-fused tricycle 78 in which two ether
rings were formed in a single operation. Use of HFIP improved the yield of both 71 and 73 to
19% and 28%, respectively (Table 2-1, entry 6). Due to the high price of HFIP and the
improved reactivity observed at higher dilutions however, conducting the reactions at 0.05 M
was considered an appropriate compromise of yield and cost.
Scheme 2-14. Use of HFIP in an electrophilic cascade for polyether synthesis (Holton)24
0
BnOn,. OTIPS O MOM NSePhBnO-- OTIPSM H OMOM MeOH," Mee"n'" OSeHM
Me'~Me 0 70 0-
OBn 0 Me OBn O Me
/0O HFIP 0
me H H'C Q~80min Me H 0 H H H
76 83% yield SePh 78
The requirement for low reaction concentrations may be attributed to a deleterious
counterion effect (e.g., undesired ring-opening of the epoxide or product) and thus a screen of
counterions was conducted (Table 2-2). However, no effect on yield was observed.
Nitromethane, a highly polar, much less expensive solvent was also examined at this juncture.
We were pleased to find that treatment of epoxide 72 with Br(coll) 2BF 4 in nitromethane (entries
5 and 6) gave results similar to HFIP.
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Table 2-2. Evaluation of counterion effects in the cyclization of 72
Me Me Me H
Me Br(coll) 2X Me +
0 Ot-Bu Solvent, rC)0.05 M Be
72 71 (desired)
Entry X Solvent Scale (mmol) Yield 71 (%) Yield 73 (%)
1 C104D HFIP 0.37 19 28
2 C104 HFIP 2.27 18 32
3 OTfD HFIP 0.37 17 30
4 PF 6 D HFIP 1.84 19 n.d.
5 BF4 0  HFIP 2.27 17 31
6 BF4
0 MeNO 2 0.37 18 28
Me H
Me O O
Br 7
Me
73
We then examined bromodiethylsulfonium bromopentachloroantimonate (BDSB), a
reagent recently reported by Snyder to have different reactivity towards alkenes than other
reagents (Scheme 2-15).25 While none of the previously observed side products with collidine-
derived reagents formed with BDSB, other side products were formed including
26bromotetrahydropyran 80. Moreover, on larger scale, the poor solubility of BDSB gave lower
yields than those found using collidine-based reagents despite the higher yields obtained on
small scale (Table 2-3, entry 3).
Scheme 2-15
Me Me
Me 0
0 tAOt-B
BrSEt 2SbCl5Br
HFIP, 0 OC, 0.05 M
Me®H
Me-. 0 0
Ets Ot-BuEt2S-Br' 0BMe j
79
Me H
Me 0 0
Br"U C/-
Me
71 (desired)
Me
Br
Me H
M e 0 
0
Br_ 
7 Me
73
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Table 2-3. Solvent screen for the cyclization of 72 using BDSB
Me Me Me H Me H
Me O O BrSEt 2SbCI5Br Me + Me O 0A olet 0 'C, 0.05 M Br "' 0> + Br0 Ot-Bu Solvent, BrMeM e
72 71 (desired) 73
Entry Solvent Scale (mmol) Yield 71 (%) Yield 73 (%)
1 MeNO 2  0.37 22 34
2 HFIP 0.37 23 36
3 HFIP 2.2 16 24
Initial coupling strategies - fragment synthesis
Despite the poor yield in which 71 was formed, the short, three-step route installed the
challenging secondary bromide and gave rapid access to carbonate 71. With all the stereocenters
in the bromooxepane installed, we turned our attention toward suitable functional groups that
would allow for coupling strategies to be investigated (Scheme 2-16). In Chapter 1, we
examined the synthesis of tricycles 84, 85, and 86 as potential fragments in three different
strategies: 1) cross-metathesis of an allylic alcohol and an allylic ether (81 and 84 leading to 87),
2) metal-halogen exchange of a vinyl iodide in the nucleophilic addition to an aldehyde or a
ketone (82 with 85 and 86 leading to 88 and 89), and 3) alkyne addition to a ketone or an
aldehyde (83 with 87 and 88 leading to 90 and 91). A cross-metathesis strategy between 81 and
84 would require all of the stereocenters to be installed before coupling, an inconvenient
situation for determining the correct stereochemistry at C10 later in the synthesis. On the other
hand, a vinyl iodide and an alkyne fragment would be more flexible in this regard, as the
coupling reaction installs this key stereocenter at C10.
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Scheme 2-16. Coupling strategies considered
Possible sites of fragment coupling
H Me OH MeMe 0 o 2310 0~Me 0 MeMMe Me
Brl'" O0)H He Om "
armatol A (1)
functionalized bromooxepanes fused tricycle fragments
H HO Me Me
H I 0 H Me M MM 0  10 MeMe0  10 H
_ Me + Me Me Me Me
Br" OR H 0 BI bMe OPG H Me OPG81 84 87
H 0 H Me R OH0R Me 86 Me
+ 0 0 M Me 0  ~ 0 HMe Me Me Me O Me
MO+ R O HOMMe 
, Me O 10 O 0 ~
Br"" bR' H 0Me Me H 0 .Me PG Br OR, Me "OPG82 R=H, 85 R=H, 88
R=Me, 86 R=Me, 89
H0 HMe R OH MeMe H H-0 ? H 100 H
Me_+ R 10 ~ 0 Me MeO0H 0 0 MeMe Me no Me
' c Me Me sBr"Hbe ROPH H0Br" R e "'OPG
83 R=H, 87 R=H, 90
R=Me, 88 R=Me, 91
The carbonate moiety of 71 allowed for elaboration into a variety of functional groups.
Opening of the carbonate 71 using sodium hydroxide in methanol proceeded smoothly to give
diol 92 (Scheme 2-17) and this diol could then be oxidized to the aldehyde (93) using Dess-
Martin periodinane (55% yield). Takai olefination gave vinyl iodide 94.27 The Corey-Fuchs
reaction on aldehyde 93 failed to form any of the desired alkyne 95 due to decomposition upon
treatment of the gem-dibromoalkene with n-butyllithium. Gratifyingly, a Seyferth-Gilbert
homologation 28 using Bestmann's reagent2 9 successfully provided the desired alkyne (95) in 62%
yield. Finally, a silyl protection furnished silyl ether 96 suitable for coupling studies.
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Scheme 2-17. Synthesis of coupling partners
Me Me H DMP Me H MeMe OH NaOH Me O OH NaHCO 3  Me 0  O CrC12, CHI3  Me 0 H
Br' M Br'"t O H Br'"- " Bril-
O 'O Meld OH CH2CI2  OH THHMe >99% yield me OC to rt Me 57% yield Me
71 92 55% yield 93 94
1) CBr 4, PPh 3, CH2CI2
2) n-BuLi, THF, -78 *C
Decomposition
Me H
Me 0 H
Brit".
MOH
me
93
0 0
Me POMeMeO
p-TsN3, K2CO 3
MeCN/MeOH
62% yield
Me H
Me O H
Br,. i
OHMe
95
TMSOTf
2,6-lutidine
CH2CI2, -78 *C
84% yield
Me H
Me o
Br".
meOTMS
96
Investigations of fragment coupling strategies
With a variety of coupling partners in hand, the first attempts to investigate the coupling
of these two fragments of armatol A began with vinyl iodide 94. Metal-halogen exchange and
chelation-controlled addition into ketone 97 was predicted to provide allylic alcohol 98 (Scheme
2-16). Unfortunately, the vinyl iodide proved to be a capricious coupling partner. Attempts at a
lithium-halogen exchange followed by transmetalation to magnesium led only to decomposition
of the compound (Scheme 2-18). Nozaki-Hiyama-Kishi coupling 30 between vinyl iodide 94 and
aldehyde 99 was attempted in both a 3:1 THF/DMF solution and in DMSO at room
temperature. In THF/DMF no reaction was observed, and both starting materials were
recovered, while in DMSO no coupling was observed, but both starting materials had been
consumed, possibly due to reduction of the aldehyde to the primary alcohol.
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Scheme 2-18. Fragment coupling investigations with
Me HMe 0 H 1) TMSCI, DMAP, imid., DMF, 91% yield
Br' OH 2) i n-BuLi; i-PrMgCI, THF, -78 to 0 *C
Me 0H Me
94 Me 11H0Me
0 Me
9Me e OTBS
97
a vinyl iodide
Me H MeOH Me
Me 0 0 TB Me
Me 0  MeMe 98 Hme "OB
O Me H OHMe Me H Me0 + H e c C r C l 2 / N i C l 2  ( 9 9 .9 : 0 .1 ) M e O HH M __e_-_H_0_Me
94 +Me 3:1 DMF/THF or DMSO Br*. "'OH 0 Me
HMe "'Ac M ~ "
99 100
Successful coupling strategies
Successful coupling occurred between alkyne 96 and ketone 97 by deprotonation of 96
with n-butyllithium and addition to ketone 97 (Scheme 2-20). Although the reaction proceeded
with no diastereoselectivity, 102 and 103 were separable by column chromatography. It was
found that use of an aprotic solvent in the hydrogenation was required to retain the silyl
protecting group. The fact that the reduction stopped at the alkene instead of leading to the fully
reduced alkane was surprising and required further investigation.
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Scheme 2-19. Fragment coupling with alkyn
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Me oH
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MeOTMS
0H Me 96 m
Me HMe n-BuLi
0  e THF, -78 T to rt
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Me OH Me
Me 0 ~ H 0MMe 
0 
M eBr~l' nh 0 M
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Me 101
Pd/C, H2 (1 atm)
EtOAc, rt, 15 h
95% yield, 1:1 dr
Me Me
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Me 0 HMeH Me
H 0 Mef Me +Me
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Table 2-4 shows a variety of conditions attempted for the reduction of alkyne 101.
Lindlar reduction and diimide reduction both left the silyl group intact and provided exclusively
the cis-alkenes 102 and 103. Using an alcoholic solvent such as methanol led to concomitant
deprotection of the TMS group and reduction of the alkyne to alkene 104, under higher pressure
a small amount of the fully reduced alkane was detected. Table 2-5 shows attempts to reduce
this double bond further. Pearlman's catalyst led to carbon-bromide bond reduction at high
pressures, but did not reduce the alkene.3 2 Harsher conditions for diimide reduction were not
successful (entry 3).3 Use of riboflavin tetraacetate (entry 4) to perform an aerobic
hydrogenation also failed to provide any further reduction of the alkene. 34 Directed homogenous
reduction using Rh(dppb)(cod)BF 4 (entry 5) just led to recovery of starting material and provided
no desired reduction products.35
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Table 2-4. Attempts to reduce alkyne 101
Br Me Me
Me OH Me O HMe 0- H
Me OH Me Conditions Me
Me ,0 H
Br" Me R 0 o Me
OTMS Me ""OTBS Me
Me Me
Entry Reagent(s) Solvent Time Result
1 Pd/Pb/CaCO3, Quinoline, H2 (1 atm) EtOH 3 h R=TMS (102 and 103)
2 Trisyl hydrazine MeOH 16 h R=TMS (102 and 103)
3 Pd/C, H2 (1 atm) MeOH 3 h R=H (104)
4 Pd/C, H2 (900 psi) MeOH 17 h R=H (104) along
with trace alkene
reduction
Table 2-5. Attempts to reduce cis-alkene 104
BMe me 1me me
OHO
Me OH Me Conditions Me OH
MeHN O H MeH O H
e MeM
Y O O~
104 HM 'OTBS HMe ''OTBS
Entry Reagent Solvent Temp, Time Result
1 Pd(OH) 2, H2 (1 atm) EtOH rt, 18 h R=Br (104)
2 Pd(OH)2, H2 (1050 psi) 1:1 EtOH/THF rt, 36 h R=H (105), 54% yield
3 Trisyl hydrazine, NaHCO 3  2:1 THF/MeOH rt, 3 d to 80 'C, 20 h R=Br (104)
4 Riboflavin tetraacetate, H2NNH 2*H20, 02 (1 atm) MeCN 30 *C, 2 d to 50 *C, 14 h R=Br (104)
5 Rh(dppb)(cod)BF 4, H2 (900 psi) CH2CI2  30 *C, 3 d R=Br (104)
Note: Products were determined using 1H NMR and HRMS analysis.
Even though the reduction of the carbon-bromide bond was observed with Pearlman's
catalyst at high pressure, we reasoned that at higher pressures of H2 and higher temperature,
milder palladium and platinum catalysts might provide a selective olefin reduction (Table 2-6).
Unfortunately, all conditions that reduced the olefin gave competitive reduction of the carbon-
bromide bond, affording 107 and only traces of the desired product. In a 'H NMR spectrum of
104, the allylic proton was observed at approximately 5.2 ppm, suggesting that it lies in the plane
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of the olefin due to allylic 1,3-strain.3 6 The downfield shift can be attributed to an anisotropic,
induced magnetic field around the olefin, inducing a local magnetic field around this hydrogen.
This configuration of the olefin creates a congested environment that might prevent the molecule
from interacting with the metal surface. The two adjacent allylic oxygens might also serve to
deactivate the alkene towards hydrogenation.
Table 2-6
Me Me
OHMe OH Me Conditions Me Me OH Me
-1eM
10O Ri' M 10 0 MeC H0 Me OH 0 0Me
Mm e "O T B S C om e ""O T B S
104 R=Br, 106R=H, 107
Entry Conditions SM 106 107
1 Pd/C, H2 (875 psi)
1:1 MeOH/THF, 12 h, rt 100% trace trace
2 Pd/C, H2 (890 psi) 50% 50% trace1:1 MeOH/THF, rt, 89.5 h
Pd/C, H2 (890 psi) 53% 24% 22%
3 AcOH, 1:1 EtOHITHF, rt, 89.5 h
4 Pt/C, H2 (880 psi) 15% 31% 54%EtOH, rt, 88 h
5 Pd/C, H2 (880 psi) trace 9% 91%
EtOH, AcOH, 88 h
Notes: Yield determined by ratios in NMR of crude product. No other products
were observed and structures could be determined using 1H NMR and HRMS.
From these experiments it was concluded that the steric environment around the cis-
olefin was likely inhibiting reduction of the C8-C9 bond. A strategy involving formation of the
tertiary alcohol after reduction of the C8-C9 bond was then pursued (Scheme 2-20). In this
approach, coupling of alkyne 83 and tricycle 85 would lead to allylic alcohol 90. Reduction and
oxidation would provide ketone 109 with subsequent addition of an organometallic methyl
reagent, which would furnish tertiary alcohol 108.
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Scheme 2-20. Installation of key C 10 tertiary
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83 85 90
This strategy proved to be effective. Alkyne 96 was treated with Cp2Zr(H)Cl,
transmetalated to zinc using Me2Zn, and subsequently treated with aldehyde 99 to furnish allylic
alcohol 110 in 66% yield (Scheme 2-21).37 The acetate protecting group on 99 was originally
employed to aid in purification of the tricycle cascade product and was stable to these coupling
conditions.
Scheme 2-21. Successful coupling and formation of ketone 112
Me O H /" 1) [Cp 2Zr(H)Cl], CH2CI2, 1 hMe 0__________
Br OTMS 2) Me2Zn, -78 *C, 15 min
Me 3) 0 H Me
96 H Me
0 Me
HZe "OAc
99
80% yield
OH
Me H OH Me
me 0 0 H0Me
Br,"' 6 ""' OH Me -
t Me H Me ""OAcO 1
Pd/C
Me H Me H2 (1 atm)me 0 0 =~ He__
0 -H0 Me -
Br"" "" OTMS Me EtOH, rt, 17 h
Me H0 "".,, 59% yield
110
0
me H 0H Me
DMP Me 0 TO0 H M
p0 MeN a H C O 3  
'O Hc
CH2CI2  Me H Me
48% yield 112
Investigation of conditions for the reduction of alkyne 101 (Table 2-4) showed that using
a protic solvent led to concomitant cleavage of the silyl protecting group. Similarly, treating
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trans-alkene 110 with palladium on carbon at atmospheric pressure in ethanol led cleanly to the
fully reduced alkane (111) in only a few hours and revealed the free tertiary alcohol present in
the natural product at C6 in 73% yield. Oxidation of the secondary alcohol was sluggish with
Dess-Martin periodinane and proceeded in 48% yield. With a method for successful installation
of the alkyl chain in hand, we began optimization of the synthesis of the left-hand fragment with
the absolute configuration found in armatol A (1).
Confirmation of the absolute and relative stereochemistry of armatol A
The optimized synthesis of alkyne 121, with the correct stereochemistry in ring A, is
shown in Scheme 2-22. Because of the modest enantioselectivity in the Sharpless asymmetric
epoxidation of nerol, enzymatic resolution to enhance the enantioselectivity of epoxide 113 was
required. 38 Slight modification of the procedure for the bromonium-initiated cyclization using
nitromethane as the solvent gave 22% yield of the desired diastereomer 116 on large scale.
Premixing the S03-py complex with DMSO in the oxidation of 117 and using the preformed a-
diazo-p-ketophosphonate (119) for the synthesis of alkyne 120 led to increased yields of 80%
and 75%, respectively. The protected alkyne (121) was now set for coupling with both
enantiomers of the tricycle, in order to provide the four possible diastereomers of armatol A
(Figure 2-2).
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Scheme 2-22
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Figure 2-2. Four possible diastereomers of armatol A consistent with published data.
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me 0 ~ H2 10 MeMe 2 76 ."Me 10 14 18 Me
Br OH H 0  722Me
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Diastereomer A (122)
H Me OH Me
MMeMeD0  i o HMe 0 e
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Me 0 o , "\ H M
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H H Me
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Meo Me
Me Me Me
Br OH D (
Diastereomer D (125)
Coupling of 99 and 125 with alkyne 121 followed by reduction with palladium on carbon
led to diastereomers 127 and 131, respectively. Oxidation using TPAP/NMO increased the yield
of oxidation which provided ketones 128 and 132 in good yield and avoided hemiketal
formation, which had plagued the Parikh-Doering oxidation. 39
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Scheme 2-23
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An acetate protecting group was chosen in the reaction of ketone 132 with organometallic
methylating reagents due to the potentiality of concomitant deprotection under these conditions
(Scheme 2-24). Treatment of ketone 132 with methyllithium at -78 'C in THF led to a 1:1 ratio
of C10 epimers 134 and 135. Treatment of the same ketone 132 with methylmagnesium bromide
at -78 'C led only to the formation of protected alcohol 133 with high diastereoselectivity.
Based on the model for a chelation-controlled addition (Scheme 2-25), the configuration of the
key C10 tertiary alcohol 133 was assigned the (S)-configuration. In his seminal synthesis of
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venustatriol, Corey used chelation-controlled addition of methyl magnesium bromide to 136 in
order to install a similar tertiary alcohol in 137. 14d,40 Hydrolysis of acetate 133 with potassium
carbonate in MeOH gave exclusively one product, the spectrum of which matched perfectly with
134. The other product observed from the methyl lithium addition (135) was then assigned as
the opposite C1 0-epimer, with the (R)-configuration.
Scheme 2-24
O HO MeMe H Me Me H HQeMe
Me 0 ~ .~ H 0Me MeMgBr me 0 (S) H 0Me
M e m 0 T H F 6 M e y 1M eM 3
OH 0
64% yield Me
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Me 0H HOQ..Me Me
m(S) H Me
Br ~OH g ~~Me
Me M OH
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Me H 0 MeOs
Me "" H Me 8 *e 1 h 1 Me H0
o Me134 + me 0 (R) H Me
Br 0 AM THF, -78 -C, 1h Br Me)
me OcOH Mez
132 Md O~ 75% yield Me Hq Ms~ O121:1 dr 135 eO
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Scheme 2-25
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Using the same stereochemnical model, methyllithium addition to ketone 128 furnished
two diastereomeric products that were assigned as 138 and 139 (Scheme 2-26), giving us access
to four diastereomers that would lead to the four possible diastereomers of armatol A (134, 135,
138, and 139). We observed that the three carbons directly adjacent to the tertiary alcohol at C10
in two of the diastereomers were much closer to the assigned carbon shifts for armatol A (1).
Diastereomers 134 and 139 (both derived from chelation-controlled addition into their
corresponding ketones) are both within 0.4 ppm at every carbon of the left-hand side of the
molecule up to the THP ring. On the other hand, diastereomers 135 and 138 (the two other
diastereomers from methyllithium addition that did not correspond to the chelation products)
differ by as much as 2.3 ppm from the reported data, especially at carbons 9, 11, and 27. It is
reasonable that the chemical shifts of the bromoxepane are very similar for all four diastereomers
because of the intervening flexible carbon chain.
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Scheme 2-26
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Me H Me OH Me Me H HOMe Me
Me O O O H M e me 0 O H Me9 1 + 8 1 0
Br OHMe BrOH MeOH Me 0~~2
r~e0O 22 22 O
135 134
Carbon 138 139 135 134 1
8 24.7 24.1 24.6 24.4 24.1 27
Me H Me OH Me
Me 10 Me
10 73.4 73.3 73.4 73.3 73.4 OH Me
Me 0
11 76.3 75.4 76.3 761 armatol A (1) M
27 F23.0 24. 21.7 24.3 23.9
8 [ppm] in 13C NMR (C60). The 13C reference from the isolation paper of armatol A2 in C6D6 was
not reported and assumed to be 128.06 ppm. The carbon peaks in 1 reported above are adjusted to
a reference peak of 128.37 ppm to match collected data for four possible diastereomers synthesized.
The much larger differences of the carbon resonances of 1 and those of diastereomers 135
and 138 suggest that they do not correspond to the correct configurations of armatol A. This
analysis dramatically simplifies the problem, leaving only two possible diastereomers for the
correct absolute configuration of armatol A. With these two alcohols in hand, all that remains is
the elimination of the C22 secondary alcohol to form the two diastereomers of the natural
product. As discussed in Chapter 1, model systems showed that the only successful strategy for
the synthesis of the oxepene involved oxidation of the alcohol to a ketone, followed by
hydrazone formation, and then elimination. Fortunately, this strategy also worked on late-stage
intermediates 134 and 138. Ley oxidation of both diastereomers 134 and 139 in
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dichloromethane led cleanly to ketones 140 and 142, respectively (Scheme 2-27). The limited
solubility of these diols in methanol decelerated hydrazone formation significantly; however,
forcing conditions and extension of the reaction time to 2-11 days led to complete conversion.
Scheme 2-27. Converting alcohols 134 and 139 to alkenes 125 and 123 via the Bamford-
Stevens reaction
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Br OH 0 Me Br OH Me
M OH M OH
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Treatment of hydrazones 141 and 143 with sodium hydride in toluene failed to give any
of the desired elimination products, likely due to the insolubility of the hydrazone. However,
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treating hydrazones 141 and 143 with sodium hydride in THF in a sealed tube at 80-100 'C for
2-3 hours led to the desired alkenes 125 and 123, albeit in low yields. Table 2-7 shows the
tabulation of the 13C NMR data for the two possible diastereomers of armatol A. All signals in
diastereomer B (123) are within 0.1 ppm of the data reported for the isolated natural product,
with the exception of C1I (in C6D6) which differs by 0.2 ppm. Hydrogen bonding of the tertiary
alcohol with the adjacent THP ring might account for this difference. On the other hand, the 13
chemical shifts for diastereomer D (125) differ by at least 0.2 ppm in several cases, specifically
the C8 to C13 portion of the molecule suggesting that it is not the correct structure of armatol A.
Even more significantly, the optical rotation of diastereomer D (125) is -17.9, while diastereomer
B (123) is +33.9. The reported optical rotation of armatol A in chloroform is +43.4. Taken
together, these data confirm the correct structure of armatol A as 123.
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Table 2-7. Tabulation of 13C NMR data of the possible diastereomers of armatol A
1 27 28
Me H HO Me Me 24
25Me 2 10 H Me
Br OH 18 M 3
Me H Me 12
29 21
diastereomer B (123)
27 28
Me H HQ Me 24
25Me 2 0 1- H Me2 7 1 115 0
Br OH 18 Me 30
Me l 2
29 21
diastereomer D (125)
123 125
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
C26
C27
C28
C29
C30
Natural (1)
Ref: 128.0 ppm
Solvent: CeD 123 125 Natural (1)
Ref: 77.0 ppm
Solvent: CDC13
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25.3
77.7
59.2
30.4
44.3
72.3
76.4
23.4
33.4
73.1
74.9
27.0
27.2
73.5
77.2
38.4
27.3
76.4
80.1
41.9
121.9
136.4
77.8
26.0
25.7
26.0
23.4]
26.0
18.0
29.4
25.2
77.9
59.2
30.4
44.4
72.2
76. 0
23.7
33.4
73.0
75.0
27.1
27.2
73.5
77.2
38.4
27.2
76.4
80.1
41.7
121.9
136.4
77.8
25.9
25.7
25.5
23. 8
25.0
18.0
29.4
25.3 (q)
77.7 (s)
59.1 (d)
30.4 (t)
44.3 (t)
72.3 (s)
76.4 (d)
23.4 (t)
33.4 (t)
73.1 (s)
74.9 (d)
26.9 (t)
27.3 (t)
73.5 (d)
77.2 (s)
38.4 (t)
27.3 (t)
76.4 (d)
80.1 (s)
41.8 (t)
121.9 (d)
136.4 (d)
77.8 (s)
25.9 (q)
25.7 (q)
25.9 (q)
23.4 (q)
25.9 (q)
18.0 (q)
29.3 (q)
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
C26
C27
C28
C29
C30
25.4
77.6
59.3
30.6
44.3
72.0
76.61
23.9
34.1]
73.1
75.5
25.6
27.5
74.2
77.4
38.7
27.7
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80.4
42.3
122.5
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77.9
26.1
25.7
25.3
17.5
18.1
29.5
25.2
77.6
59.4
30.6
44.4
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34. 3
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38.7
27.7
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80.4
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136.7
78.0
26.1
25.7
25.2
F24.1]
17.5
18.2
29.5
25.3
77.6
59.3
30.6
44.3
71.9
76.6
23.7
34.1]
73.0
75.7
25.6
27.3
74.1
77.4
38.7
27.5
76.5
80.3
42.3
122.3
136.7
77.9
26.1
25.7
25.2
23.5]
17.5
18.1
29.5
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Attempted 7-endo-trig cyclization to form bromooxepane ring
Earlier in this chapter we discussed two bromonium-initiated cyclization pathways
(Schemes 2-7 and 2-8) and then demonstrated that the first of these (involving an epoxonium
intermediate trapped by a carbonate nucleophile) led to the desired bromooxepane ring for
armatol A. An alternative pathway (shown again in Scheme 2-28 for armatol A), involves
epoxide-opening by a molecule of water to give triol 145, which would then undergo a 7-endo-
trig cyclization to furnish 1.
Scheme 2-28. Attempts to emulate proposed 7-endo-trig cyclization with 146
proposed biosynthetic 7-endo-trig cyclization
(based on Morimoto)16  attempted emulation of biosynthetic proposal
Me H20
Me Me OH MeMe H H Me
0 OMe M 0 H
00Me Br OHM
144 M 1 OHIMeMgBr
THF, rt
7-endo-trig cyclization 21% yield
Me OH MeMH Me OH MMe OH
MeHM M
D O 0H Me O H MeMOH
Me 145M M Me 146 me OHNBS
4A MS
HFIP, 0 *C
Me Me OH Me OHMeO Me Me H MeO
B Me B MeMe OH O HM  er OH O Me
0 0
I~e me134 me O
Because we had isolated 146 from a reductive dehalogenation of 132 as a side product,
we could test this biogenetic hypothesis. Based on precedence from Morimoto,16 treating this
tetraol with NBS in HFIP should lead to 134. Comparison of a 'H NMR spectrum of the
reaction mixture with that of an authentic sample of 134, however, showed that no desired
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product was obtained. While this result does not exclude epoxide-opening by water followed by
a bromoetherification as a biosynthetic pathway, it does lend support in favor of a biosynthetic
pathway in which a bromonium-initiated epoxide-opening cyclization occurs, similar to that used
in the synthesis of armatol A described here.
Revised biogenesis
In these investigations we have shown that a Lewis acid-mediated triepoxide cascade can
be used to form the BCD rings of armatol A and that a bromonium-initiated epoxide-opening
cyclization provides the bromooxepane ring (ring A). Therefore, we propose that a similar
bromonium-initiated epoxide-opening cascade may be part of the biosynthetic pathway for the
BCD rings of the armatol family.4 1 Based on the relative stereochemistry observed in the six
natural products, the requisite tetraepoxide biosynthetic precursors, 147, 151, and 161, are
proposed (Schemes 2-29 and 2-30). Applying our cascade hypothesis to the three tetraepoxides
would lead to revised structures for the other members of the armatol family. For each proposed
tetraepoxide, a bromonium-initiated epoxide-opening cascade to generate the tricycle leads to an
epoxonium intermediate (148, 152, and 162). Opening by water with inversion then installs the
C10 stereocenter. The bromonium formation at the C22-C23 alkene would not need to be
stereoselective, as both diastereomers at C22 are found in the natural products. A bromonium-
initiated epoxide-opening cyclization at the C2-C3 alkene would install the C3 bromide. The
resulting epoxonium intermediate (150, 154, and 164) can also be opened with inversion by
water leading to armatols B-F as shown. Armatol A (155) could then result from an elimination
of either armatol B or D (Scheme 2-30).
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Scheme 2-29. Revised biosynthetic proposal leading to armatols B-E
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Scheme 2-30. Revised biosynthetic proposal leading to armatol A and F
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Further evidence for the newly assigned structures of the five other armatols is found by
comparing the reported 'H NMR data for the key tertiary alcohol at C27 and the "C NMR data
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armatol F (160)
for the bromooxepane ring in the natural products (Table 2-8).2 The tabulated data is consistent
with the hypothesis that the stereochemistry at the C27 methyl group is identical to armatol A
with the exception of armatol D (6). Since armatol D has been reported to share the same
bromooxepane subunit with armatols A, B, and F, the large degree of inconsistency in the 13C
data for armatol D call into question the ability of this study to predict the correct structure for
armatol D. We have now not only shown the correct absolute stereochemistry of armatol A, but
we have strong support for the absolute configurations of four of the remaining five members of
the armatol family (Figure 2-3).
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Table 2-8. NMR tabulation of the diastereomer B (123) to the reported armatol natural products
27
Me H Me OH Me
Me O 0 ,HO Me2 7' 10H0
Br 6zOH Me
Me 13 Me
26
diasteromer B (123)
armatol D (6)
27
armatol B (4)
27
25 H Me OH Me
Me 0 O a O H
Me 7 10 0 Me1 2 7 6"-OH Me
Br Me 13 H OM
26 C Br
armatol C (5)
armatol E (7)
27
armatol F (8)
Position 123a armatol A (I)b
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C25
C26
25.3
77.7
59.2
30.4
44.3
72.3
76.4
23.4
33.4
73.1
74.9
27.0
27.2
25.8
26.0
25.3
77.7
59.1
30.4
44.3
72.3
76.4
23.4
33.4
73.1
74.9
26.9
27.3
25.7
25.9
armatol B (4 )b armatol C (5 )b
25.3
78.1
59.2
30.4
44.3
72.3
76.5
23.4
33.5
73.2
75.4
25.2
27.1
25.7
25.0
25.5
78.1
60.1
31.4
44.3
72.4
76.5
23.3
33.4
73.4
75.5
25.3
27.3
25.7
21.3
armatol D (6 )b
25.8
78.3
59.7
30.9
44.9
72.8
76.9
23.9
34.0
73.7
75.7
25.7
27.8
26.6
24.0
armatol E ( 7 )b armatol F ( 8 )b
25.8
78.2
60.4
30.2
45.5
72.8
78.8
23.5
33.7
73.7
75.3
25.7
27.5
26.6
21.3
25.3
79.1
59.2
30.4
44.3
72.2
79.5
25.1
33.1
72.9
76.6
24.5
23.3
27.8
24.9
C27 23.4 23.4 23.5 23.5 25.5 23.5 23.4
H27 1.09 1.08 1.09 1.09 1.09 1.10 1.10
1H NMR shifts in ppm referenced to 7.26 ppm, 13C NMR shifts in ppm referenced to 77.0 ppm
a) Synthetic data for armatol A b) Reported data2
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Figure 2-3. Revised structures of armatol A, B, C, E, and F
Me Me OH
B O H Me Me
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Br Me
:fi OH 
M
Me HMe Br
armatol C (157) Me MeOH
me 0~ 0 H M
Me OH ~ Br 
0M
Me H MeHMe OH H
0 Me
me 0 M e Me HMe Br
Br ,, H0Me armatol F (160)
Me HMe ~"Br
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Conclusion
The completion of the synthesis of armatol A has allowed us to confirm the absolute
structure and stereochemistry of not only armatol A, but also five of the six members of the
natural product family. Additionally, the stereoselective synthesis of a bromooxepane ring via a
bromonium-initiated epoxide-opening cascade was explored. Functionalization of the primary
alcohol formed from this cascade (92) allowed for a variety of coupling strategies to form the
carbon framework of armatol A to be investigated. Difficulties in reducing a cis alkene adjacent
to a tertiary alcohol forced a strategic revision, where a trans alkene was easily reduced to form
the acyclic alkyl chain connecting the two sides of armatol A. Formation of the key C10 tertiary
alcohol allowed for complete analysis and determination of the absolute structure of armatol A.
Synthesis of the two possible diastereomers of armatol A and comparison of the spectral data
support a structure for armatol A with absolute configuration shown in 123. Using this
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information, structural revisions of the entire family of armatols and a new biogenesis of these
natural products have been proposed.
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Experimental Section
General Information
Unless otherwise noted, all reactions were performed under an oxygen-free atmosphere
of argon or nitrogen with rigorous exclusion of moisture from reagents and glassware. Unless
otherwise noted, all solvents and triethylamine used in the reactions were purified via a SG
Water USA solvent column system. 4A MS used in the Sharpless asymmetric epoxidations or
the bromonium-initiated epoxide-opening cascades were activated by flame drying under high
vacuum three times (with cooling in between) immediately before use. 1,1,1,3,3,3-Hexafluoro-2-
propanol (HFIP) (99%) was purchased from Aldrich@ Chemical Company and was used without
further purification. N-Bromosuccinimide (NBS) was recrystallized from H2 0 before use and
kept at 0 'C in the absence of light. Analytical thin-layer chromatography was performed using
EM Science silica gel 60 F254 plates. The developed chromatogram was visualized by UV lamp
or stained using one of the following: aqueous potassium permanganate (KMnO4), ethanolic
phosphomolybdic acid (PMA), aqueous cerium ammonium molybdate (CAM, Hanessian's
stain), or ethanolic vanillin. Liquid chromatography was performed using a forced flow (flash
chromatography) of the indicated solvent system on Silicycle silica gel (230-400 mesh).
'H and 13C NMR spectra were recorded on Varian 300 MHz, Varian 500 MHz, Bruker
400 MHz, or Bruker 600 MHz spectrometer in CDCl 3 or C6 D6 . Chemical shifts in 'H NMR
spectra are reported in parts per million (ppm) on the 8 scale from an internal standard of
residual chloroform (7.27 ppm) or residual benzene (7.16 ppm). Data are reported as follows:
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and bs
= broad singlet), coupling constant in hertz (Hz), and integration. Chemical shifts of 13C NMR
spectra are reported in ppm from the central peak of CDCl 3 (77.23 ppm) or C6D6 (128.37 ppm)
on the 6 sc ale. Infrared (IR) spectra were recorded on a Perkin-Elmer 2000 FT-IR. High-
resolution mass spectra (HRMS) were obtained on a Bruker Daltonics APEXII 3 Fourier
Transform Mass Spectrometer by Ms. Li Li of the Massachusetts Institute of Technology,
Department of Chemistry Instrumentation Facility. Chiral HPLC analysis was performed on a
Hewlett-Packard 1100 chromatograph equipped with a variable wavelength detector and
Chiralcel OD or OD-H, or AD-H columns. Specific Rotations ([a] 24D) were measured on a
Perkin-Elmer 241 polarimeter at 589 nm.
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Ti(O'Pr)4
Me Me D-(-)-DET Me MeTBHP""
Me TH *Me
CH2CI2, -23 C
nerol (34) OH 88% yield 23nerol(34)79  ee
Epoxy alcohol 23: To a 1 L round-bottom flame-dried flask equipped with a stir bar was added 4
A molecular sieves (1.005g) and heated under vacuum for 15 min. CH 2Cl2 (40 mL) was added
and the flask was cooled with a CryoCool to -23 0C. Titanium isopropoxide (0.62 mL, 2.1
mmol) and D-(-)-diethyl tartrate (0.49 mL, 2.8 mmol) were added and stirred for 30 min. A
solution of tert-butyl hydrogen peroxide (5.5 M in decanes, 7.2 mL, 39.6 mol) was added and
stirred for 30 min. Nerol (3.6 mL, 20.4 mmol) was added slowly over 15 min. The reaction was
stirred at this temperature for 15 h. The reaction was quenched by adding of H20 at 0 0C and
stirring for 5 h. Added 74 mL of 22.1 g of NaOH in 72 mL of H20 followed by saturating with
NaCl. The reaction mixture was filtered through Celite. Extracted with CH 2Cl2 (3x) and the
organic layers were dried over Na2 SO 4, filtered, and the solvent was removed in vacuo. The
crude oil was purified by column chromatography (20% EtOAc in hexanes) to provide 23 (3.05
g, 17.9 mmol, 88% yield) as a colorless oil.
1H NMR (500 MHz; CDCl 3 ): 6 5.09-5.05 (in, 1H), 3.79 (d, J = 12.0, 1H), 3.62 (dd, J = 12.0, 7.1,
1H), 2.95 (dd, J = 7.0, 4.2, 1H), 2.59 (s, 1H), 2.12-2.03 (in, 2H), 1.67 (s, 3H), 1.63 (dt, J = 9.6,
4.9, 1H), 1.59 (s, 3H), 1.46 (ddd, J = 13.7, 9.9, 7.0, 1H), 1.32 (s, 3H).
13C NMR (125 MHz; CDCl 3): 6 132.6, 123.4, 64.6, 61.7, 61.4, 33.3, 25.8, 24.3, 22.3, 17.8.
Chiral HPLC analysis of the acetate (Ac20, Et3N, DMAP, CH2Cl 2): (Chiralcel OD, hexanes:2-
propanol, 200:1, 1.0 mL/min): tR(2S,3S) = 13.5 min; tR(2R, 3R) = 14.7 min. The enantiomeric
excess was determined to be 79%.
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CH2CI2, rt
OH 66% yield
23 35
Epoxyaldehyde 35: To a 100 mL round-bottom flask equipped with a stir bar was added
epoxyalcohol 23 (498 mg, 2.93 mmol) and dissolved in 30 mL of CH2 Cl 2. Et3N (990 uL, 7.10
mmol) and DMSO (1.05 mL, 14.8 mmol) were added and the reaction was cooled to 0 'C.
S03-py. (563 mg, 3.54 mmol) was added and the reaction was stirred for 2 h while warming to
room temperature. The reaction was quenched with saturated NH4Cl and then extracted with
CH 2Cl2 (3x). The organic layers were dried over Na2SO 4, filtered, and the solvent was removed
in vacuo. The crude oil was purified by column chromatography (10% EtOAc in hexanes) to
provide epoxyaldehyde 35 (325 mg, 1.93 mmol, 66% yield) as a colorless oil.
'H NMR (500 MHz; CDCl 3): 6 9.42 (dd, J = 5.1, 1.1, 1H), 5.06-5.02 (m, 1H), 3.15 (d, J = 5.1,
1H), 2.23-2.16 (m, 1H), 2.12-2.04 (m, 1H), 1.86 (ddd, J = 14.1, 8.9, 5.3, 1H), 1.71 (dd, J = 2.4,
0.3, 1H), 1.67 (s, 3H), 1.64-1.60 (m, 1H), 1.59 (s, 3H), 1.43 (s, 3H)
13 C NMR (125 MHz; CDCl 3): 6 199.1, 133.5, 122.6, 68.5, 64.8, 33.6, 25.8, 24.4, 22.3, 17.8
[aD]24 = -66.9 (c 0.73, CHCl3).
IR (NaCl, thin film): 3584, 2970, 2928, 2857, 1722, 1452, 1410, 1382, 1109, 1058.
HRMS-ESI (m / z): [M + Na]* calcd for CioH160 2Na, 191.1043; found, 191.1051.
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Me Me PPh3MeBr - Me Men-BuLi e Me AD-mix-p HO
Me Me IMeIF Jt tBuQH/H 20 OH53% yield . - 49% yield, 3:1 d.r.
35 SI-35A 22
Terminal alkene 22: To a 25 mL round-bottom flask equipped with a stir bar was added
methyltriphenylphosphonium bromide (643 mg, 1.80 mmol) in 10 mL of THF. A 2.5 M of n-
BuLi in hexanes (660 uL, 1.65 mmol) was added and the reaction was stirred for 30 min. A
solution of aldehyde 35 (251 mg, 1.49 mmol) in 2 mL of THF was added and stirred for 15 h.
The reaction was quenched with saturated NH4 Cl and extracted with Et20 (3x). The organic
layers were dried over Na2 SO 4, filtered, and concentrated in vacuo. The crude was purified by
column chromatography (2% EtOAc in hexanes) to furnish alkene SI-35A (131 mg, 0.788 mmol,
53% yield) which was carried used without further purification.
To a 20 mL vial with stir bar was added alkene SI-35A (131 mg, 0.788 mmol) and 4 mL of t-
BuOH. 4 mL of H20 was cooled to 0 *C. AD-mix p (1.099 g) was added and the reaction was
stirred at 4 'C for 24 h. The reaction was quenched with saturated Na2 SO 3 and warmed to room
temperature. The aqueous layer was extracted with CH 2Cl 2 (3x), dried over Na2SO 4, filtered, and
concentrated in vacuo. The crude reaction was purified by column chromatography (20% to
50% EtOAc in hexanes) to furnish 22 (72 mg, 0.382 mmol, 49% yield) as a colorless oil.
'H NMR (500 MHz; CDCl 3): 6 5.84-5.77 (in, 1H), 5.50-5.45 (m, 1H), 5.38 (ddd, J = 10.5, 1.4,
0.7, 1H), 3.46 (d, J = 10.7, 1H), 3.26 (d, J = 7.2, 1H), 2.44 (d, J = 3.9, 1H), 1.98 (bs, 1H), 1.88-
1.81 (m, 1H), 1.72-1.64 (m, 1H), 1.64-1.59 (m, 1H), 1.57 (s, 3H), 1.53-1.46 (in, 1H), 1.37 (s,
3H), 1.25 (s, 3H)
3 C NMR (125 MHz; CDCl 3): 6 133.1, 120.7, 77.8, 77.4, 73.2, 65.0, 29.3, 27.0, 26.9, 23.5, 21.9
[a]24 D=+11.5 (c 0.04, CHCl3).
IR (NaCl, thin film): 3434, 2926, 1381.
HRMS-ESI (m / z): [M + Na]* calcd for C IH 2003Na, 223.1305; found, 223.1303.
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Carbonate 72: To a 500 mL flame-dried round-bottom flask equipped with a stir bar was added
epoxyalcohol 23 (6.7 g, 39 mmol) in toluene (130 mL). 1-methylimidazole (4.15 mL, 52.1
mmol) was added and the reaction was cooled to 0 'C. Liquid di-tert-butyl dicarbonate (9.72 g,
44.5 mmol) was added dropwise over 15 min and then stirred while warming to room
temperature overnight. The reaction was poured into water and enough CH2Cl 2 was added to
separate into two layers. The aqueous layer was extracted with CH 2Cl 2 (3x) and then the organic
layers were dried over MgSO 4, filtered, and concentrated in vacuo. The crude was purified by
column chromatography (10% EtOAc in hexanes) to provide carbonate 72 (7.91 g, 29.3 mmol,
74% yield) as a colorless oil.
'H NMR (500
11.8, 6.6, 1H),
1.63 (s, 3H), 1.
MHz; CDCl 3): 6 5.11-5.08 (m, 1H), 4.24 (dd, J = 11.8, 4.7, 1H), 4.10 (dd, J =
3.02 (dd, J = 6.6, 4.7, 1H), 2.14-2.10 (m, 2H), 1.70 (s, 3H), 1.67-1.64 (m, 1H),
50 (s, 9H), 1.49-1.48 (m, 1H), 1.35 (s, 3H)
13 C NMR (125 MHz; CDCl 3): 6 153.5, 132.6, 123.4, 82.7, 65.7, 61.0, 60.9, 33.4, 27.9, 25.9,
24.3, 22.1, 17.8
[a]24D =+5.8 (c 0.26, CHCl 3).
IR (NaCl, thin film): 3584, 2981, 2925, 1744, 1457, 1369, 1278, 1255, 1163, 1094.
HRMS-ESI (m / z): [M + Na]* calcd for C15H26 0 4Na, 293.1723; found, 293.1727.
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0 Ot-Bu 0.05 M HFIP Me Me
72 30 min 73 71 (desired)
Bromooxepanes 71 and 73: To a 500 mL round-bottom flask equipped with a stir bar was
added 4A molecular sieves (27 g) followed by carbonate 72 (3.87 g, 14.3 mmol) and 278 mL of
HFIP. The reaction was cooled to 0 'C and Br(coll) 2BF4 (17.6 g, 43.0 mmol) was added in one
portion and the reaction was stirred for 30 min. The reaction was filtered through Celite and then
added to 150 mL of brine and 150 mL of saturated Na2 S2O3 . The aqueous layer was extracted
with CH 2C 2 (3x) and then the organic layers were dried over MgSO 4, filtered, and concentrated
in vacuo. The crude solid was purified by dry loading onto a silica gel column and performing
column chromatography (20 to 50 to 100% EtOAc in hexanes) to furnish 73 (1.313g, 4.48 mmol,
31% yield) and 71 (693.1 mg, 2.36 mmol, 17% yield) as white solids.
Me H
Me 00
Br O O
Me
73
Carbonate 73:
'H NMR (600 MHz; CDC 3): 6 4.46 (dd, J = 11.6, 2.8, 1H), 4.18 (dd, J = 11.6, 2.2, 1H), 4.13
(dd, J = 10.3, 2.5, 1H), 3.94 (t, J = 2.5, 1H), 2.35 (ddt, J = 14.9, 10.2, 2.2, 1H), 2.14 (ddd, J =
14.8, 10.1, 1.5, 1H), 2.03-1.99 (m, 1H), 1.86-1.80 (m, 1H), 1.46 (s, 3H), 1.43 (s, 3H), 1.41 (s,
3H)
13C NMR (125 MHz; CDCl3 ): 6 149.4, 86.6, 79.5, 70.4, 67.8, 61.9, 38.4, 30.4, 29.2, 25.8, 22.4
[[a]24 D - 9.7 (c 1.2, CHC 3).
IR (NaCl, thin film): 2981, 1750, 1457, 1388, 1292, 1247, 1218, 1122, 1091, 1042..
HRMS-ESI (m / z): [M + H]* calcd for C, HIsO 4Br, 293.0389; found, 293.0374.
Me H
Me 0 0
Br"' O O0
Me
71
Carbonate 71:
'H NMR (600 MHz; CDC 3): 6 4.52 (dd, J = 11.5, 2.9, 1H), 4.22 (dd, J = 11.4, 1.8, 1H), 3.88
(dd, J = 10.6, 1.9, 1H), 3.77 (dd, J = 2.7, 1.9, 1H), 2.50 (dtd, J = 14.5, 10.6, 3.6, 1H), 2.20 (ddd, J
= 15.0, 6.9, 3.3, 1H), 2.03-1.99 (in, 1H), 1.72-1.67 (in, 1H), 1.43 (s, 3H), 1.42 (s, 3H), 1.39 (s,
3H)
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13 C NMR (100 MHz; CDC13): 6 149.2, 83.7, 79.2, 71.2, 66.8, 57.1, 39.9, 30.3, 25.7, 25.5, 24.4
[a]24D = -23.0 (c 0.1, CHCl3).
IR (NaCl, thin film): 2937, 1732, 1159, 1540, 1457, 1298, 1208, 1120, 1086, 1040.
HRMS-ESI (m / z): [M + Na]* caled for CI 1H170 4BrNa, 315.0202; found, 315.0214.
Me
Me 0  > NaOH
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Diol 92: To a 100 mL round-bottom flask equipped with a stir bar was added 71 (693.1 mg, 2.36
mmol) in 24 mL of MeOH. NaOH (101.7 mg, 2.54 mmol) was added and the reaction was
stirred for 45 min at room temperature. The reaction was concentrated in vacuo and then the
remaining oil was redissolved in EtOAc and extracted with EtOAc (3x) from a saturated NH 4Cl
solution followed by extraction with CH 2C12 (3x). The organic layers were dried over Na 2SO 4 ,
filtered, and concentrated in vacuo to provide a colorless oil 92 (631.1 mg, 2.36 mmol, 100%
yield) which was carried on without further purification.
1H NMR (500 MHz; CDCl 3): 6 3.87 (ddd, J = 11.6, 7.2, 4.1, 1H), 3.81 (ddd, J = 11.8, 8.6, 3.2,
1H), 3.36 (dd, J = 6.9, 3.2, 1H), 3.30 (dd, J = 9.7, 3.7, 1H), 2.76 (s, 1H), 2.34 (dd, J = 8.5, 4.0,
1H), 1.86-1.80 (m, 3H), 1.79 (s, 3H), 1.76 (s, 3H), 1.61-1.54 (m, 1H), 1.18 (d, J = 10.3, 3H)
13C NMR (125 MHz; CDC 3): 6 84.9, 83.6, 68.2, 67.6, 61.8, 37.3, 30.6, 24.6, 23.1, 30.3
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Aldehyde 93: To a 100 mL round-bottom flask equipped with a stir bar was added diol 92
(631.1 mg, 2.36 mmol) followed by NaHCO 3 (1.89 g, 22.5 mmol) and 100 mL of CH2 Cl 2 . Dess-
martin periodinane' (1.16 g, 3.37 mmol) was added in portions and the reaction was stirred at 0
'C for 2 h then warmed to room temperature overnight. The reaction was quenched with
saturated Na 2SO 3 and saturated NaHCO 3 and then extracted with CH 2Cl 2 (5x). The combined
organic layers were dried over Na2 SO 4, filtered, and concentrated in vacuo. The crude reaction
was purified by column chromatography (20 to 70% EtOAc in hexanes) to provide a 93 (343.8
mg, 1.30 mmol, 55% yield) as a colorless oil and some recovered diol 92 (115.1 mg, 0.43 mmol,
18% yield).
'H NMR (500 MHz; CDCl 3): 6 9.52 (d, J= 3.0, 1H), 3.86 (dd, J= 11.0, 0.7, 1H), 3.59 (d, J= 3.0,
1H), 3.25 (s, 1H), 2.40 (dddd, J = 15.0, 13.0, 10.9, 2.2, 1H), 2.07 (dddd, J = 14.9, 5.3, 3.2, 0.9,
1H), 1.79 (ddd, J = 14.8, 5.4, 2.3, 1H), 1.63-1.55 (m, 1H), 1.52 (s, 3H), 1.37 (s, 3H), 1.20 (d, J=
0.9, 3H)
13 C NMR (125 MHz; CDCl3 ): 6 200.6, 80.1, 79.6, 72.5, 57.8, 44.3, 30.3, 25.6, 24.7, 23.7
[a] 24D= -35.4 (c 0.65, CHC 3).
IR (NaCl, thin film): 3456, 2978, 2940, 1733, 1446, 1386, 1371, 1313, 1271, 1218, 1174, 1141,
1065.
HRMS-ESI (m / z): [M + Na]* calcd for CioH17BrO3Na, 287.0253; found, 287.0258.
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Vinyl iodide 94: To an oven-dried 10 mL round-bottom flask equipped with a stir bar was
added CrCl2 (337.8 mg, 2.75 mmol) in the dry box and transferred into the hood under nitrogen.
The solid was dissolved in 3 mL of THF and cooled to 0 'C. A solution of aldehyde 93 (80.6
mg, 0.304 mmol) and iodoform (384.7 mg, 0.977 mmol) dissolved in THF was slowly added to
the flask and the solution turned from yellow to a shade of burgundy. The reaction was allowed
to warm to room temperature overnight. The reaction was poured into water and extracted with
Et20 (3x). The combined organic layers were dried over Na2 SO 4, filtered, and concentrated in
vacuo. The crude reaction mixture was purified by column chromatography (5% to 10% EtOAc
in hexanes) to provide vinyl iodide 94 (29.9 mg, 0.077 mmol, 25% yield) as a colorless oil.
H NMR (500 MHz; CDCl 3): 8 6.63-6.59 (in, 1H), 6.33 (dd, J = 14.5, 1.1, 1H), 3.92 (d, J = 11.1,
1H), 3.76 (d, J = 6.8, 1H), 3.03 (s, 1H), 2.37-2.29 (in, 1H), 2.05-2.00 (in, 1H), 1.79 (ddd, J =
14.7, 5.3, 2.2, 1H), 1.57-1.51 (m, 1H), 1.43 (s, 3H), 1.37 (s, 3H), 1.09 (s, 3H)
13C NMR (100 MHz; CDCl 3): 6 142.9, 79.2, 78.8, 78.5, 72.1, 58.5, 44.0, 30.5, 25.8, 25.0, 24.4
[a]24 = -20.8 (c 1.5, CHCl 3).
IR (NaCl, thin film): 3546, 2970, 2933, 1607, 1446, 1384, 1369, 1269, 1169, 1140, 1095, 1038.
HRMS-ESI (m / z): [M + Na]* calcd for C1 1H 18BrIO2Na, 410.9427; found, 410.9425.
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Alkyne 95: To an oven-dried 50 mL round-bottom flask equipped with a stir bar was added
pTsN3 (417.5 mg, 2.12 mmol) and 26 mL of acetonitrile followed by potassium carbonate (743.0
mg, 5.38 mmol) and the solution was stirred. Dimethyl-(2-oxopropyl)-phosphate (290 uL, 2.12
mmol) was added and the reaction was stirred at room temperature for 2 h. Aldehyde 93 (462.6
mg, 1.74 mmol) was dissolved in 5.2 mL of MeOH and added as a solution. The reaction was
allowed to stir for 15 h. The solvents were removed in vacuo and then 15 mL of H20 and Et 20
were added. The aqueous layer was extracted with Et2O (3x) and then dried over Na2SO 4 ,
filtered, and concentrated in vacuo. The crude solid was dry loaded onto silica gel and purified
by column chromatography (10->20% EtOAc in hexanes) to provide 95 (283.0 mg, 1.08 mmol,
62% yield) as a colorless oil.
'H NMR (600 MHz; CDCl 3 ): 64.15 (d, J = 2.1, 1H), 3.89 (d, J = 11.0, 1H), 3.10 (s, 1H), 2.50 (d,
J = 2.1, 1H), 2.39-2.33 (m, 1H), 2.04 (ddd, J = 14.8, 5.3, 3.1, 1H), 1.88 (ddd, J = 14.8, 5.4, 2.1,
1H), 1.54 (td, J= 14.0, 2.6, 1H), 1.49 (s, 3H), 1.48 (s, 3H), 1.31 (s, 3H)
13 C NMR (100 MHz; CDCl 3): 6 80.5, 79.3, 74.5, 72.3, 68.2, 58.1, 43.0, 30.4, 25.7, 25.6, 24.5
[a]24 = -5 3 .2 (c 1.1, CHC 3).
IR (NaCl, thin film): 3541, 3293, 2972, 2937, 1447, 1385, 1371, 1319, 1286, 1172, 1141, 1090,
1048, 1032.
HRMS-ESI (m / z): [M + Na]* calcd for C,H17BrO2Na, 283.0304; found, 283.0284.
236
MeH H Me H H
Me 0  H TMSOTf Me 0  H
Br "-- 2,6-lutidine Br''-.
MeOH CH2CI2, -78 *C MeOTMS
95 84% yield 96
Silyl-protected alkyne 96: To a 20 mL vial with stir bar was added alkyne 95 (260.9 mg, 0.999
mmol) in 10 mL of CH2 Cl2 . The vial was cooled to 0 'C and 2,6-lutidine (350 uL, 3.02 mmol)
and TMSOTf (275 uL, 1.52 mmol) were added and the reaction was tired at 0 'C for 90 min.
The reaction was quenched with NaHCO 3 and then extracted with CH 2Cl 2 (3x). The combined
organic layers were dried over Na 2SO 4 , filtered, and concentrated in vacuo. The crude oil was
purified by column chromatography (2% EtOAc in hexanes) to furnish 96 (278.6 mg, 0.836
mmol, 84% yield) as a white solid.
1H NMR (500 MHz; CDC13): 6 3.99 (d, J = 2.3, 1H), 3.86 (d, J = 10.7, 1H), 2.59-2.51 (m, 1H),
2.42 (d, J = 2.3, 1H), 1.90 (s, 1H), 1.93-1.86 (m, 1H), 1.45 (s, 3H), 1.42 (s, 3H), 1.30 (s, 3H),
0.16 (s, 9H)
13C NMR (125 MHz; CDCl 3): 6 81.9, 78.5, 75.6, 73.8, 69.5, 60.0, 44.1, 30.7, 27.7, 25.9, 24.4,
2.8
[a]24D = -25.7 (c 0.13, CHCl3).
IR (NaCl, thin film): 2966, 1996, 1371, 1249, 1178, 1145, 1068, 1015.
HRMS-ESI (m / z): [M + H]+ calcd for C14H25O2BrSi, 333.0880; found, 333.0874.
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Allylic alcohols 102 and 103: To a 5 mL round-bottom flask equipped with a stir bar was added
alkyne 96 (80.5 mg, 0.241 mmol) in 2.3 mL of THF and cooled to -78 0C. A 2.5 M of nBuLi in
hexanes (95 uL, 0.238 mmol) was added slowly over 5 min and the reaction was stirred at this
temperature for 20 min. The reaction was warmed to 0 0C for 10 min and then recooled to -78
'C. A solution of ketone 97 (50.9 mg, 0.115 mmol) in 700 uL of THF was added and the
reaction was slowly warmed to room temperature over 4 h. The reaction was quenched with 1
mL of water and then saturated NH 4 Cl was added. The reaction was extracted with EtOAc (3x)
and with Et20 (2x). The combined organic layers were dried over Na2 SO 4, filtered, and
concentrated in vacuo. The crude oil was purified by column chromatography (2 to 10% EtOAc
in hexanes) to furnish alkyne 101 (60.1 mg, 0.077 mmol, 67% yield) as a colorless oil that was
used without further purification.
To a 5 mL round-bottom flask equipped with a stir bar was added alkyne 101 (6.2 mg, 7.99
umol) in 1 mL of EtOAc. The flask was placed under nitrogen and Pd/C (1.8 mg, 10% w/w) was
added. The reaction was placed under hydrogen (1 atm) and stirred for 15 h. The reaction was
filtered through Celite washing with EtOAc to remove the palladium. The solvent was removed
in vacuo and then purified by column chromatography (2 to 5% EtOAc in hexanes) to furnish a
mixture of alkenes 102 and 103 (6.0 mg, 7.59 umol, 95% yield). Further purification in the same
solvent system allowed for separation of the two alkenes 102 (0.52 Rf in 10% EtOAc in hexanes)
and 103 (0.42 Rf in 10% EtOAc in hexanes).
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Allylic alcohol higher Rf (102):
1H NMR (500 MHz; CDC13): 6 5.46 (dd, J = 12.4, 9.7, 1H), 5.14 (dd, J = 12.5, 1.0, 1H), 5.03 (d,
J = 9.8, 1H), 4.02 (d, J = 10.6, 1H), 3.75 (dd, J = 11.6, 2.4, 1H), 3.69 (d, J = 6.9, 1H), 3.52-3.49
(m, lH), 3.26-3.23 (m, 1H), 2.60-2.52 (m, 1H), 2.48 (s, 1H), 2.06-1.95 (m, 3H), 1.94-1.70 (m,
6H), 1.62-1.59 (m, 5H), 1.46 (s, 3H), 1.45-1.40 (m, 1H), 1.39 (s, 3H), 1.25 (s, 3H), 1.23 (s, 3H),
1.20 (s, 3H), 1.16 (s, 3H), 1.08 (s, 3H), 1.07 (s, 3H), 0.96 (s, 9H), 0.11 (s, 9H), 0.03 (d, J = 1.6,
6H)
13C NMR (125 MHz; CDCl 3): 6 131.1, 127.4, 79.1, 78.6, 77.7, 77.6, 77.4, 76.5, 75.9, 75.5, 72.7,
72.2, 70.1, 61.4, 44.5, 40.8, 36.2, 31.2, 29.9, 29.1, 28.7, 28.4, 27.6, 26.6, 26.2, 26.0, 25.2, 23.1,
20.0, 18.4, 16.7, 2.8, -4.1, -5.3
[a] 24D = +35.0 (c 0.14, CHCl3).
IR (NaCl, thin film): 3425, 2927, 2855, 1462, 1454, 1377, 1249, 1138, 1075, 1009.
HRMS-ESI (m / z): [M + H]+ caled for C39H73BrO7Si 2, 789.4151; found, 789.4138.
Allylic alcohol lower Rf (103):
'H NMR (500 MHz; CDCl 3): 6 5.46 (dd, J = 12.5, 9.5, 1H), 5.25 (d, J = 12.8, 1H), 5.01 (d, J
9.2, 1H), 4.00 (d, J = 10.6, 1H), 3.76-3.73 (m, 1H), 3.68 (d, J = 6.7, IH), 3.55-3.51 (m, 1H),
3.39-3.36 (m, 1H), 2.97 (d, J = 1.0, 1H), 2.59-2.50 (m, 1H), 2.06-1.61 (m, 1OH), 1.54-1.45 (m,
2H), 1.41 (s, 3H), 1.40 (s, 3H), 1.26 (s, 3H), 1.23 (s, 3H), 1.16 (s, 3H), 1.15 (s, 3H), 1.12 (s, 3H),
1.07 (s, 3H), 0.96 (s, 6H), 0.11 (s, 9H), 0.03 (s, 9H).
13C NMR (125 MHz; CDC13): 6 132.3,
70.3, 70.2, 61.4, 44.4, 40.8, 36.2, 29.9,
23.1, 19.9, 18.4, 16.7, 2.8, -4.1, -5.2
128.3, 79.1, 78.6, 77.8, 77.7, 77.4, 76.4, 75.8, 72.5, 71.2,
29.1, 28.7, 28.1, 27.6, 26.4, 26.2, 26.1, 25.9, 25.5, 24.1,
[a]24 = +3.0 (c 0.06, CHCL3).
IR (NaCl, thin film): 3417, 2928, 2854, 1462, 1377, 1250, 1145, 1076.
HRMS-ESI (m / z): [M + H]+ caled for C39H73BrO7Si 2, 789.4151; found, 789.4132.
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Alcohol 110: To a 25 mL round-bottom flask equipped witha stir bar was added [Cp 2Zr(H)Cl]
(71.3 mg, 0.276 mmol) and alkyne 96 (92.3 mg, 0.277 mmol) and placed under nitrogen in the
dark. 2.8 mL of CH2Cl2 was added and stirred for 1 h at room temperature. The flask was then
cooled to -78 'C and Me2Zn (2.0 M in toluene, 145 uL, 0.290 mmol) was added dropwise. After
stirring for 15 min, a solution of aldehyde 99 (74.9 mg, 0.203 mmol) in 2 mL of CH 2Cl2 was
added and the reaction was allowed to slowly warm to room temperature overnight. A saturated
solution of NH4Cl was added and a white solid formed. The aqueous layer was extracted with
CH 2Cl 2 (3x) and then the organic layers were dried over Na 2SO4 , filtered, and concentrated in
vacuo to provide a colorless oil. The crude reaction mixture was purified by column
chromatography (10 to 20 to 30 to 50% EtOAc in hexanes) to provide allylic alcohol 110 (114.0
mg, 0.162 mmol, 80% yield) as a colorless oil.
'H NMR (500 MHz; CDCl 3): 6 5.827 (ddd, J = 15.53, 6.92, 0.72, 1H), 5.53-5.47 (m, 1H), 4.91
(d, J = 6.7, 1H), 3.95 (d, J = 10.4, 1H), 3.84 (q, J = 7.4, 1H), 3.63 (d, J = 6.4, 1H), 3.58 (dd, J =
16.1, 7.3, 1H), 3.45 (dd, J = 11.4, 2.3, 1H), 3.33 (ddd, J = 11.7, 7.2, 2.0, 1H), 2.76 (d, J = 1.3,
1H), 2.57-2.50 (m, 1H), 2.11 (s, 3H), 2.08-2.01 (m, 2H), 1.95-1.84 (m, 4H), 1.81-1.76 (m, 1H),
1.72-1.69 (m, 1H), 1.68-1.56 (m, 4H), 1.52-1.43 (m, 3H), 1.40 (s, 3H), 1.31 (s, 3H), 1.25 (s, 3H),
1.23 (s, 3H), 1.16 (s, 3H), 1.14 (s, 3H), 1.10 (s, 3H), 0.10 (s, 9H)
"C NMR (125 MHz; CDCl 3): 6 (Major diastereomer) 170.2, 132.1, 130.7, 78.8, 78.6, 78.3, 78.0,
77.7, 77.6, 77.4, 76.1, 72.9, 70.3, 60.7, 44.2, 40.6, 36.7, 31.1, 29.1, 28.9, 28.1, 28.0, 27.3, 26.2,
24.3, 23.2, 21.8, 21.3, 20.2, 16.4, 2.8
[a]24D= +6.2 (c 1.0, CHCl 3).
IR (NaCl, thin film): 3473, 2940, 2875, 1737, 1441, 1379, 1249, 1067, 840. 755.
HRMS-ESI (m / z): [M + H]* calcd for C34Hs9BrOsSi, 725.3055; found, 725.3032.
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Secondary alcohol 111: To a 10 mL round-bottom flask equipped with a stir bar was added
allylic alcohol 110 (114.0 mg, 0.162 mmol) and 1.6 mL of EtOH. Palladium on carbon (9.1 mg,
10% by weight) was added and placed under vacuum. Hydrogen gas (1 atm) was added and the
reaction was stirred at room temperature for 17 h. The solution was filtered through Celite
washing with EtOAc to remove the palladium. The crude reaction mixture was purified by
column chromatography (50% EtOAc in hexanes) to provide alcohol 111 (61.0 mg, 0.096 mmol,
59% yield) as a colorless oil.
'H NMR (500 MHz; CDCl 3): 6 4.92 (d, J = 6.6, 1H), 3.91 (d, J = 11.1, 1H), 3.58 (t, J = 7.9, 1H),
3.45 (dd, J = 11.4, 2.4, 1H), 3.34 (dd, J = 10.3, 2.9, 1H), 3.37-3.25 (m, 1H), 3.27 (d, J = 9.7, 1H),
3.01 (bs, 1H), 2.68 (bs, 1H), 2.38-2.30 (m, 1H), 2.12 (s, 3H), 2.08-1.99 (m, 2H), 1.91-1.84 (m,
2H), 1.83-1.69 (m, 5H), 1.68-1.56 (m, 6H), 1.53-1.46 (m, 4H), 1.42 (s, 3H), 1.36 (s, 3H), 1.26 (s,
3H), 1.24 (s, 3H), 1.16 (s, 3H), 1.14 (s, 3H), 1.12 (s, 3H)
13 C NMR (125 MHz; CDCl 3): 6 170.3, 78.9, 78.6, 78.3, 78.0, 77.4, 77.4, 76.1, 75.0, 73.3, 72.4,
70.3, 59.4, 44.5, 40.6, 36.8, 30.6, 30.0, 29.1, 28.9, 28.0, 27.4, 26.5, 25.9, 25.5, 25.2, 23.2, 21.8,
21.3, 20.2, 16.4
[U]2D =+4.5 (c 0.25, CHCl3).
IR (NaCl, thin film): 2937, 1734, 1684, 1636, 1559, 1540, 1507, 1457.
HRMS-ESI (m / z): [M + Na]* calcd for C3 1H53BrO8, 655.2816; found, 655.2812.
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Ketone 112: To a 50 mL round-bottom flask equipped with a stir bar was added alcohol 111
(26.6 mg, 0.042 mmol) and sodium bicarbonate (34.6 mg, 0.412 mmol) in 1 mL of CH 2 Cl 2 . A
0.3 M solution of Dess-Martin periodinane (300 uL, 0.090 mmol) was added and the reaction
was stirred for 13 hours at room temperature. The reaction was quenched with a 1:1 solution of
saturated NaHCO 3 and Na2 SO3. The aqueous layer was extracted with CH2Cl2 (3 x) and the
organic layers were collected and dried over Na2 SO 4, filtered, and concentrated in vacuo. The
crude reaction mixture was purified by column chromatography (20 to 30% EtOAc in hexanes)
to furnish ketone 112 (12.5 mg, 0.0 198 mmol, 47% yield) as a colorless oil.
H NMR (500 MHz; CDCl 3): 6 4.93 (d, J = 6.6, 1H), 3.92 (d, J = 2.9, 1H), 3.89 (d, J = 11.6, 1H),
3.58 (dd, J = 9.0, 7.2, 1H), 3.47 (dd, J = 11.4, 2.4, lH), 3.40 (dd, J = 10.3, 2.8, 1H), 2.97 (s, 1H),
2.73-2.61 (m, 2H), 2.37-2.29 (m, 1H), 2.12 (s, 3H), 2.08-1.94 (m, 4H), 1.92-1.72 (m, 4H), 1.71-
1.59 (m, 5H), 1.59-1.46 (m, 4H), 1.41 (s, 3H), 1.33 (s, 3H), 1.26 (s, 6H), 1.17 (s, 3H), 1.15 (s,
3H), 1.14 (s, 3H)
13 C NMR (125 MHz; CDCl 3 ): 6 211.8, 170.2, 79.0, 78.6, 78.3, 78.0, 77.9, 77.4, 75.5, 74.7, 72.3,
70.0, 59.1, 44.5, 40.5, 36.7, 34.4, 30.5, 29.0, 28.9, 28.4, 27.4, 25.9, 25.3, 25.0, 23.2, 23.2, 21.8,
21.3, 19.5, 16.4
[a]24 D = -5.9 (c 0.23, CHCl 3).
IR (NaCl, thin film): 2936, 1844, 1734, 1717, 1653, 1559, 1540, 1507, 1457, 1242.
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Epoxy alcohol 113: To a 1 L round-bottom flame-dried flask equipped with a stir bar was added
4 A molecular sieves (9.00 g) and heated under vacuum for 15 min. CH 2Cl2 (500 mL) was
added and the flask was cooled with a CryoCool to -23 'C. Titanium isopropoxide (19 mL, 64.8
mmol) and L-(+)-diethyl tartrate (14 mL, 81.8 mmol) were added and stirred for 30 min. A
solution of tert-butyl hydrogen peroxide (5.5 M in decanes, 64 mL, 11.6 mol) was added and
stirred for 30 min. Nerol (57 mL, 326 mmol) was added slowly over 49 min. The reaction was
stirred at this temperature for 3 h. The reaction was quenched by adding 370 mL of H2 0 at 0 'C
and stirring for 5 h. Added 74 mL of 22.1 g of NaOH in 72 mL of H20 followed by saturating
with NaCl. The reaction mixture was filtered through Celite. Extracted with CH 2Cl 2 (3x) and
the organic layers were dried over Na2 SO 4, filtered, and concentrated in vacuo to furnish 113
(40.1 g, 235.5 mmol). The reaction mixture was carried on directly to the enzymatic resolution.
Me Me Amono lipase-PS Me Me
Oe vinyl acetate
Me -. Me
Et2O, 14 hours
113 OH 57% yield, 98.8% ee 114 OAc
Acetate 114: To a 1 L flask with stir bar was loaded alcohol 113 (40.1 g, 235.5 mmol) in vinyl
acetate (100 mL) and Et20 (390 mL) and cooled to 0 'C in an ice bath. Amano lipase-PS (2.6096
g) was added and stirred at 0 'C for 14.25 h. The reaction mixture was filtered through Celite
(eluted with Et20) and the solvent was removed in vacuo. The reaction mixture was purified by
column chromatography (10 to 20 to 30% EtOAc in hexanes) to provide known acetate 1142
(28.59g, 134.7 mmol, 57% yield) as a colorless oil.
[a]24D= -25.7 (c 5.9, CHC13) {lit.2 [U] 23D = -25.7 (c 0.58, CHCl 3)}
IR (NaCl, thin film): 2968, 2928, 2863, 1746, 1451, 1376, 1233, 1036, 887.
Chiral HPLC analysis: (Chiralcel OD, hexanes:2-propanol, 200:1, 1.0 mL/min): tR(2S,3S) = 13.5
min; tR(2R, 3R)= 14.7 min. The enantiomeric excess was determined to be 98.8%.
Me Me K2CO 3  Me Me
Me _1Me MeOH
114 OAc 99% yield 113 OH
Epoxy alcohol 113: To a 1 L round-bottom flask equipped with a stir bar was added 114 (28.59
g, 134.7 mmol) in 340 mL of MeOH. K2 C0 3 (1.88 g, 13.6 mmol) was added and stirred for 4 h.
The solvent was removed in vacuo, and the crude product was redissolved in Et2 0. The resulting
suspension was filtered through Celite and concentrated in vacuo to provide epoxy alcohol 113
(22.66 g, 133 mmol, 99% yield) which was used without further purification.
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Me Me Boc 2O Me MeMe N-methylimidazole
Me * Me O
PhMe
113 OH 77% yield 115 0 Ot-Bu
Carbonate 115: To a 1 L flame-dried round-bottom flask equipped with a stir bar was added
epoxyalcohol 113 (22.66 g, 133.1 mmol) in toluene (620 mL). 1-methylimidazole (14 mL, 175.6
mmol) was added and the reaction was cooled to 0 'C. Liquid di-tert-butyl dicarbonate (117.3 g,
537 mmol) was added dropwise over 15 min and then stirred while warming to room
temperature overnight. The reaction was poured into 1 L of water and enough CH 2Cl 2 was
added to separate into two layers. The aqueous layer was extracted with CH 2Cl 2 (3x) and then
the organic layers were dried over MgSO 4, filtered, and concentrated in vacuo. The crude was
purified by column chromatography (10% EtOAc in hexanes) to provide carbonate 115 (27.73g,
103 mmol, 77 % yield) as a colorless oil.
[a]24 D -9.6 (c 4.6, CHCl3).
Me Me H 0o Br(coll)2BF4  Me 0
Me ~ 0 Me 0
MeNO2  me
115 0 Ot-Bu 0 OC, 4A MS Br
15 min 116
22% yield
Bromooxepane 116: ' To a 2 L round-bottom flask equipped with a stir bar was added 4A
molecular sieves (104.38 g) followed by 2:1 mixture of Boc 20 and carbonate 115 (13.86 g, 51.3
mmol) and 1 L of nitromethane. The reaction was cooled in an ice bath for 15 min with manual
shaking. The reaction was covered with foil and Br(coll) 2BF 4 (51.55g, 126 mmol) was added in
one portion and the reaction was swirled in an ice bath for 15 min. The reaction was filtered
through Celite and the solvent was removed in vacuo at 40 'C. The reaction turned dark brown
and was dissolved in CH 2C12 and 1:1 Na2S2O3/NaCl solutions. The aqueous layer was extracted
with CH 2Cl 2 (3x) and then washed with IN HCl. The organic layer was dried over MgSO 4,
filtered, and concentrated in vacuo. The crude solid was purified by column chromatography
(25% to 50% to 63% to 75% EtOAc in hexanes) to furnish 116 (3.3g, 11.3 mmol, 22% yield) as
a white solid and a small amount of SI-116A for characterization purposes.
[a]24D= 33.6 (c 0.66, CHCl 3).
Me
Me O=
Brill 0
Me
SI-116A
[a] 24D=+19.1 (c 1.1, CHCl3).
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'Me MeOH-
Br 93% yield Br Me
116 117
Diol 117: To a 200 mL round-bottom flask equipped with a stir bar was added 116 (3.3 g, 11.3
mmol) in 115 mL of MeOH. NaOH (536 mg, 13.4 mmol) was added and the reaction was
stirred for 2 h at room temperature. The reaction was concentrated in vacuo and then the
remaining oil was redissolved in EtOAc. A saturated NH 4 Cl solution was added and was
extracted with EtOAc (3x) followed by extraction with CH 2Cl 2 (3x). The organic layers were
combined and dried over Na2 SO 4, filtered, and concentrated in vacuo to provide a colorless oil
117 (2.8 g, 10.5 mmol, 93% yield) which was used without further purification.
H SO3'PY H OMe O OH DM0ISO Me Oj H
Me OH , Me OH
Br Me Et3  Br Me
117 80% yield 118
Aldehyde 118: To a 25 mL round-bottom flask equipped with a stir bar was added S03-py
(3.654 g, 23.0 mmol) in 12 mL of DMSO and stirred for 15 min. To a separate 250 mL round-
bottom flask equipped with a stir bar was added diol 117 (3.06 g, 11.5 mmol) in 120 mL of
CH 2 Cl 2. Triethyl amine (4.8 mL, 34.4 mmol) and 2 mL of DMSO was added and cooled to 0
'C. The S03-DMSO complex was added slowly and the reaction was stirred for 8 h while
warming to room temperature. The reaction was poured into 100 mL of saturated NH4 Cl and
extracted with CH2 Cl 2 (3x). The organic layers were dried over Na 2 SO 4, filtered, and
concentrated in vacuo. The crude oil was purified by Biotage column chromatography to furnish
aldehyde 118 (2.42 g, 9.13 mmol, 80% yield) as a colorless oil.
0 0
Me -OMeMe OMe
H 0 ~119 N2  eHMe 0j H K2CO3  Meo
Me OH KMe OH
Br Me MeOH
75% yield Br M
118 120
Alkyne 120: To a 200 mL round-bottom flask equipped with a stir bar was added aldehyde 118
(1.64g, 6.18 mmol) and dissolved in 86 mL of MeOH. Potassium carbonate (1.985 g, 14.4
mmol) was added followed by dropwise addition of dimethyl-1-diazo-2-oxopropylphosphate
(1.3252 g, 6.90 mmol). The reaction was stirred for 16 h at room temperature, during which time
the color the mixture changed from yellow to orange. 100 mL of Et2O was added to the reaction
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followed by 150 mL of saturated NaHCO3. The aqueous layer was extracted with Et2O (3x) and
then dried over Na 2SO 4 . The reaction was filtered and concentrated in vacuo to provide a milky
light yellow solution. The crude was loaded directly onto the Biotage and alkyne 120 (1.2155 g,
4.65 mmol, 75% yield) was obtained a colorless oil.
TMSOTf H /
Me O 2,6-lutidine Me OH
Me OH Me OTMS
CH2CI2, 0 *CBr M 82% yield Br Me
120 121
Alkyne 121: To a 100 mL round-bottom flask equipped with a stir bar was added alkyne 120
(1.2155 g, 4.65 mmol) and dissolved in 47 mL of CH 2Cl 2 . The reaction was cooled to 0 'C and
2,6-lutidine (1.62 mL, 14.0 mmol) was added followed by dropwise addition of TMSOTf (1.26
mL, 7.00 mmol). The reaction was stirred for 1 h at this temperature and then quenched with 30
mL of saturated NaHCO 3. The aqueous layer was extracted with CH 2Cl 2 (3x) and the organic
layers were dried over Na2 SO4, filtered, and concentrated in vacuo. The crude oil was purified
by column chromatography (2% to 5% EtOAc in hexanes) to provide alkyne 121 (1.2095 g, 3.63
mmol, 78% yield) as a white solid.
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1) [Cp 2Zr(H)Cl], CH2CI2  OHMeH A' 2) Me2Zn, -78 'C MeHMMee
TMS H 0 Me 3OTMVS 3) 0 H M Br OTMS Me
Br Me H H HH Me He "OAc
0 Me0 
-
99 HMe "'QOAc
64% yield
Alcohol 126: To a 25 mL round-bottom flask equipped with a stir bar was added [Cp 2Zr(H)Cl]
(256.0 mg, 0.99 mmol) and alkyne 121 (320.6 mg, 96 mmol) and placed under nitrogen in the
dark. 9.6 mL of CH 2Cl2 was added and stirred for 30 min at room temperature. The flask was
then cooled to -78 'C and Me 2Zn (2.0 M in toluene, 505 uL, 1.01 mmol) was added dropwise.
After stirring for 15 min, a solution of aldehyde 99 (306.3 mg, 0.83 mmol) in 8 mL of CH 2 Cl 2
was added and the reaction was allowed to slowly warm to room temperature overnight. A
saturated solution of NH 4 Cl was added and a white solid formed. The aqueous layer was
extracted with CH 2Cl 2 (3x) and then the organic layers were dried over Na 2SO 4 , filtered, and
concentrated in vacuo to provide a colorless oil. The crude was purified by column
chromatography (5 to 50% EtOAc in hexanes) to provide allylic alcohol 126 (373.2 mg, 0.53
mmol, 64% yield) as a colorless oil.
H NMR (600 MHz; CDCl 3): 6 5.85 (dd, J = 15.6, 7.5, 1H), 5.50 (dd, J = 15.6, 6.7, 1H), 4.91 (d,
J = 6.8, IH), 3.96 (d, J = 10.4, 1H), 3.86-3.84 (m, 1H), 3.63 (t, J = 6.8, 1H), 3.58 (dd, J = 9.7,
6.1, 1H), 3.45 (dd, J = 11.3, 2.0, 1H), 3.34 (ddd, J = 11.8, 7.2, 1.9, 1H), 2.69 (d, J = 2.4, 1H),
2.54 (td, J = 12.9, 10.1, 1H), 2.12 (s, 3H), 2.08-2.01 (m, 2H), 1.94-1.86 (m, 4H), 1.79 (dd, J =
14.4, 13.6, 2H), 1.70 (t, J = 14.0, 1H), 1.62 (dt, J= 6.8, 3.1, 2H), 1.52-1.44 (m, 4H), 1.41 (s, 3H),
1.33 (s, 3H), 1.25 (s, 3H), 1.24 (s, 3H), 1.16 (s, 3H), 1.15 (s, 3H), 1.06 (s, 3H), 0.11 (s, 9H)
13 C NMR (125 MHz; CDC13): 6 170.3, 131.6, 131.0, 78.8, 78.6, 78.3, 78.3, 77.7, 77.6, 77.4,
75.9, 75.5, 73.2, 70.3, 60.8, 44.2, 40.6, 36.8, 31.0, 29.1, 28.9, 28.1, 27.8, 27.4, 26.2, 24.4, 23.2,
21.8, 21.3, 20.1, 16.4, 2.8
[a]24 D=+28.2 (c 0.4, CHCl 3).
IR (NaCl, thin film): 3583, 2939, 1739, 1442, 1379, 1248, 1067, 840, 753.
247
OH Pd/C OH
Me H Me H'm me H Me
Me 0 M Et y Me Ow 0 Me
Br0M Me EtOH, rt, 1.5 h BOHMe
Me 126 H Me "Qc66% yield Me 127 H Me ""QAc
Secondary alcohol 127: To a 25 mL round-bottom flask equipped with a stir bar was added
allylic alcohol 126 (373.2 mg, 0.53 mmol) and 5.2 mL of EtOH. Palladium on carbon (218 mg,
10% by weight) was added and placed under vacuum. Hydrogen gas was added and the reaction
was stirred at room temperature for 90 min. The solution was filtered through Celite (eluted with
EtOAc) to remove the palladium. The crude reaction mixture was purified by Biotage (25 g
column) to provide alcohol 127 (223.3 mg, 0.352 mmol, 66% yield) as a colorless oil.
1H NMR (400 MHz; CDCl 3): 6 4.92 (d, J= 6.3, 1H), 3.91 (d, J = 10.7, 1H), 3.57 (dd, J = 8.8, 7.0,
1H), 3.45 (dd, J = 11.4, 2.5, 1H), 3.38-3.31 (m, 3H), 3.03 (s, 1H), 2.64 (d, J = 2.8, 1H), 2.39-2.29
(m, 1H), 2.11 (s, 3H), 2.09-1.96 (m, 3H), 1.92-1.71 (m, 7H), 1.68-1.61 (m, 5H), 1.57-1.44 (m,
4H), 1.41 (s, 3H), 1.37 (s, 3H), 1.26 (s, 3H), 1.23 (s, 3H), 1.16 (s, 3H), 1.14 (s, 3H), 1.12 (s, 3H)
"C NMR (100 MHz; CDCl 3): 6 170.3, 78.9, 78.6, 78.3, 78.0, 77.4, 77.4, 75.9, 74.1, 72.6, 72.4,
70.4, 59.4, 44.6, 40.6, 36.8, 30.6, 29.2, 29.1, 28.9, 27.8, 27.4, 25.9, 25.9, 25.6, 25.2, 23.2, 21.8,
21.3, 20.2, 16.4
[U]2D +19.5 (c 0.25, CHCl3).
IR (NaCl, thin film): 3542, 2977, 2938, 1732, 1446, 1380, 1243, 1137, 1076, 1029, 983.
HRMS-ESI (m / z): [M + H]* calcd for C31Hs4BrO8Na, 633.2997; found, 633.3004.
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Me 127 HMe "'QAc 4CAMSr Me 128 H Me "QcMe 0 CH2CI2, 0 C to rOc
81% yield
Ketone 128: To a 10 mL round-bottom flask equipped with a stir bar were added 4A molecular
sieves (193.8 mg) followed by alcohol 127 (223.3 mg, 0.352 mmol) in 3.5 mL of CH2Cl2. N-
Methylmorpholine-N-oxide (131.0 mg, 1.12 mmol) was added and the reaction was cooled to 0
0C. Tetrapropylammonium perruthenate (29.0 mg, 82.5 mmol) was added and the reaction was
allowed to warm to room temperature over 2 h. The crude reaction was filtered through Celite
using a CH 2Cl 2 and EtOAc wash and concentrated in vacuo. The reaction was purified by
Biotage (25 g column) to provide 128 (179.9 mg, 0.285 mmol, 81% yield) as a colorless oil.
'H NMR (600 MHz; CDCl 3): 6 4.92 (d, J = 6.6, 1H), 3.89 (td, J = 7.5, 4.0, 2H), 3.60 (dd, J =
13.8, 7.0, 1H), 3.47 (dd, J = 11.4, 2.3, 1H), 3.41 (dd, J = 10.3, 2.8, 1H), 2.96 (s, 1H), 2.69-2.67
(m, 2H), 2.33 (qd, J = 13.0, 1.6, 1H), 2.12 (s, 3H), 2.04-1.60 (m, 13H), 1.53-1.46 (m, 4H), 1.41
(s, 3H), 1.31 (s, 3H), 1.26 (s, 3H), 1.25 (s, 3H), 1.17 (s, 3H), 1.15 (s, 3H), 1.14 (s, 3H)
13 C NMR (125 MHz; CDCl 3): 6 212.1, 170.2, 78.9, 78.6, 78.2, 78.0, 77.8, 77.4, 75.8, 74.6, 72.3,
69.8, 68.1, 59.1, 44.5, 43.0, 40.5, 36.7, 34.1, 30.5, 30.4, 28.9, 25.8, 25.7, 25.6, 25.0, 24.5, 23.2,
21.8, 21.3, 19.6, 16.4
[a] D= -4.8 (c 0.24, CHC 3).
IR (NaCl, thin film): 3584, 2976, 2938, 1736, 1445, 1379, 1243, 1138, 109, 1069, 1029.
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121 H 19A 0 Me 131 e OAc
Me
129 HM4 OAc
78% yield
Secondary alcohol 131: To a 50 mL round-bottom flask equipped with a stir bar was added
[Cp 2Zr(H)Cl] (387.2 mg, 1.50 mmol) and alkyne 121 (498.2 mg, 1.49 mmol) and placed under
nitrogen in the dark. 15 mL of CH 2Cl2 was added and stirred for 30 min at room temperature.
The flask was then cooled to -78 0C and Me 2Zn (2.0 M in toluene, 780 uL, 1.56 mmol) was
added dropwise. After stirring for 20 min, a solution of aldehyde 129 (450 mg, 1.22 mmol) in
12.5 mL of CH 2Cl 2 was added and the reaction was allowed to slowly warm to room temperature
overnight. A saturated solution of NH4Cl was added and a white solid formed. The aqueous
layer was extracted with CH 2Cl 2 (3x) and then the organic layers were dried over Na2 SO 4 ,
filtered, and concentrated in vacuo to provide a colorless oil. The crude was purified by column
chromatography (5 to 50% EtOAc in hexanes) to provide allylic alcohol 130 (667.2 mg, 0.948
mmol, 78% yield) as a colorless oil, which was used without further purification.
To a 25 mL round-bottom flask equipped with a stir bar was added allylic alcohol 130 (599.6
mg, 0.85 mmol) and 17 mL of EtOH. Palladium on carbon (235 mg, 10% by weight) was added
and placed under vacuum. Hydrogen gas was added and the reaction was stirred at room
temperature for 2 h. The solution was filtered through Celite (eluted with EtOAc) to remove the
palladium. The crude reaction mixture was purified by Biotage (25 g column) to provide alcohol
131 (401.6 mg, 0.634 mmol, 75% yield) as a colorless oil.
1H NMR (400 MHz; C6D6): 6 4.98 (d, J = 6.7, 1H), 3.63-3.53 (m, 3H), 3.34-3.23 (m, 2H), 2.92
(s, 1H), 2.88 (dd, J = 9.9, 3.1, 1H), 2.67 (d, J = 3.1, 1H), 2.23-2.12 (m, 2H), 1.98-1.90 (m, 3H),
1.86-1.74 (m, 4H), 1.68 (s, 3H), 1.67-1.41 (m, 8H), 1.36 (s, 3H), 1.28 (s, 3H), 1.27 (s, 3H), 1.25
(s, 3H), 1.23-1.10 (in, 3H), 1.07 (s, 3H), 1.02 (s, 3H), 1.00 (s, 3H)
13C NMR (100 MHz; C6D6): 6 169.5, 79.2, 78.7, 78.7, 77.9, 77.7, 77.6, 76.4, 75.5, 74.0, 72.3,
70.9, 59.8, 44.7, 41.2, 37.5, 31.0, 30.6, 29.8, 29.1, 28.3, 28.1, 27.3, 26.2, 25.7, 25.6, 23.6, 22.0,
20.8, 20.5, 16.8
[a]24D = +5.1 (c 0.91, C6H6).
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131 CH2CI2, O *C to rt 132
94% yield
Ketone 132: To a 10 mL round-bottom flask equipped with a stir bar were added 4A molecular
sieves (360 mg) followed by alcohol 131 (382.9 mg, 0.604 mmol) in 3.5 mL of CH2 Cl 2. N-
Methylmorpholine-N-oxide (230 mg, 1.96 mmol) was added and the reaction was cooled to 0 'C.
Tetrapropylammonium perruthenate (30 mg, 0.085 mmol) was added and the reaction was
allowed to warm to room temperature over 4 h. The crude reaction was filtered through Celite
using a CH 2Cl 2 and EtOAc wash and concentrated in vacuo. The reaction was purified by
Biotage (25 g column) to provide 132 (358.8 mg, 0.568 mmol, 94% yield) as a colorless oil.
IH NMR (400 MHz; CDCl 3): 6 4.97 (d, J = 6.8, 1H), 3.67 (dd, J = 11.9, 2.9, 1H), 3.63-3.54 (in,
2H), 3.47 (d, J = 10.8, 1H), 2.98 (dd, J = 9.4, 3.7, 1H), 2.84 (s, 1H), 2.68-2.60 (in, 2H), 2.20-2.10
(in, 1H), 1.91-1.74 (in, 8H), 1.70 (s, 3H), 1.66-1.36 (in, 9H), 1.31 (s, 3H), 1.22 (s, 3H), 1.22 (s,
3H), 1.21 (s, 3H), 1.07 (s, 3H), 1.04 (s, 3H), 0.99 (s, 3H)
13 C NMR (100 MHz; CDCl 3): 6 210.5, 169.5, 79.3, 78.7, 78.6, 78.3, 78.0, 77.6, 75.8, 75.1, 72.3,
70.6, 59.6, 44.6, 41.1, 37.4, 34.8, 30.9, 29.7, 29.0, 28.7, 28.0, 26.0, 25.50, 25.5, 23.8, 23.6, 22.0,
20.8, 19.8, 16.8
[a] 24D =+17.4 (c 1.6, CHCl 3).
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Tertiary alcohol 133: To a 20 mL vial with stir bar was added ketone 132 (11.7 mg, 18.5 mmol)
in 1 mL of THF. The reaction was cooled to -78 'C and then a 3.0 M solution of
methylmagnesium bromide in Et 20 (50 uL, 150 mmol) was added dropwise. The reaction was
allowed to stir at this temperature for 1 h. The reaction was quenched with saturated NH4 Cl (1
mL) and then 5 mL of brine was added. The aqueous layer was extracted with Et20 (5x) and
then the organic layers were dried over Na2 SO 4, filtered, and concentrated in vacuo. The crude
oil was purified by column chromatography to furnish starting material 132 (4.2 mg, 6.6 mmol)
and acetate 133 (7.7 mg, 11.9 mmol, 64% yield, 100% BRSM).
H NMR (500 MHz; CDCl 3): 6 4.92 (d, J = 6.8, 1H), 3.91 (d, J = 11.1, 1H), 3.55 (dd, J = 10.5,
5.7, 1H), 3.46 (dd, J = 11.4, 2.5, 1H), 3.31-3.27 (in, 2H), 3.04 (s, 1H), 2.37 (s, 1H), 2.39-2.34 (in,
1H), 2.12 (s, 3H), 2.07-2.00 (in, 3H), 1.90-1.85 (in, 2H), 1.82-1.70 (m, 5H), 1.70-1.60 (m, 5H),
1.52-1.46 (in, 4H), 1.42 (s, 3H), 1.37 (s, 3H), 1.26 (s, 3H), 1.23 (s, 3H), 1.16 (s, 3H), 1.15 (s,
3H), 1.12 (s, 3H), 1.11 (s, 3H)
3C NMR (125 MHz; CDCl3 ): 6 170.3, 78.8, 78.6, 78.3, 78.0, 77.4, 77.4, 76.2, 75.7,
70.5, 59.4, 44.6, 40.7, 36.8, 33.6, 30.6, 29.1, 28.9, 27.6, 25.9, 25.7, 25.4, 25.2, 24.0,
21.8, 21.3, 20.1, 16.4
HRMS-ESI (m / z): [M + Na]* calcd for C32H5 5BrO8Na, 669.2973; found, 669.2979.
73.2, 72.4,
23.8, 23.2,
Me H O Me
Me O O H Me
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Alcohols 134 and 135: To a 20 mL vial equipped with a stir bar were added ketone 132 (192.0
mg, 0.304 mmol) and 6 mL of THF and the reaction was cooled to -78 'C. MeLi (2 mL, 1.6 M
in Et2 0, 3.2 mmol) was added dropwise and the reaction was stirred for 2.5 h. Saturated NH 4C1
was added and the reaction was allowed to warm to rt. The aqueous layer was extracted with
Et 20 (3x), dried over Na2 SO 4, filtered, and concentrated in vacuo. The crude product was
purified by the Biotage (100g column) to provide clean alcohol 135 (56.2 mg, 0.0928 mmol,
31% yield) and the remaining material as a mixture of alcohol 134 and alcohol 135 (80.2 mg,
0.132 mmol, 44% yield).
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1H NMR (400 MHz; C6D6): 6 3.82 (dd, J = 11.4, 2.6, 1H), 3.66 (dd, J = 10.1, 6.1, 1H), 3.54 (d, J
= 11.1, 1H), 3.28-3.23 (m, 2H), 2.94 (s, 1H), 2.76 (dd, J = 9.3, 3.1, 1H), 2.25-2.15 (m, 4H), 1.92-
1.80 (m, 5H), 1.72-1.44 (m, 13H), 1.34 (s, 3H), 1.33 (s, 3H), 1.28 (s, 3H), 1.24 (s, 3H), 1.16 (s,
3H), 1.15 (s, 3H), 1.00 (s, 3H), 0.98 (s, 3H).
"C NMR (100 MHz; C6 D6): 6 79.6, 78.2, 78.1, 78.0, 77.9, 76.7, 76.5, 76.3, 73.3, 72.4, 71.2,
59.8, 44.8, 41.1, 36.8, 34.7, 31.0, 30.0, 29.4, 28.4, 26.3, 26.1, 26.1, 25.6, 25.5, 24.4, 24.3, 22.1,
20.2, 17.1.
[a] 24D = -15.0 (c 0.2, CHCl3).
IR (NaCl, thin film): 3451, 2974, 2937, 1445, 1378, 1138, 1071, 801, 755.
HRMS-ESI (m / z): [M + H] calcd for C30H53BrO7, 605.3047; found, 605.3035.
Me H Me OH Me
Me 00
O H 0Br Me M
MeMe OH
135
IH NMR (400 MHz; C6D6): 6 3.82 (dd, J = 11.4, 2.6, 1H), 3.62 (t, J= 8.1, 1H), 3.55 (d, J 10.9,
1H), 3.27-3.15 (m, 2H), 2.94 (bs, 1H), 2.80 (dd, J = 8.1, 4.3, 1H), 2.31 (bs, 1H), 2.27-2.11 (m,
3H), 1.96-1.79 (m, 4H), 1.73-1.40 (m, 13H), 1.36 (s, 3H), 1.34 (s, 3H), 1.28 (s, 3H), 1.25 (s, 3H),
1.14 (s, 3H), 1.04 (s, 3H), 1.02 (s, 3H), 0.98 (s, 3H).
13C-NMR (100 MHz, C6D6): 6 79.6, 78.1, 78.1, 77.9, 77.9, 76.7, 76.7, 75.4, 73.4, 72.4, 71.0,
59.8, 44.7, 41.0, 36.8, 36.8, 31.0, 30.0, 29.4, 28.4, 26.3, 26.1, 25.9, 25.7, 25.6, 24.6, 22.0, 21.7,
20.4, 17.1.
[a]2 4D = -22.1 (c 0.5, CHCl3)
IR (NaCl, thin film): 3451, 2975, 2937, 1447, 1379, 1302, 1137, 1071, 1034, 995, 891, 754.
HRMS-ESI (m / z): [M + H]* caled for C30H54BrO7, 605.3047; found, 605.3029.
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139
Alcohol 139: To a 5 mL round-bottom flask equipped with a stir bar was added ketone 128 (65.2
mg, 103.2 umol) and 1.6 mL of THF. The reaction was cooled to -78 'C and MeMgBr (200 uL,
3.0 M in Et2 0, 600 umol) was added and the reaction was allowed to warm to 0 'C over 1 h.
The reaction was quenched with sat. NH 4Cl and the aqueous layer was extracted with Et 20 (3x).
The organic layer was dried over Na 2 SO4 , filtered, and concentrated in vacuo. The crude oil was
purified by column chromatography (20->50% EtOAc in hexanes) to provide acetate SI-139A
(19.6 mg, 30.3 umol, 29% yield) and alcohol 139 (9.6 mg, 15.9 umol, 15% yield) along with
recovered ketone 128 (35.0 mg, 55.4 umol, 54% yield).
The recovered starting material was redissolved in 3.2 mL of THF and MeMgBr (200 uL, 3.0 M
in Et 20, 600 umol) was added at -78 'C and allowed to stir for 1 h. The reaction was quenched
with saturated NH 4 Cl and extracted with Et 2O (3x). The organic layers were dried over Na2 SO 4 ,
filtered, and concentrated in vacuo. The crude residue along with acetate SI-139A (19.6 mg,
30.3 umol) was dissolved in 3.4 mL of MeOH and K2 CO 3 (18.3 mg, 132.4 umol) was added and
stirred at room temperature for 4 h. The reaction was then quenched with saturated NH4Cl and
extracted with Et2 0 (5x). The organic layers were dried over Na2 SO 4 , filtered, and concentrated
in vacuo. The crude was purified by column chromatography (50% EtOAc in hexanes) to
provide alcohol 139 (34.6 mg, 57.1 umol, 67% yield) as a colorless oil.
'H NMR (500 MHz; C6 D6 ): 6 3.81 (dd, J = 11.4, 2.4, 1H), 3.65 (dd, J = 10.6, 5.4, 1H), 3.51 (d, J
= 11.1, 1H), 3.23 (td, J = 8.5, 3.5, 2H), 2.92 (s, 1H), 2.78 (dd, J = 9.9, 3.0, 1H), 2.24 (s, J = 5.2,
1H), 2.24-2.14 (m, 3H), 1.95-1.43 (m, 17H), 1.34 (s, 3H), 1.33 (s, 3H), 1.25 (s, 6H), 1.14 (s, 6H),
1.01 (s, 3H), 0.98 (s, 3H).
"C NMR (125 MHz; C6 D6 ): 6 79.6, 78.2, 78.1, 78.0, 77.9, 76.9, 76.7, 76.3, 73.4, 72.4, 71.2,
59.7, 44.7, 41.1, 36.8, 34.4, 31.0, 30.0, 29.4, 28.3, 26.3, 26.1, 26.0, 25.7, 25.6, 24.1, 24.0, 22.1,
20.2, 17.1.
[a]24 D= +40.9 (c 0.2, CHCl3). For reference, ent-139: [a] 2 4D= -41.7 (c 0.1, CHCl 3)
IR (NaCl, thin film): 3583, 3452, 2932, 1659, 1641, 1462, 1451, 1378, 1137, 1071, 891.
HRMS-ESI (m / z): [M + H]+ calcd for C3 0 H54BrO7, 605.3047; found, 605.3059.
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Alcohol 138: To a 20 mL vial with stir bar was added ketone 128 (179.9 mg, 0.285 mmol) and
3.5 mL of THF and the reaction was cooled to -78 'C. MeLi (950 uL, 1.6 M in Et 20, 1.52
mmol) was added dropwise and the reaction was stirred for 1 h. The reaction solidified and
eventually stirring ceased. Saturated NH4Cl was added, and the reaction was allowed to warm to
rt. The aqueous layer was extracted with Et 20 (3x), dried over Na 2SO 4 , filtered, and the solvent
was removed in vacuo. The crude was redissolved in 10 mL of THF and cooled to -78 'C.
MeLi (1 mL, 1.6 M in Et2O, 1.6 mmol) was added dropwise and the reaction was stirred at this
temperature for 1 h. The reaction stayed in solution and went to completion by TLC. Saturated
NH4Cl was added and allowed to warm to rt. The aqueous layer was extracted with Et20 (3x)
and then the organic layers were dried over Na2 SO 4 , filtered, and concentrated in vacuo. The
crude product was purified by careful column chromatography (0.1% to 2% MeOH in Et 20) on
the Biotage (100g HP column) to provide clean alcohol 138 (29.7 mg, 49.3 mmol, 17% yield)
and the remaining material as a mixture of alcohol 138 and alcohol 139 (116.5 mg, 0.192 mmol,
67% yield).
Me H Me OH Me
Me 0 0 H
Br ~OH 0 Me
Z Me 138 H Me O
'H NMR (400 MHz; C6D6): 6 3.80 (dd, J = 11.4, 2.3, 1H), 3.62 (dd, J = 10.2, 6.0, 1H), 3.50 (d, J
= 11.0, 1H), 3.29-3.19 (m, 2H), 2.90 (bs, 1H), 2.78 (dd, J = 9.3, 3.2, 1H), 2.30 (bs, 1H), 2.27-
2.12 (m, 3H), 1.92-1.75 (m, 4H), 1.72-1.53 (in, 8H), 1.53-1.40 (in, 5H), 1.33 (s, 6H), 1.25 (s,
3H), 1.24 (s, 3H), 1.13 (s, 3H), 1.10 (s, 3H), 1.02 (s, 3H), 0.97 (s, 3H)
13C-NMR (100 MHz, C6D6 ): 8 79.6, 78.1, 78.1, 77.9, 77.9, 76.7, 76.6, 74.4, 73.4, 72.4, 71.0,
59.8, 44.7, 41.1, 36.9, 36.8, 31.0, 30.1, 29.4, 28.3, 26.3, 26.1, 25.9, 25.6, 25.6, 24.7, 23.0, 22.0,
20.3, 17.1.
HRMS-ESI (m / z): [M + H]+ calcd for C30Hs4 BrO 7, 605.3047; found, 605.3051.
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Ketone 140: To a 5 mL round-bottom flask equipped with a stir bar was added 30 mg of 4A MS
and heated under vacuum for 5 min. The flask was cooled to 0 'C and alcohol 134 (26.7 mg,
0.0441 mmol) was added in 2 mL of CH 2Cl 2 . NMO (20 mg, 0.171 mmol) was added and then
TPAP (~2 mg, 0.006 mmol) was added and the reaction was allowed to slowly warm to room
temperature for 2 h. The crude material was loaded directly onto a Biotage column (10 g) to
furnish ketone 140 (25.8 mg, 0.0427 mmol, 97% yield).
'H NMR (400 MHz; C6D6 ): 6 3.57 (d, J=6.7, 1H), 3.56 (d, J = 10.7, 1H), 3.25 (dd, J = 11.3, 2.8,
1H), 2.90 (dd, J = 11.2, 2.5, 2H), 2.78 (dd, J = 9.2, 3.2, 1H), 2.68 (ddd, J = 13.1, 11.6, 4.3, 1H),
2.25-2.10 (m, 1H), 2.07 (ddd, J = 11.5, 5.7, 3.0, 1H), 1.93-1.81 (m, 4H), 1.75-1.70 (m, 2H), 1.69
(dd, J = 5.7, 2.0, 1H), 1.64-1.58 (m, 3H), 1.56-1.46 (m, 6H), 1.35 (s, 3H), 1.26 (s, 3H), 1.25 (s,
3H), 1.24 (s, 3H), 1.17 (s, 3H), 1.11 (s, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.97-0.93 (m, 1H)
13 C NMR (100 MHz; C6D6): 6 215.7, 83.7, 83.1, 78.4, 78.0, 77.5, 76.4, 76.2, 73.2, 72.4, 71.4,
59.7, 44.8, 41.9, 40.7, 35.6, 34.8, 31.0, 29.7, 28.1, 26.7, 26.1, 26.0, 25.6, 25.5, 24.4, 24.4, 21.2,
20.0, 16.0
[a] 24D=+6.4 (c 1.3, C6H).
IR (NaCl, thin film): 3583, 3457, 2976, 2937, 1714, 1462, 1445, 1379, 1261, 1137, 1088, 1053.
HRMS-ESI (m / z): [M + H]* calcd for C30H52BrO7, 603.2891; found, 603.2873.
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Ketone 142: To a 5 mL round-bottom flask equipped with a stir bar was added 15 mg of 4A MS
and heated under vacuum for 5 mi. The flask was cooled to 0 C and alcohol 139 (18.0 mg,
0.0298 mmol) was added in 2 mL of CH2 Cl2 . NMO (15 mg, 0.128 mmol) was added and then
TPAP (-2 mg, 0.006 mmol) was added and the reaction was allowed to slowly warm to room
temperature for 2 h. The crude material was loaded directly onto a Biotage column (10 g) to
furnish ketone 142 (14.7 mg, 0.0244 mmol, 82% yield).
1H NMR (400 MHz; C6D6): 6 3.57-3.54 (m, 1H), 3.52 (d, J = 11.2, 1H), 3.22 (dd, J = 10.4, 3.2,
1H), 2.91 (d, J = 2.3, 1H), 2.88 (d, J = 2.5, 1H), 2.79 (dd, J = 9.3, 3.4, 1H), 2.68 (td, J = 12.3, 3.7,
1H), 2.24-2.15 (m, 1H), 2.09-2.04 (m, 1H), 1.87-1.78 (m, 2H), 1.76-1.67 (m, 3H), 1.65-1.41 (m,
1OH), 1.35 (s, 3H), 1.26 (s, 3H), 1.24 (s, 3H), 1.16 (s, 3H), 1.09 (s, 3H), 1.03 (s, 3H), 1.02 (s,
3H), 0.99-0.95 (m, IH)
13C NMR (100 MHz; C6D6): 6 215.7, 83.7, 83.1, 78.4, 78.0, 77.5, 76.9, 76.2, 73.4, 72.4, 71.4,
59.7, 44.7, 41.9, 40.7, 35.6, 34.6, 31.0, 29.7, 28.0, 26.7, 26.1, 25.9, 25.7, 25.6, 24.1, 24.0, 21.2,
20.1, 16.0
[a]24 D= +28.7 (c 0.44, C6H6).
IR (NaCl, thin film): 3583, 3453, 2976, 2938, 1714, 1462, 1444, 1379, 1137, 1087, 895.
HRMS-ESI (m / z): [M - H]f calcd for C30H5oBrO 7, 601.2734; found, 601.2770.
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Hydrazone 141: To a 5 mL flask equipped with a stir bar was added ketone 140 (25.8 mg, 42.7
umol) and tosyl hydrazone (19.3 mg, 0.104 mmol) in 300 uL of MeOH. The reaction was heated
to 45 'C with a reflux condenser for 18 h. The reaction was cooled to room temperature and
concentrated in vacuo and loaded directly onto a silica gel column. The crude was purified by
column chromatography (50 to 100% EtOAc in hexanes) to furnish hydrazone 141 (20.7 mg,
26.8 umol, 63% yield) as a white solid.
IH NMR (600 MHz; C6D6): 6 8.02 (d, J = 8.2, 2H), 6.79 (d, J = 8.2, 2H), 3.54 (d, J = 11.1, 2H),
3.50 (t, J = 8.0, 2H), 3.28 (dd, J = 11.7, 2.2, 1H), 2.96 (s, 1H), 2.75 (dd, J = 9.4, 2.9, 1H), 2.54
(dd, J = 11.3, 2.1, 1H), 2.24-2.17 (m, 1H), 2.13-2.05 (m, 2H), 2.02-1.97 (m, 1H), 1.92 (s, 3H),
1.91-1.80 (in, 6H), 1.65-1.57 (m, 4H), 1.53-1.48 (m, 3H), 1.48-1.38 (in, 4H), 1.35 (s, 3H), 1.29
(s, 3H), 1.25 (s, 3H), 1.17 (s, 3H), 1.12 (s, 3H), 1.05 (s, 3H), 1.01 (s, 3H), 0.99 (s, 3H)
13C NMR (150 MHz; C6 D6 ): 6 164.1, 143.9, 136.8, 129.9, 128.8, 80.8, 80.2, 78.10, 77.95, 77.4,
76.33, 76.20, 73.3, 72.4, 71.1, 59.7, 44.7, 41.2, 40.8, 37.1, 34.7, 31.0, 29.5, 27.4, 26.10, 26.03,
25.56, 25.48, 24.36, 24.30, 23.3, 21.7, 20.0, 16.2
[a]24o = -15.4 (c 1.0, CHCl3)
IR (NaCl, thin film): 3535, 3220, 2977, 2937, 1644, 1598, 1463, 1381, 1342, 1262, 1169, 1088,
1031, 814, 756
HRMS-ESI (m / z): [M + H]+ caled for C37H6oBrSN 20 9, 771.3248; found, 771.3245.
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Hydrazone 143: To a 5 mL flask equipped with a stir bar was added ketone 142 (2.5 mg, 4.1
umol) and tosyl hydrazone (2.7 mg, 14.5 umol) in 830 uL of MeOH. The reaction was heated to
40 'C with a reflux condenser for 11 d. The reaction was cooled to room temperature and
concentrated in vacuo and loaded directly onto a silica gel column. The crude was purified with
(50->100% EtOAc in hexanes) to furnish hydrazone 143 (3.0 mg, 3.89 umol, 94% yield) as a
white solid.
'H NMR (500 MHz; C6D6): 6 8.00 (d, J = 8.2, 2H), 6.80 (d, J = 8.5, 2H), 3.51 (d, J = 10.9, 1H),
3.48 (d, J = 7.1, 1H), 3.25 (dd, J = 11.4, 2.2, 2H), 2.92 (bs, 1H), 2.78 (dd, J = 9.5, 3.3, 1H), 2.57-
2.54 (m, 1H), 2.24-2.15 (m, 1H), 2.07-2.02 (m, 1H), 1.92 (s, 3H), 1.90-1.76 (m, 4H), 1.77-1.66
(m, 3H), 1.57 (dd, J = 12.1, 3.9, 4H), 1.55-1.39 (m, 6H), 1.35 (s, 3H), 1.29 (s, 3H), 1.25 (s, 3H),
1.15 (s, 3H), 1.12 (s, 3H), 1.03 (s, 3H), 1.02 (s, 3H), 0.98 (s, 3H)
13C NMR (125 MHz; C6D6): 6 164.0, 143.9, 136.9, 129.9, 128.9, 80.8, 80.3, 78.11, 77.97, 77.5,
76.8, 76.3, 73.4, 72.4, 71.2, 59.6, 44.6, 41.1, 40.8, 34.6, 31.0, 29.5, 28.0, 27.4, 26.1, 25.87, 25.68,
25.62, 24.09, 23.95, 23.3, 21.6, 20.8, 20.1, 16.2
[a] 24D=+27.8 (c 1.4, CHCl3).
IR (NaCl, thin film): 3534, 3219, 2976, 2935, 1598, 1462, 1380, 1345, 1169, 1138, 1088, 1031,
895.
HRMS-ESI (m / z): [M + Na]* calcd for C37H59BrSN 2O9Na, 793.3068; found, 793.3060.
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143 6% yield diastereomer B (123)
Alkene 123: To a 500 uL sealed tube equipped with a stir bar was added sodium hydride (6.5
mg, 0.285 mmol, 95% in mineral oil) in the glove box and then transferred to the hood under
nitrogen. The reaction was purged while a solution of hydrazone 143 (16.6 mg, 21.5 umol) in
500 uL of THF was added by syringe. The reaction was sealed and heated to 90 0C for 100 min
then to 110 'C for 70 min. The reaction turned brown and was then cooled to room temperature.
H2 0 was added to quench remaining sodium hydride, followed by addition of 1 mL of saturated
NH 4Cl. The aqueous layer was extracted with Et2 0 (5x) and then dried over Na2SO 4 , filtered,
and concentrated in vacuo. Careful column chromatography (20 to 50% HPLC-grade EtOAc in
hexanes) provided a small amount of analytically clean 123 (0.8 mg, 1.3 umol, 6% yield) as
colorless oil.
'H NMR (600 MHz; C6D6): 6 5.46-5.42 (in, 4H), 5.21 (d, J = 11.7, 1H), 3.85 (dd, J = 11.4, 4.6,
1H), 3.53 (d, J = 11.0, 1H), 3.48 (dd, J = 11.5, 4.5, 1H), 3.26 (dd, J = 7.7, 4.3, 1H), 3.22 (dd, J =
10.9, 3.2, 1H), 2.89 (d, J = 0.5, 1H), 2.81 (dt, J = 6.4, 3.4, 1H), 2.58 (ddd, J = 15.4, 5.7, 1.7, 1H),
2.25-2.14 (m, 2H), 2.14-2.10 (m, 1H), 2.03 (t, J = 7.5, 1H), 2.01-1.95 (m, 1H), 1.84-1.67 (m,
5H), 1.65-1.46 (m, 6H), 1.34 (s, 3H), 1.29 (s, 3H), 1.25 (s, 6H), 1.22 (s, 3H), 1.15 (s, 3H), 1.10
(s, 3H), 1.02 (s, 3H), 0.96-0.90 (m, 1H)
"C NMR (125 MHz; C6D6): 6 137.0, 122.8, 80.7, 78.3, 77.9, 77.8, 77.0, 76.9, 75.8, 74.5, 73.4,
72.4, 59.7, 44.7, 42.6, 39.1, 34.4, 31.0, 29.9, 28.1, 27.9, 26.5, 26.1, 26.0, 25.6, 25.4, 24.1, 23.9,
18.5, 17.9
[a]24D =33.9 (c=0.04, CHC13)
IR (NaCl, thin film): 3432, 2922, 2851, 1727, 1463, 1378, 1261, 1088
HRMS-ESI (m / z): [M + H]* calcd for C3 0H520 6Br, 587.2942; found, 587.2930.
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Alkene 125: To a 500 uL sealed tube equipped with a stir bar was added sodium hydride (7.8
mg, 0.309 mmol, 95% in mineral oil) in the glove box and then transferred to the hood under
nitrogen. The reaction was purged while a solution of hydrazone 141 (20.7 mg, 26.8 umol) in
500 uL of THF was added by syringe. The reaction was sealed and heated to 100 'C for 3 h.
The reaction turned brown and was then cooled to room temperature. H20 was added to quench
remaining sodium hydride, followed by addition of 1 mL of saturated NH 4Cl. The aqueous layer
was extracted with Et2O (5x) and then dried over Na 2SO 4, filtered, and concentrated in vacuo.
Careful column chromatography (20->50% HPLC-grade EtOAc in hexanes) provided a small
amount of analytically clean 125 (0.9 mg, 1.5 umol, 6% yield) as colorless oil.
'H NMR (600 MHz; C6D6): 6 5.46 (dt, J = 11.8, 6.0, 1H), 5.21 (d, J = 11.5, 1H), 3.88 (dt, J
11.4, 6.4, lH), 3.53 (d, J = 11.2, lH), 3.48 (dd, J = 11.5, 4.3, lH), 3.28-3.24 (m, lH), 2.92 (bs,
1H), 2.75 (dd, J = 9.1, 2.7, 1H), 2.61 (ddd, J = 15.5, 5.6, 1.7, 1H), 2.25-2.17 (m, 2H), 2.11 (bs,
1H), 1.99-1.96 (m, H), 1.93-1.85 (m, 2H), 1.86-1.68 (m, 5H), 1.67-1.58 (m, 2H), 1.58-1.54 (m,
1H), 1.54-1.44 (m, 4H), 1.46 (td, J = 7.9, 3.9, 1H), 1.33 (s, 3H), 1.30 (s, 3H), 1.25 (s, 3H), 1.24
(s, 3H), 1.18 (s, 3H), 1.12 (s, 3H), 1.10 (s, 3H), 1.01 (s, 3H), 0.95-0.90 (m, lH)
13C NMR (125 MHz; C6D6): 6 137.1, 122.8, 78.3, 77.9, 77.8, 77.7, 76.9, 76.5, 75.8, 74.6, 73.2,
72.3, 59.8, 44.8, 42.6, 39.1, 34.6, 31.0, 29.9, 28.0, 28.0, 26.5, 26.2, 26.1, 25.6, 25.5, 24.4, 24.3,
18.5, 17.81
[a]2 4D = -17.9 (c=0.05, CHCl3)
IR (NaCl, thin film): 3428, 2926, 2852, 1726, 1464, 1377, 1262, 1139, 1084
HRMS-ESI (m / z): [M + Na]* calcd for C30H51BrO6Na, 609.2761; found, 609.2770.
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Alkene 146: To a 5 mL round-bottom flask equipped with a stir bar was added ketone 132 (59.1
mg, 93.6 umol) in 1.6 mL of THF. The reaction was cooled to -78 'C and then 200 uL of
methyl magnesium bromide (200 uL, 600 umol, 3.0 M solution in Et20) was added dropwise.
The reaction was stirred for 2 h at this temperature, during which time a precipitate had formed.
An additional 1.6 mL of THF was added followed by more methyl magnesium bromide (300 uL,
900 umol, 3.0 M solution in Et 20) and the reaction was allowed to warm to 0 'C for 4 h and then
room temperature overnight. The reaction was quenched with saturated NH 4Cl and then Et2O
was added. The reaction was extracted with Et20 (3x), then the organic layers were dried over
Na2SO 4, filtered, and concentrated in vacuo. The crude reaction mixture was purified by Biotage
(10 g column) to furnish 146 (10.2 mg, 19.4 umol, 21% yield) as a colorless oil.
'H NMR (500 MHz; C6D6 ): 6 5.27 (t, J = 7.1, 1H), 3.80 (dd, J = 11.4, 2.6, 1H), 3.59 (dd, J
11.2, 5.1, 1H), 3.59 (dd, J = 11.2, 5.1, 1H), 3.44 (dd, J = 8.4, 2.7, 1H), 3.22 (d, J = 6.9, 1H), 3.10
(dd, J = 11.2, 2.9, 1H), 2.33-2.08 (m, 3H), 1.96-1.71 (m, 6H), 1.69 (s, 3H), 1.65 (dt, J = 7.6, 4.1,
2H), 1.62 (s, 3H), 1.61-1.45 (m, 8H), 1.34 (s, 3H), 1.23 (s, 3H), 1.20 (s, 3H), 1.14 (s, 3H), 1.11
(s, 3H), 0.98 (s, 3H), 0.97-0.91 (m, 1H)
13C NMR (125 MHz; C6 D6): 6 131.4, 126.0, 79.6, 78.7, 78.1, 78.1, 78.0, 76.7, 76.5, 74.8, 73.7,
71.0, 40.9, 39.8, 36.8, 35.3, 30.6, 30.0, 29.4, 28.3, 26.3, 26.3, 25.8, 23.6, 23.0, 22.0, 22.0, 20.3,
18.1, 17.1
[a]24D= - 2 3 .4 (c=0.51, CHC 3)
IR (NaCl, thin film): 3416, 2971, 2934, 2872, 1462, 1451, 1377, 1136, 1071, 1034, 891.
HRMS-ESI (m / z): [M + Na]* calcd for C30H540 7Na, 549.3762; found, 549.3773.
1 Dess, D. B.; Martin, J. C. . Org. Chem. 1983, 48, 4155-4156.
2 Tashiro, T.; Mori, K. Tetrahedron: Asymmetry 2005, 16, 1801-1806.
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Chapter 2 'H NMR and 13C NMR Spectra
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